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ABSTRACT 
The aims of this study were a) to identify what constitutes visual disability 
resulting from glaucoma by means of a questionnaire developed for this purpose, 
b) to examine visual function in glaucoma using a wide range of psychophysical 
tests and c) to assess the relationship between objective visual function and 
patients' perception of their visual disability. 
The study was carried out in two phases. Firstly, a pilot questionnaire on 
visual disability in glaucoma was tested on 63 glaucoma patients. Results 
suggested that there were four main areas of difficulty in the daily life of 
glaucoma subjects: outdoor mobility, glare and lighting, household tasks and 
personal care. A significant correlation between self- reported disability and a 
measure of visual field loss was shown. The questionnaire was subsequently 
modified for the purpose of the main study and completed by 49 glaucoma 
subjects with various degrees of visual field loss and 20 normal controls. A range 
of psychophysical tests was carried out including automated perimetry, contrast 
sensitivity, critical flicker frequency, glare sensitivity, stereoacuity, colour 
perception and dark adaptation. 
Using factor analysis, the most frequently reported problems were grouped 
into the following five categories: central and near vision, peripheral vision, dark 
adaptation and glare, personal care and household tasks and outdoor mobility. 
These five factors accounted for 79% of the variability in the patients 
questionnaire responses. Fifteen questions related to the factors dark adaptation 
and glare, peripheral vision, outdoor mobility and central and near vision were 
found to be significantly correlated with the extent of visual field loss (p= 0.0001, 
r = -0.6) and could discriminate between patients and normals and also between 
groups with mild and severe visual field loss. Patients with moderate visual field 
xvii 
loss did not experience significantly greater disability than patients with mild 
visual field loss (p= 0.08), although there was a trend towards significant 
difference. A strong relationship was found between the severity of visual field 
loss and all psychophysical tests (p<0.01), except colour vision. When comparing 
normals and early glaucoma patients, the best results were obtained for dark 
adaptation (p= 0.013), glare disability (p= 0.023) and the contrast sensitivity test 
(p= 0.039). When comparing objective visual function and self -reported visual 
disability, a strong relationship was found between the questionnaire 
performance index and all psychophysical tests (p <0.05), with the exception of 
colour vision. Glare disability (p<0.0001), contrast sensitivity (p <0.0001) and 
dark adaptation (p= 0.007) appear to be the tests that give the best information 
about quality of life issues. 
Glare disability, dark adaptation and contrast sensitivity appear to be the 
tests which give the best information about the quality of life in glaucoma. In 
addition these tests best separated early glaucoma from normal controls and 
deserve more attention in future research work on glaucoma. 
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Glaucomatous optic disc. 
INTRODUCTION 
In a recent paper by Quigley it was pointed out that glaucoma is the second 
leading cause of visual loss in the world, and the estimated number of people 
suffering from this eye disease world -wide in the year 2000 will be approximately 
67 million (1). About 10% of those with this disease may suffer from bilateral 
blindness, while the remaining 90% have varying degrees of visual impairment 
and disability (1). Loss of vision in glaucoma is irreversible and those who have 
glaucoma have to live with their disease and cope with its consequences. 
Outcome assessment has become increasingly important as a critical 
measure for treatment and management of medical conditions, and Zimmerman (2) 
and Lee (3) have recently highlighted this issue in glaucoma. Reduced vision, as 
shown in many studies, is correlated with perceived difficulties in everyday tasks 
(4-9). Very little is known about the impact of glaucoma on the quality of life of 
those affected (2). For many patients the ability to remain independent is not 
crucially influenced, but little knowledge is available on the extent and character 
of visual disability experienced by patients in their daily life. More scientific 
information is needed on the evaluation of patient capabilities in performing 
visual tasks and on the correlation of perceived disabilities with psychophysical 
testing of visual function. 
The aims of this study were a) to identify what constitutes visual disability 
resulting from glaucoma by means of a questionnaire developed for this purpose, 
b) to examine those aspects of visual function that seem to be compromised in 
glaucoma, such as contrast sensitivity, flicker sensitivity, colour vision, dark 
adaptation, brightness acuity (glare disability), Esterman visual field and 
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stereoacuity, and c) to assess the relationship between objective visual function 
and patients' perception of their visual disability. 
To meet these overall aims, two studies were carried out. Firstly, a pilot 
study was undertaken. Its purpose was to identify the most commonly perceived 
disabilities in the daily life of glaucoma patients by means of a questionnaire, to 
rank the perceived problems with regard to frequency, to group related visual 
problems and assess their impact on daily life activities, and to examine the 
relationship between perceived visual difficulties and the severity of visual field 
loss, looking in particular at those variables which could discriminate between 
different grades of visual field loss. A pilot questionnaire was designed for this 
purpose. A further task was to specify a glaucoma- specific subgroup of questions 
and to test the validity and reliability of this newly created questionnaire 
sub scale. 
Secondly, in the main study, a range of psychophysical tests was carried 
out and visual disability was measured using the questionnaire developed in the 
pilot study. The relationship between various aspects of visual function 
(contrast/flicker sensitivity, colour vision, dark adaptation, glare disability, 
Esterman visual field and stereoacuity) and patients' perception of visual 
impairment was examined. 
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SECTION I 
BACKGROUND AND LITERATURE REVIEW 
Chapter 1 
VISUAL IMPAIRMENT 
1.1 Visual Impairment: terminology and definitions 
There is a marked lack of consistency in the use of terms to describe people with 
visual loss. For example Baranga in 1983 (10) listed nineteen different terms which 
have been used at different times by different professionals. The World Health 
Organisation (WHO) (11) published the International Classification of Impairments, 
Disabilities and Handicaps (ICIDH). The definitions it presents are widely used 
and accepted and it is these definitions that have been adopted for this study. In 
1976 Colenbrander (12) worked on the WHO committee and offers the following 
defmitions specific to visual problems. 
1.1.1 Visual Disorder 
A visual disorder is a disease, injury or congenital anomaly, that is, a deviation 
from the normal structure of the visual apparatus. 
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1.1.2 Visual Impairment 
A visual disorder is considered to give rise to a visual impairment if it results in an 
uncorrectable limitation of one or more of the basic visual functions, such as 
acuity, fields, colour discrimination and so on. 
1.13 Visual Disability 
The impairment may result in a disability, that is, a limitation in performing certain 
visual tasks. A visual impairment can result in multiple disabilities, such as 
difficulty in reading, poor mobility, difficulty with personal care etc. A disability 
does not occur if aids, such as spectacles, are able to compensate for the 
impairment. 
1.1.4 Visual Handicap 
A visual handicap is the disadvantage a person experiences as a result of the 
visual impairment or disability. A disability such as difficulty in reading, for 
example, could become a handicap if it results in a person's loss of independence 
or self -esteem. Handicaps are therefore often affected by the environment, the 
roles an individual is expected to fulfil and the person's own expectations. 
It is important to note that these four terms are not interchangeable but 
represent qualitatively different levels of functioning. Disorders and impairments 
are essentially medical in origin, disabilities and handicaps are essentially social. 
People with similar disorders and impairments might respond in very different 
5 
ways and therefore have different disabilities and handicaps, both in terms of type 
and severity. 
1.2 Blindness and Partial Sight: registration, history and 
benefits 
The legal definition of blindness in the UK has remained unchanged since it was 
introduced in 1921 in the Blind Persons' Act. It states that a person is blind when 
'he /she is so blind as to be unable to perform any work for which eyesight is 
essential.' 
This act was followed in 1948 by the National Assistance Act which made 
further provision for a second category know as partial sight. No statutory 
definition of partial sight was given, although the Ministry of Health 
subsequently advised that a person who is 'substantially and permanently 
handicapped by a congenital defect, illness or injury is eligible to be registered as 
partially sighted.' 
These definitions are essentially functional and there is no legal definition 
of the visual acuity that a person must have in order to be registered in either 
category. Form BD8 (or form BP1 in Scotland), which the ophthalmologist must 
complete in order to register a person, offers guidelines which are detailed in the 
Table 1. 
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TABLE 1. Guidelines provided to ophthalmologists on visual acuity (VA) and 
fields likely to warrant registration as blind or partially sighted: 
Category Guidelines * 
blind 
partially sighted 
corrected VA 3/60 or less, or, 
corrected VA 3/60 but less then 6/60 with a contracted 
field of vision, or, 
corrected VA 6/60 but visual field markedly restricted 
corrected VA of 3/60 to 6/60 with a full visual field, or, 
corrected VA of 6/24 with moderate constriction of the 
field, or, corrected VA of 6/18 or better with a gross visual 
field defect 
* all refer to acuity in the better eye 
The ophthalmologist is also advised that they should take into account that a 
person who has lost their vision recently might find it harder to adapt than a 
person who lost their sight some time ago and that an older person may not adapt 
as readily as a younger person. The registration form also states that, because not 
all cases will fall precisely within the guidelines, the ophthalmologist may use their 
own judgement with regard to registration. 
The register is kept by the Social Services Department of the local county 
council, with whom the responsibility lies for providing services. Central 
government is responsible for deciding the financial benefits of registration. At 
present, people registered as blind are entitled to extra income tax relief, some 
7 
financial advantages if they are entitled to other forms of financial support, a small 
reduction in the cost of a television licence, some car parking concessions and 
some postal concessions. 
People registered as partially sighted are not entitled to any financial 
benefits but they are entitled to the same help from social services as people on 
the blind register. The basis for these services lies in the National Assistance Act 
(1948) which has been reinforced by a series of Acts of Parliament, including the 
Chronically Sick and Disabled Persons' Act (1970), the Disabled Person's Act 
(1986) and the National Health Service (NHS) and Community Care Act (1990). 
In essence, these include provision for daily living skills, communication, mobility 
training and recreational and social activities. 
All local authorities are constrained by limited resources, meaning that 
there is a shortage of specialist workers and, for operational reasons, there is often 
an uneven spread of existing staff around the country. In some cases, people may 
wait many months between the original date of certification and the first visit by a 
social worker. Bruce et al (13) conducted a survey of around 900 visually impaired 
people on behalf of the Royal National Institute for the Blind (RNIB) in 1991. 
They found that 45% of newly registered people claimed not to have been visited 
by someone from the local Department of Social Services. They conclude that, 
although some of these people were probably visited, it made such an 
insignificant impact that they could not remember it. 
1.3 Prevalence of Blindness and Partial Sight 
Statistical projections suggest that the number of visually impaired people is on 
the increase (Lowman and Kirchner, 1979) (14). The incidence of visual 
impairment increases with age and people over the age of sixty -five will soon 
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represent a much larger proportion of the population. In the UK, the number of 
people over sixty -five has risen by 9% since 1979 (White, 1994) (15). People aged 
sixty or more make up 90% of all visually impaired people (Bruce et al, 1991) (13). 
One way of measuring prevalence rates of partial sight and blindness is to 
examine registration figures. There has been a steady increase in the number of 
people registered as blind and partially sighted over the last few decades and this 
is caused almost entirely by an increasing number of people aged seventy -five or 
more on the register ( Cullinan, 1987) (16). Of those people who are registered as 
blind or partially sighted, 69% are aged seventy five or more and 88% are aged 
sixty or more (Bruce et al, 1991)(13). This is partly because more older people are 
seeking registration and partly because of the increasing longevity of those 
already registered. 
The total numbers of people registered as blind or partially sighted in the 
UK (i.e. regardless of age), represents 0.47% of the population although the 
RNIB suggests that the true proportion of the UK population which is visually 
impaired is 1.8% (Bruce 1991)(13). Registration figures probably underestimate 
true prevalence rates partly because not all blind and partially sighted people will 
choose, or have the opportunity, to register (Cullinan, 1986) (17), partly because 
many people may be disabled by their vision, but do not meet the criteria for 
registration (Farrall, 1991) (18) and partly because of the wide differences among 
ophthalmologists' in the way they interpret the guidelines for registration. 
Cullinan (1986) (17) also argues that the criteria for blind registration serves older 
people badly, because it concerns work only and because it omits any idea of 
near vision. 
Gibson et al (1986) (19) surveyed a sample of 529 members of the general 
population recruited at a local general practice. They found that the blind register 
was relatively good at reflecting true prevalence rates, but the partially sighted 
register underestimated the prevalence of actual partial sight present in the 
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population. In all, those not registered represented 21% of the registrable visually 
impaired population. 
1.4 Principal Diseases Causing Blindness and Partial Sight 
Amongst Older People 
There is a difference between more and less economically well -off countries in 
relation to the causes of visual loss. In developing countries diseases affecting 
vision are related to malnutrition and infection. Fortunately, both are preventable 
and treatable. Visual impairment in technically developed countries is mostly 
related to age and can be caused by systemic disease or acute or chronic diseases 
of the eye. Less often, a birth defect is responsible for the impaired eyesight. 
The Office of Population Censuses and Surveys (OPCS) provides the 
following statistics for the principal disorders causing registration for blindness 
and partial sight amongst older adults in England and Wales (Evans, 1995) 
(20)(Table 2). 
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TABLE 2. Statistics for the principal diseases causing blindness and partial 
sight amongst older adults in England and Wales (Evans, 1995)(2o). 
Disorder Partially sighted Blind 
Age related macular degeneration 53% 55% 
Glaucoma 11% 13% 
Cataract 8% 4% 
Diabetic retinopathy 2% 2% 
Other 26% 27% 





Quigley has observed that glaucoma is the second leading cause of vision loss in 
the world and the estimated number of people suffering from this eye disease 
world -wide in the year 2000 will be 66.8 million (1). The commonest form of this 
disease in older age is chronic simple glaucoma with a prevalence of 10% at age 
80. It is the cause of one in eight registrations for blindness (21). 
Loss of sight in glaucoma is the result of progressive damage to the optic 
nerve, particularly in its upper and lower parts, with a resulting characteristic 
pattern of visual field loss, superiorly, inferiorly and nasally, with eventual tunnel 
vision. 
Chronic glaucoma is often asymptomatic. Central vision of a patient is 
usually not affected for many years and very few patients experience pain or 
notice any specific problems with their vision if the defect is not extensive. In a 
large proportion of cases the condition is discovered by an optician during a 
regular eye examination. 
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2.2 Definition of Glaucoma 
Glaucoma is a progressive form of optic neuropathy which is characterised by the 
following features (22): 
cupping of the optic nerve head 
visual field loss 
the intraocular pressure may be elevated or normal 
2.3 Pathogenesis of Glaucoma 
There are two possible reasons for developing glaucomatous field loss (22): 
Direct mechanical damage of the optic nerve due to increased intraocular 
pressure (IOP), which is a result of increased resistance to the outflow of 
aqueous humour through the trabecular meshwork. Studies of axoplasmic 
flow show vulnerability of the nerve axon bundles to elevated IOP as they 
pass through the lamina cibrosa in the optic nerve head (22). 
Damage due to changes in the vascular system when optic nerve fibre bundles 
are indirectly affected as a result of compromised optic nerve blood 
circulation. In as many as one in six subjects, IOP is never raised above normal 
(22). 
It seems likely that both mechanisms may play a part in most cases. The damage of 
the nerve bundles results in a characteristic pattern of visual field loss. Visual loss 
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is irreversible but early detection is essential as treatment may stop or slow down 
the rate of further damage. 
2.4 Optic Nerve Head 
Approximately 1.2 million nerve fibres (axons) distributed across the retina pass 
through the optic nerve head (optic disc) as they follow to enter the brain. As 
mentioned earlier, these nerve axon bundles are vulnerable to damage due to 
elevated intraocular pressure or vascular compromise. The damage can be 
detected by visualisation of the changes in the shape, appearance and colour of 
the optic disc and the surrounding blood vessels. The glaucomatous changes and 
enlargement of the optic cup are referred to as cupping of the optic disc head 
(Figure 1) (22). In eyes with early glaucoma subtle signs of retinal nerve fibre 
damage can be detected prior to the development of either pathological cupping 
or clinically detectable visual field defects. 
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FIGURE 1. Glaucomatous optic disc. 
2.5 Visual Field Loss 
Dropout of the nerve fibres results in a visual field defect. Fortunately in chronic 
glaucoma the damage often progresses slowly and patients may not experience 
any problems with their vision for years as good central vision is usually retained 
until the later stages of the disease. Over the years, patients also may have 
subconsciously developed techniques to counteract their visual impairment. 
Clinically the field loss is almost exclusively detected using perimetry (22). 
Visual field loss and visual function in glaucoma is of primary importance 
to this study and will be discussed in later chapters in greater detail. 
2.6 Intraocular Pressure (IOP) 
The normal IOP varies between 10 lion Hg and 21 mm Hg (mean 16 +- 2.5 mn 
Hg). Although there is no absolute cut -off point, 21 mm Hg is considered as the 
upper limit of normal and levels above this are viewed with suspicion (22). 
However, in some patients glaucomatous damage occurs with IOPs less than 21 
mm Hg whilst others remain unscathed, at least in the short term , with IOPs up to 
30 HMI Hg. Although the actual level of IOP is important in the development of 
glaucomatous damage, other factors also play a part (see Pathogenesis of 
glaucoma) (22). The level of IOP is inherited so that first- degree relatives of 
patients with primary open -angle glaucoma have higher pressures (22). 
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2.7 Classification of the Glaucomas 
The many types of glaucoma are classified as being of the open -angle or angle - 
closure type, according to the manner by which aqueous outflow is impaired. 
Further classification describes the disorder as primary or secondary depending 
on the presence or absence of associated factors contributing to the rise in IOP. In 
some cases the age of the patient at the onset of glaucoma is also taken into 
consideration and the condition is then described as congenital, infantile, 
juvenile or adult onset accordingly (22). 
2.8 Medical Treatment 
In spite of controversy on the subject of treatment, there is evidence that the 
lowering of ocular pressure slows down the progression of field loss. Reduction 
in IOP can be achieved medically or surgically (22). Most patients are started on 
medical therapy, using a ß- adrenergic blocker, which reduces aqueous inflow. 
Progressive optic nerve damage may result from poor compliance, spikes of raised 
IOP from intermittent dosing, or failure to reduce IOP far enough. There are side 
effects resulting from systemic absorption - visual disturbance, increased airways 
obstruction in asthmatic patients; decreased exercise tolerance; postural 
hypotension and falls; and occasional psychiatric disturbances, such as confusion, 
insomnia and depression (23 -26). 
Surgical therapy by laser trabeculoplasty produces only a 25% fall in IOP; 
and its effects are of limited duration. Another option is surgical trabeculectomy, 
often a very successful procedure, although this too has its problems (21). 
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2.9 Visual Disturbance Due to Treatment 
Pilocarpine and Dipivefrin were the most widely used alternatives to beta 
adrenoceptor blockade therapy in the medical management of open -angle 
glaucoma. In comparison to the majority of other antiglaucoma medication, these 
types of drugs have a specific influence on visual performance. 
It is generally agreed that the miosis produced by pilocarpine adversely 
affects the visual field as evaluated by both kinetic (27, 28) and automatic static 
perimetry (29, 30). This can have important implications where serial fields are used 
to monitor the effect of therapy in glaucoma. Transitory reductions in visual 
acuity caused by ciliary spasm following the instillation of pilocarpine have been 
well documented (23, 24), and may prevent the use of the drug in younger patients. 
Dipivefrin, a prodrug of epinephrine, has been reported to cause mydriasis 
(pupil enlargement) in several long -term clinical trials involving patients with 
glaucoma and /or ocular hypertension (31, 32), and may affect visual performance. 
2.10 Probability of Blindness from Glaucoma when Treated 
Preliminary results from retrospective studies indicate the cumulative probability 
of blindness in at least one eye from open -angle glaucoma is 27% and for both 
eyes is 8% at 20 year follow up (33). 
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Chapter 3 
VISUAL FUNCTION IN GLAUCOMA 
3.1 Measures of Visual Performance in Glaucoma 
Psychophysical tests of visual function have been used to detect glaucoma for 
many years. Conventional perimetry using a white stimulus on a white 
background has become the essential test in the diagnosis and management of 
glaucoma, but whether or not it can give a good prediction of functional 
problems encountered by glaucoma patients is not known. 
In recent years a new generation of psychophysical tests has emerged 
which aims to detect glaucoma at an earlier stage. The development of these tests 
has been stimulated by evidence that glaucomatous damage in the form of 
ganglion cell loss could be quite advanced before a defect could be detected by 
conventional perimetry (34, 35). It is also claimed that it is the large ganglion cells 
which project predominantly to the magnocellular layers of the lateral geniculate 
nucleus which are selectively damaged in early glaucoma (M -cells) (36). Motion 
detection, which is considered a predominantly magnocellular (M -cell) function 
has been described as abnormal in patients with early glaucoma by Fitzke et al 
(37), Bullimore et al (38), Trick et al (39) and others. Many studies have also 
described abnormalities in both spatial contrast sensitivity and temporal flicker 
contrast sensitivity in glaucoma (40 -45). A number of research investigations 
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indicated that glaucoma patients develop blue /yellow colour defects at an early 
stage (46 -48). This is believed to be because, at the photoreceptor level, the short 
wavelength sensitive cones (S cones) were damaged earlier than the medium (M) 
and long (L) wavelength cones. High -pass resolution perimetry has been 
advocated by other authors as an alternative form of perimetric testing for 
screening and for follow up of glaucomatous visual field loss (49 -52). The findings 
of Fellman et al suggest that glaucomatous optic nerve damage affects rod 
thresholds more than cone thresholds (53, 54). Studies by Drum, Quigley, 
Congdon and others on dark adaptation in glaucoma have also shown that 
scotopic sensitivity may be impaired (55 -57). Dengler -Harnes et al showed that 
forward light scatter exaggerates existing visual field loss in glaucoma patients 
and increases glare disability (58). Hoshino and Mizokami found a significant 
correlation between glare sensitivity measured with the Millar- Nadler glare tester 
and central visual field damage in patients with early to middle stage glaucoma 
(59). Research on stereoacuity in glaucoma indicates a profound disruption of 
stereoacuity which appears to result from disorder in the spatial sampling array at 
the ganglion -cell level (60, 61). Essock et al found that the mean stereoacuity of 
glaucoma patients and suspects was significantly worse than the level of 
stereoacuity expected for normals with the same Snellen acuity level (62). 
Although many authors have repeatedly investigated differences between 
glaucoma patients or patients with ocular hypertension and normal controls and 
showed decreased function, it is not known whether these deficits in visual 
function have any effect on the day to day function of patients. Since Ross, Bron 
and Clarke (41) published their study on visual disability in glaucoma no other 
study (to our knowledge) has addressed the subject in the same comprehensive 
manner. 
In this study, visual function of glaucoma patients and normal controls was 
assessed using a number of psychophysical visual function tests including 
20 
standard clinical measurements (Snellen visual acuity and white -on -white 
perimetry) and a battery of research tests of special aspects of visual function 
that have been shown to be affected in glaucoma. These include contrast 
sensitivity (CS), critical flicker frequency (CFO), dark adaptation (DA), glare 
disability (GD), colour vision and stereoacuity. 
3.2 Distance Visual Acuity 
The measure of distance visual acuity is one of the most universally accepted 
elements of an eye examination. It is quick and, when conducted under identical 
conditions, reliable. In glaucoma, it is used traditionally with other clinical 
indicators such as intraocular pressure levels, perimetric findings and side effects 
of treatment to monitor and evaluate different treatment methods. Out of these 
clinical outcome measures, visual acuity testing may be the most important 
indicator of day -to -day functioning. However, in glaucoma, distance vision 
usually remains unaffected until the late stages of the disease and many patients 
may not notice any difference in their central vision for years. With the exception 
of cases with severe glaucoma any change in visual acuity is usually a result of 
other age -related conditions such as cataract or macular degeneration. Snellen 
visual acuity is a measure of patient's visual performance in high contrast 
conditions on a white background and does not deal with medium to low 
contrast levels. In patients with glaucoma it also does not inform about what 
patients can achieve with their residual vision and therefore several authors have 
pointed out that it is not suitable as the single measure of visual performance in 
daily life situations (63). 
There are several different ways of assessing distance vision. In the UK, it 
is generally the Snellen chart that is used. The mathematical basis for these 
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charts is that each letter subtends a five minute of arc visual angle when viewed 
from six metres. Normal vision is defined by the figure 6/6, while the figure 6/18, 
for example, shows that the person must be at six metres in order to see what a 
'normally' sighted person could see from a distance of eighteen metres. If a person 
is unable to read any of the chart, even at a distance of one metre, there are four 
further categories to which their visual acuity may be assigned. These categories 
are known as 'count fingers' (if the person can only see how many fingers the 
tester holds up at a distance of approximately one metre in front of their eyes), 
'hand movements', 'perception of light' and finally 'no perception of light'. 
The main disadvantage, or shortcoming with the Snellen chart is that there 
is insufficient detail in the range of letter sizes (i.e. steps between the lines on the 
chart) commonly needed with visually impaired people and it has been argued 
that this can be particularly discouraging to people with low vision (64). Another 
point being criticised is the different number of letters in each line and the ability 
to learn the order of the letters by memory too quickly. 
Distance acuity is also sometimes measured by means of a Bailey -Lovie 
chart (65). This consists of fourteen rows of letters ranging in size from 6/60 tO 6/3 
equivalent. It is designed to be viewed at six metres, but can be converted to 
shorter viewing distances. Adjacent lines differ in size by a factor of 0.1 log unit. 
The spaces between lines and letters also follow the same logarithmic basis such 
that spaces between letters are equal to the width of the letters on that line and 
the spaces between the lines equal the height of the row of letters beneath that 
space. 
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3.3 Visual Field Examination 
In the last two decades a large body of evidence has been published on the 
subject of extensive nerve fibre damage that can exist before defects in the visual 
field are discovered by conventional perimetry (34). In addition, it was found that 
pathologic changes in the optic disc and retinal nerve fibre layer can predate field 
loss (34, 35). Attempts have been made to develop an accurate, rapid test to 
diagnose glaucoma at the earliest possible stage but none of this research work 
diminishes the clinical importance of visual field examination using traditional 
techniques. Perimetric examination remains one of the most important 
investigations in the clinical management of glaucoma (66). 
3.3.1 Perimetry 
The visual field is frequently described as being an island of vision surrounded by 
a sea of darkness. It is not a flat plane but a three- dimensional structure (66). 
The outer aspect of the visual field extends approximately 60 degrees 
nasally, 90 degrees temporally, 50 degrees superiorly and 70 degrees inferiorly. 
The visual acuity is sharpest at the very top of the island (fovea) and it declines 
progressively towards the periphery, the nasal slope being steeper than the 
temporal. The blind spot is located temporally between 10 and 20 degrees (66). 
Perimetry is a method of evaluating the visual field. Various methods of 
attempting this psychophysical function have been developed from simple 
confrontation testing with hands or targets of various sizes and colours to the 
sophisticated but still subjective science of automated and computer assisted 
perimetry. Because of the subjective nature of the patient's responses, efforts 
have been made to standardise the many aspects of testing in an endeavour to 
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eliminate as many variables as possible. Despite this, when interpreting a visual 
field defect, it is still very important to take into account the patient's reliability 
(66). 
Qualitative perimetry. This is a method of detecting a visual field defect 
and is the first screening phase of glaucoma suspects (22, 66). 
Quantitative perimetry (22, 66). After a visual field defect has been detected 
the next phase is quantitative perimetry by which its severity in terms of size, 
shape and depth is determined. Subsequent analysis of the visual field defects is 
used to determine either their stability or progression. 
Kinetic perimetry (22, 66). This involves the presentation of a moving 
stimulus of known luminance or intensity from a non - seeing area to a seeing area 
until the patient reports that the stimulus has been perceived. The stimulus is 
moved at a steady speed along a series of meridians and the point of perception is 
recorded on a chart. By joining these points along different meridians an isopter is 
plotted for that stimulus size and intensity. Using different stimulus intensities a 
contour map of the visual field with several different isopters can be plotted. 
Kinetic perimetry can be performed by simple confrontation, as well as using 
perimeters such as the tangent screen, Lister perimeter and the Goldmann 
perimeter. 
Static perimetry (22, 66). This is a more difficult concept to perceive but 
once grasped forms the basis of modern visual field assessment. Static perimetry 
involves the presentation of stimuli of varying luminance in the same position to 
obtain a vertical boundary of the visual field. Although it is slower than kinetic 
perimetry it is much better suited for quantitative testing. Static perimetry can be 
performed manually with the Goldmann perimeter or with various automated 
instruments such as Humphrey Visual Field Analyzer (Humphrey Instruments, 
Inc.; Allergan Humphrey, San Leandro, Ca, USA), Medmont (Medmont Pty. Ltd. 
Melbourne, Australia) or Octopus perimeters (Interzeng, Bern, Switzerland). 
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3.4 Contrast Sensitivity 
The clinical relevance of visual sensitivity to contrast was first appreciated in the 
last century (67). Though its use did not become widespread, a practical test of 
contrast sensitivity was first described in the second volume of the British Journal 
of Ophthalmology in 1918 (68). A true understanding of the role that contrast 
plays in the visual discrimination was not achieved until the pioneering studies of 
Campbell and his colleagues at Cambridge in the mid 1960s (69, 70). They found 
that we are able to see, at least at contrast threshold and for simple sinusoidal 
gratings, targets of `medium' resolution better than those of either low or high 
resolution - the contrast sensitivity function. This led to the notion that testing 
contrast sensitivity over a range of target resolutions (spatial frequencies) 
provides a more comprehensive evaluation of spatial function than does visual 
acuity. 
In glaucoma, instances of disruption in contrast sensitivity function have 
been demonstrated in patients or glaucoma suspects for static or temporally 
modulated stimuli in a number of studies (41 -45). Essock et al found that both 
binocular and monocular testing distinguished glaucoma from normals (62). 
Binocular testing better separated the groups and this test had the highest 
combined sensitivity and specificity (0.89 and 0.67, respectively) of the battery of 
psychophysical tests including flicker sensitivity, critical flicker frequency (CFF), 
contrast sensitivity as measured by Pelli- Robson chart (71), and stereoacuity. 
Thus, Essock et all concluded that binocular testing of contrast sensitivity 
appears more effective than monocular testing at detecting functional visual loss 
in glaucoma patients (62). Ross et al found that contrast sensitivity correlates 
well with subjective visual disability (41). 
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Contrast sensitivity has been very successfully measured by the simple to 
use Pelli- Robson chart (Clement Clarke, Columbus, OH, USA) (9, 72 -74). Some 
studies have shown that the Pelli- Robson chart is more reliable than sinewave 
grating charts (75). Although the test is limited to providing information only 
about low to medium spatial frequencies, this is the range that is most closely 
associated with visual performance in tasks like reading (76), face recognition (77) 
and mobility (78). In addition, work by Elliot done in 1989 -90 has demonstrated 
that contrast sensitivity at higher spatial frequencies is more highly correlated 
with visual acuity and thus would be less likely to provide new information (79). 
3.5 Flicker Sensitivity. Critical Flicker Frequency 
Quigley et al suggested that the retinal ganglion cells whose axons project to the 
magnocellular layers of the visual pathways suffer preferential loss in early 
glaucoma (36). These nerve fibres are concerned with the processing of 
information from stimuli of high temporal contrast , e.g. flicker and movement (80). 
Flicker perimetry has been shown to detect defects in the visual field of glaucoma 
sufferers earlier than traditional luminance based systems (81). Kosmin et al 
suggested that flicker perimetry using critical flicker frequency (CF) threshold 
has promise for earlier detection of glaucoma in the middle aged, particularly 
where there is associated ocular hypertension (82). The use of this technique for 
both diagnosis and monitoring in older age groups seems to be limited due to a 
decline in flicker sensitivity with age. 
Essock et al (62) found that binocular testing of flicker sensitivity at 
temporal rates 5 Hz and 34 Hz was more effective at separating glaucoma patients 
from normal controls than was monocular testing, while the critical flicker 
frequency (CFF), in contrast to the report by Kosmin et al (82), did not differ 
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between groups of early glaucoma and normals for either monocular or binocular 
testing. 
Kosmin et al (82) used a prototype flicker perimeter for their study while 
Essock et al (62) used an instrument developed by Tyler (40). A new research 
instrument, the Visual Stimulus Generator is available from Cambridge Research 
Systems Ltd. (Rochester, Kent, England, U.K.) and can be used to generate stimuli 
to assess various aspects of psychophysical visual function. 
3.6 Dark Adaptation 
The finding by Quigley and co- workers (34, 35) which showed that the 
conventionally measured visual field may appear normal in the presence of 
substantial histologically measured nerve fibre loss, has lead to studies of the 
effect of adapting field luminance on the earlier detection of glaucomatous field 
loss. The findings of Fellman et al suggest that glaucomatous optic nerve damage 
affects rod thresholds more than cone thresholds (53, 54). Studies by Drum, 
Glovinsky, Quigley, Congdon and others on dark adaptation in glaucoma also 
have shown that scotopic sensitivity may be impaired (55 -57, 83). Stirling and co- 
workers found abnormal scotopic thresholds in patients with ocular hypertension 
who represent a glaucoma high risk group (84). Glovinsky et al found abnormal 
scotopic sensitivity in glaucoma using a newly designed whole -field scotopic 
retinal sensitivity test with a diagnostic power 0.91 and specificity and sensitivity 
91% and 86 %, respectively when discriminating glaucomatous from normal eyes 
(56). Clear evidence that rod thresholds were extensively affected in glaucoma 
would not only provide a basis for early detection of optic nerve damage but 
would also explain the presence of disproportional visual disability in low 
luminance conditions as indicated from the study by Ross et al where the vision 
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at night appeared to be a separate issue of concern among patients with 
glaucoma (41). 
There are few instruments available which can be used to measure scotopic 
sensitivity. Glovinsky developed an instrument that was successfully used to 
study glaucoma patients (56), Stirling et al used a modified Friedman Mark 1 
campimeter with test stimuli generated by light - emitting diodes (84), while 
Congdon used a modified Humphrey perimeter, and the Goldman- Weekers Dark 
Adaptometer was used in studies on diabetic retinopathy 
3.7 Glare Disability 
(85, 86). 
Glare disability has traditionally been an issue in cataract patients and often a 
crucial parameter to rely on in making the decision about surgery. Bailey 
highlighted importance of this phenomenon in detecting early vision loss in the 
elderly (87). Recently a number of studies have shown the presence of this 
symptom in glaucoma patients. 
In 1989 Dengler -Harles et al showed that forward light scatter exaggerates 
existing visual field loss in glaucoma patients (58). In 1992 Ochsner and Zrenner 
included some glaucoma patients in their glare sensitivity study, and suggested 
that changes in the visual acuity - luminance function accompanied with high 
glare sensitivity are most often due to pathological changes in neuronal circuity 
of the retina (88). They remark that sensitivity to glare is an unspecific 
ophthalmologic symptom which can be caused by different anatomical 
structures, and although it can be related to optical and to cortical structures, it 
can also be due to defects in the neuronal mechanisms of the retina that control 
adaptation processes. Van den Berg found that visual acuity correlates rather 
weakly with the amount of scatter (89). Since the amount of scatter causes a 
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considerable loss of visual function, the results of his study showed that for glare 
sensitive patients the standard Snellen visual acuity test gives a rather limited 
impression of visual handicap. Hoshino and Mizokami found a significant 
correlation between glare sensitivity measured with the Millar- Nadler glare tester 
and central visual field damage in patients with early to middle stage glaucoma 
(59). Others studies have shown that objectively measured glare disability when 
taken together with other tests (especially contrast sensitivity and visual acuity) 
made a distinct contribution to the overall characterisation of visual function (9, 
73). More research into the problems associated with intraocular light scatter and 
brightness acuity and sensitivity in glaucoma is needed. 
From the small range of instruments that are available to measure glare 
disability the Brightness Acuity Tester (BAT) by Mentor O & O (Norwell, MA, 
USA) has several advantages. It is easy to use and reliable and although it has 
been around for years it is still claimed to be one of the best or the best tool 
available for glare disability measurements. In a study by Neumann et al of the 
different instruments including the Miller- Nadler glare tester, the InnoMed true 
vision analyzer, the VisTech VCT 8000 and the Eye -Con 5, the BAT showed the 
best performance characteristics (90). The BAT was successfully used in a number 
of studies by Harper and Halliday (91), Bailey (87), Steen et al (92), and Rubin et al 
(74). 
3.8 Colour Vision 
It is widely accepted that colour vision is diminished in glaucoma. A number of 
research studies have suggested a correlation between colour vision deficits 
(dyschromatopsia) and increased intraocular pressure in both glaucoma and 
ocular hypertension (93). Investigations by Pokorny, 1979 (4e, Adams, 1982 (47), 
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Drance 1981 (48), Sample 1993 (94), Graham and Drance 1996 (52) and others show 
that a blue -yellow deficit is the most common form of colour vision deficits found 
in patients with glaucoma. This suggests that, at the photoreceptor level, the short 
wavelength sensitive blue cones (S cones) or their neural connections are in some 
way more susceptible to damage from increased intraocular pressure than are the 
red and green cone systems (the medium, M; and long, L wavelength cones). 
These colour vision deficits can be found on central colour vision tests, 
such as the Farnsworth -Munsell 100 hue tests (48, 95, 96) or the Farnsworth D -15 
(47) and are often present before peripheral visual field loss is found by standard 
perimetry. 
Short -wavelength automated perimetry (SWAP) uses a blue stimulus on a 
bright yellow background and in recent years it has been reported by a number 
of authors as a superior technique for detecting early glaucomatous loss. 
Scotomas were deeper and larger than they were on conventional perimetry (97- 
99). 
A number of instruments are available to measure colour vision defects in 
glaucoma. When examining central vision, the Farnsworth -Munsell 100 -Hue test 
and the Farnsworth D -15 (saturated and desaturated) and the L'Anthony D -15 
(saturated and desaturated) were found to be useful in glaucoma. Bassi et al 
found that the desaturated version of the two shorter tests had a better 
correlation with ` the gold standard' 100 -Hue test and advocated its use for 
assessing the severity of colour vision loss in glaucoma at a fraction of the time it 
takes to perform the 100 -Hue test (100). 
Short- wavelength automated perimeters are sophisticated tools mainly 
used in research studies for peripheral evaluation of colour perception function. 
Although it's possible future use as a definitive tool for the diagnosis and 
management of glaucoma has been recently advocated by many authors, it's 
clinical usefulness is currently limited. Wild et al. found that the increased 
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interindividual normal variability, exacerbated by the lack of correction for ocular 
media absorption results in the reduction in sensitivity required to indicate 
abnormality and this problem is proportionately greater than it is for white -on- 
white perimetry (101). 
3.9 Stereoacuity 
Stereopsis is defined as a relative ordering of visual objects in depth, that is, in the 
third dimension. Relative localisation in the third dimension in depth parallels that 
of visual objects in the horizontal and vertical dimensions. The ability to perceive 
relative depth allows one to localise the peripherally seen wires just alluded to in 
front of or in back of the fixation wire, and it is this ability that permits one to 
perceive a cube as a solid. 
Wheatstone, by his invention of the stereoscope in 1838, was the first to 
recognise that stereopsis occurs when horizontally disparate retinal elements are 
simulated simultaneously (102). 
A solid object placed in the median plane of the head produces unequal 
images in the two eyes. Owing to the horizontal separation of the two eyes (the 
interpupillary distance), for geometric reasons each eye receives a slightly 
different image. The sensory fusion of the two unequal retinal images results in a 
three- dimensional percept. Stereopsis is a response to disparate stimulation of the 
retinal elements. It is the highest form of binocular cooperation that adds a new 
quality to vision. 
The responsiveness to disparate stimulations has its limits There is a 
minimal disparity beyond which no stereoscopic effect is produced. This limiting 
disparity characterises a person's stereoscopic acuity. 
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Stereoscopic acuity depends on many factors and is influenced greatly by 
the method used in determining it. There are no standardised clinical stereoscopic 
acuity tests, and no results of mass examinations. Generally speaking, a threshold 
of 15 to 30 sec of arc obtained in clinical tests may be regarded as excellent (102). 
A relationship exists between visual acuity and stereoscopic acuity. 
Stereoacuity cannot be greater than the vernier acuity of the stimulated retinal 
area. Stereoacuity decreases from the centre to the periphery of the retina. 
Matsubayashi demonstrated that reduction of visual acuity with neutral filters 
over one eye did not raise the threshold if the acuity was lowered to as low as 
0.3. A further decrease in vision to 0.2 greatly increased the threshold. With a 
decrease in acuity of the covered eye to 0.1, stereopsis was impossible. 
If poor stereoacuity is associated with poor Snellen acuity (103), this should 
influence the patient selection criteria when investigating stereoacuity. 
Research on stereoacuity in glaucoma indicates profound disruption of 
stereoacuity which appears to result from a disorder in the spatial sampling array 
at the ganglion -cell level, which was reported by Bassi and Galanis (60) and 
Liebergall et al (61). Essock et al found that the mean stereoacuity of glaucoma 
patients and suspects was significantly worse than the level of stereoacuity 
expected for normals with the same Snellen acuity level (62). 
In clinical practice, stereoacuity can be measured using simple stereoplates such 
as the Frisby stereotest by Clement Clarke International, Ltd, or instruments such 
as Keystone Orthoscope (Keystone view, Meadville, PA, USA). 
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Chapter 4 
VISUAL IMPAIRMENT AND DISABILITY 
IN GLAUCOMA 
4.1 Visual Impairment and Disability in Older Adults 
4.1.1 Disability in the Elderly 
Men and women aged 65 years and older are a rapidly growing segment of the 
population. In 1994 this age group represented 16% of the UK population and 
although this proportion is not expected to increase substantially by the year 
2009, as the total population is also increasing, the number of those aged 75 -84 
years is expected to rise by 7.2% and of those aged 85 and over by 32% (104). In 
the USA the proportion of the elderly in the population seems to be even higher, 
it is estimated that over 20% of the USA population will be 65 or over by the year 
2000 (9). This demographic shift has important implications for the provision of 
services as older people receive a higher proportion of health and social care than 
younger groups. In 1992 those aged 75 and over, comprising 6.8% of the UK 
population were responsible for 15.6% of hospital stays, as measured by finished 
consultant episodes (104). Although most elderly people continue to live 
independently, and many do so alone, one study found that over 40% of people 
over 65 years of age report difficulty in performing their usual activities (105). A 
33 
community -based study in Ohio showed that 20% of people 65 to 75 are 
functionally dependent (106). Measures of health status and disability in elderly 
people are required for planning services, monitoring progress, making 
comparisons with other areas etc. Previously, the emphasis has been on objective 
measures of disability and ill health. In recent years, there has been growing 
interest in patients' perception of their own health. The traditional measures of 
mortality and morbidity, although useful, have limitations: showing changes in 
mortality requires prolonged periods of observation or large number of events, or 
both, and changes in morbidity are more expensive to measure and do not take 
account of the functional impact on a patient's life. Since levels of functioning 
are important in predicting demand for services, changes in such health related 
quality of life outcomes might complement mortality and morbidity measures. 
A number of studies in various conditions was carried out to determine the 
level of disability in chronic diseases such as arthritis (107) (108), asthma (109), 
multiple sclerosis and Parkinson's disease (110) or acute conditions such as stroke 
(111). 
4.1.2 Visual Impairment and Visual Disability in the Elderly 
Along with many types of chronic disorders, vision impairment dramatically 
increases with advancing age. For example, The Baltimore Eye Survey reported 
unadjusted prevalence of visual impairment (acuity worse than 6/18 in better eye) 
of 0.6% for whites and 1% for blacks aged 40 to 49 years and 2.1% for whites 
and 6% for blacks aged 70 to 79 years (112). In the Salisbury Eye Evaluation 
Project the population of Americans aged between 65 and 84 years was 
examined. The overall prevalence of visual acuity impairment in blacks was found 
to be 5.6% versus 3.0% for whites, using the traditional United States definition 
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(worse than 20/40 to better than 20/200) and 3.3% for blacks versus 1.6% for 
whites, using the World Health Organisation definition (worse than 20/60 to 
20/400) (74). 
In addition to the known figures on visual impairment in the population 
based studies, Wormald et al suggest that there is a considerable amount of 
undetected ocular disease in the elderly community (113) and a little is known 
about vision -related quality of life in such groups. 
Several population and community based studies have found that 
deterioration of vision with advancing age interferes with the older adults' ability 
to carry out activities essential for personal independence. The Massachusetts 
Health Care Panel Study (5) showed that persons 65 years old with visual 
impairment by self -report were more likely to have difficulty with daily activities. 
In the Salisbury Eye Evaluation project a strong correlation was found between 
visual impairment and any of the Activities of Daily Living or The Instrumental 
Activities of Daily Living (114). Other studies in Britain (6), USA (9,115,116), Sweden 
(7), Finland (4) and Italy (117) concluded that visual impairment measured by 
objective means was associated with a lack of self -sufficiency in the home and 
difficulty in daily tasks. 
4.2 Age -Related Decline in Visual Acuity and Other 
Visual Functions. Implications for Visual Disability 
Because visual acuity is the most commonly used single measure of visual 
function, many population based studies evaluated only age -related visual acuity 
loss, for example The Framigham Eye Study (118), The Baltimore Eye Survey (112), 
or The Beaver Dam Eye Study (119). It has been well documented that other 
aspects of visual function, including contrast sensitivity, glare sensitivity, 
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stereopsis, visual search, visual processing speed and visual field may be 
compromised despite near -normal visual acuity (9, 74, 115, 120, 121). Acuity tests 
describe the eye's ability to resolve fine detail in high contrast. They are not 
adequate enough to predict one's ability to see large or small, low contrast 
patterns like faces or nearby objects and therefore do not correlate with some 
types of functional disability. 
Other visual tests, such as contrast sensitivity tests, provide important 
additional information about visual function that may decline with pathological 
changes before decline in visual acuity. Rubin and colleagues reported contrast 
sensitivity as one of the most important factors for predicting reading difficulties, 
face recognition, mobility and independent navigation (9, 76). Leat and 
Woodhouse also showed that contrast sensitivity is important for predicting 
reading speed (122). Owsley et al found that older observers require higher 
contrast to recognise "real world" targets such as traffic signs or faces 
presumably because of their reduced contrast sensitivity at middle to high spatial 
frequencies (77, 123). Marron and Bailey also indicated relationship between 
decreased contrast sensitivity and mobility (78). Wood and Troutbeck found 
significant correlations in relation to contrast sensitivity and driving performance 
(124). 
Similarly, some subjects with excellent visual acuity report functional 
disability resulting from disability glare. Disability glare refers to the reduced 
visibility of a target caused by a light source elsewhere in the visual field. Any 
disorder that increases intraocular light scatter or exaggerates its effect, such as 
lens opacity or visual field loss, may cause problems produced by disability glare 
(59, 125). The use of glare tests has received increasing attention because they 
have been shown to be more sensitive to anterior segment disorders than 
ordinary acuity tests. Holladay et al found that glare testing of cataract patients 
can predict the reduction in visual acuity out of doors when facing the sun or in 
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indirect overhead sunlight (126). For normal elderly observers, glare sensitivity as 
reported by Pulling et al, is correlated with simulated night -time driving 
performance (127). Wolbarsht suggest that disability glare may be associated with 
accident frequency or limitations in night -time driving (128). Steen and colleagues 
also suggest that glare can in older patients dramatically reduce chromatic 
discrimination ability by desaturating the component colours (92). 
Newitt and co- workers found that stereoacuity is significant risk factor for 
recurrent falls in the elderly (129). Owsley, Wood and Troutbeck separately 
showed that the size of the useful field of view is significant in predicting car - 
crash risk factors in older drivers (124, 130). 
4.3 Measures of Visual Impairment and Disability 
To help clarify the relation between visual impairment and disability most authors 
undertake studies with the following objectives: 
to determine whether self- reported disability is associated with visual 
impairment assessed by objective methods 
to determine whether various components of vision impairment besides 
reduced acuity contribute to the reduction in functional independence 
4.4 Visual Disability Studies in Ophthalmic Patients 
The presence of different ophthalmic conditions significantly increases with older 
age and causes further deterioration of vision that multiplies the effect of decline 
due to normal ageing process. 
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Ocular diseases can have a major impact on quality of life because visual 
impairment potentially affects so many different aspects of function. Therefore, it 
is critical to compare alternative approaches to managing ocular disease on the 
basis of their effects on visual disability and quality of life (63, 131 -140). 
A number of successful studies were carried out among patients with 
cataract as their visual disability is very difficult to assess on the sole basis of 
visual acuity (132, 141 -143). In addition, the amount of disability related to certain 
decrease in visual acuity may vary between patients in relation to their 
occupation and interests. 
Retinitis pigmentosa, diabetic retinopathy, age -related macular 
degeneration and corneal transplantation are other conditions where visual 
disability was examined using self -reports and was found to be a useful addition 
to clinical examination (137 -139). 
4.5 Visual Disability in Glaucoma 
Although preventing visual disability that decreases the quality of life should be 
the determining factor in the treatment of glaucoma (2), little is known about 
visual disability in people with visual field loss Zimmerman and colleagues have 
recently published an editorial paper (2) stressing the need to perform studies on 
this subject as a recent review of 102 randomised clinical trials published between 
1975 and 1991 showed that only three of the studies gave evidence on long term 
visual field changes and none addressed the question of visual disability (144). 
There is a need to determine what constitutes visual disability from glaucoma, 
what it is and how to measure it (2). While glaucoma has been shown to play a 
relatively small role in causing legal blindness (in U.K.: approx. 13% (20); in USA: 
monocular blindness 0.8 %, legal blindness 0 %, in Beaver Dam Eye Study (142)), 
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Johnson and Kellner, through their study with the California motor vehicle 
department, showed more traffic violations and accidents in people with visual 
field defects (120). It would be beneficial if this could be further investigated with 
particular attention to glaucomatous visual field defects. No studies were 
published to explain the relationship between clinically present visual field loss 
and performance in certain tasks Zimmerman and colleagues writes: "Is a nasal 
step in one eye visual disability? Bjerrums in both eyes? Field defect within 10 
degrees of fixation? Some guidelines speak to this, but these need to be refined 
specifically for glaucoma. This may not be simply a matter of defining a degree of 
visual field loss, as there are variations in an individuals ability to `compensate' 
for visual field loss. Visual disability is correlated with visual field loss and visual 
acuity but is not entirely explained or measurable using these parameters. Means 
must be developed to quantify visual disability from glaucoma, so we can better 
define our goal of glaucoma detection and treatment" (2), p.153. 
4.5.1 Measures of Visual Impairment and Disability in Glaucoma 
To help clarify the relation between visual impairment and disability, research 
work carried out in this area usually consists of the two steps: 
To determine whether self -reported disability is associated with visual 
impairment assessed by objective clinical methods, i.e. visual field loss. 
To determine whether various components of vision impairment besides 
reduced acuity contribute to the reduction in functional independence. In 
glaucoma, this could be contrast and flicker sensitivity, colour vision, dark 
adaptation, glare disability, motion threshold and stereopsis. All these aspects 
of visual function have been found to be compromised in glaucoma (see 
chapter `Visual Function in Glaucoma'). 
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4.5.2 Relationship Between Self -Reported Disability 
and Visual Field Loss in Glaucoma 
Among the first to notice the need to examine visual disability in glaucoma were 
Ross, Bron and Clarke who, in 1984, published a study examining the 
relationship between self -reported visual disability and objective measures of 
visual function (41). A battery of vision tests was used to quantify visual defect in 
a group of 50 patients with chronic simple glaucoma. The vision tests were near 
and distant visual acuity, visual fields, and contrast sensitivity to static and 
temporally modulated sinusoidal grating patterns. Visual disability was quantified 
by means of an 84 -item questionnaire about the effect of vision on everyday 
activities. The authors found that near visual acuity, visual field, and contrast 
sensitivity measures, were the best predictors of the difficulty experienced by 
patients in performing visually dependent daily activities. Factor analysis was 
used to process the questionnaire results. Four factors emerged related to 
navigation out of doors, near vision, navigation at night, vision when cooking as 
the four main areas of difficulty in the daily life of glaucoma subjects. 
Two years later, American ophthalmologists Mills and Drance published a 
study on the Esterman Disability Rating in glaucoma subjects (145). At that time 
The Esterman score had been adopted by the American Medical Association as a 
new standard for rating visual field impairment (146). Contrary to Ross, Bron and 
Clarke (41) who examined a group of respondents with visual field loss varying 
from mild to severe, Mills and Drance concentrated on those with severe loss 
only, as these patients present a challenge to any disability rating system. Many 
of these subjects had defective visual acuity and visual field, and the 
abnormalities are asymmetric and noncongruous. Other ocular or systemic disease 
may further complicate the glaucoma disability. In this study of forty two patients 
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with severe loss from glaucoma, the patients were assigned an Esterman visual 
function score according to their performance on a binocular visual field test 
using an automated perimeter. The visual function score was correlated with 
patients' responses to questions about perceived visual disability. Among the 
questions best correlated or predictive of visual field disability scores were 
activities demanding functional peripheral vision such us bumping into, or 
tripping over objects or trouble following a line of print/ finding next line (145). 
Some authors investigating vision in older adults devoted their attention to 
particular difficulties related to postural stability. Falls have come to be 
recognised as a major threat to the health and independence of elderly persons 
(129). In the USA the dangers of falling are particularly real for the estimated 22% 
of all elderly Americans who have visual impairment (147). Visual deficits are 
considered to be important determinants of the risk of falls in the elderly (129, 148). 
Glyn et. al. (147) who studied falls in elderly patients with glaucoma analysed the 
determinants of serious falls among 489 ambulatory elders aged 65 years and 
older who received a comprehensive examination at a glaucoma consultation 
service. For the previous year, at least one fall requiring medical attention or 
restricted activity was reported by 9.6% of participants. The greatest single risk 
factor for falls was the use of nonmiotic topical eye medication. Three other 
characteristics were also associated with the risk of falls: use of miotic eye 
medications, visual field impairment of 40% or greater and the use of sedatives, 
often prescribed to the elderly. The authors concluded that systemic effects of 
ocular medication may contribute more than the ocular effects such as pupil 
constriction to the factors that lead to falling. 
Recently a number of new studies on the subject of visual disability in 
glaucoma have emerged. Gutierrez et al (149) carried out a study on glaucoma 
patients as a part of research work to test the validity and specificity of the 
National Eye Institute Visual Functioning Questionnaire (NEI VFQ) in various eye 
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conditions. This questionnaire was developed by Mangione et al in relationship 
to visual acuity across five diseases as a new vision - specific measure of health - 
related quality of life (134, 150). 
In the study by Gutierrez et al, vision -targeted and generic health status 
were assessed across five glaucoma treatment categories and a normal reference 
group (149). The sample consisted of 147 patients and 44 normals. Apart from the 
NEI VFQ (150), the VF14 (132) questionnaire was also used as a vision - specific 
measure. The Medical Outcomes Study 36 -Item Short Form Questionnaire (151) 
was used for generic health- related quality of life assessment. Vision -targeted 
questionnaires were shown to be more sensitive than a generic health -related 
measure to differences between glaucoma and normal reference participants. 
Both the VF14 and 7 of 11 subscales of the NEI -VFQ questionnaire were 
significantly related to a measure of visual field loss (p >0.05, r = -0.28 -- 0.46), but 
for the VF14 questionnaire the relationship was not strong enough to 
significantly discriminate between normals and glaucomas (p<0.07). The authors 
concluded that self -reports of vision -targeted health- related quality of life are 
sensitive to visual field loss and may be useful in tandem with the clinical 
examination to fully understand outcomes of treatment for glaucoma (149). 
In a study by Parrish et al both the VF14 questionnaire and subscales 
`peripheral vision', `distance activities' and `vision - specific dependency' of the 
NEI -VFQ questionnaire did show moderate correlations with visual field loss (r =- 
0.55) (136). Just as in the Gutierrez study (135), the Medical Outcomes Study 36- 
Item Short Form Questionnaire did not demonstrate more than a weak correlation 
with visual impairment in the Parrish study (136). 
Lastly Sherwood et al examined glaucoma's impact on quality of life and 
its relation to clinical indicators (63). The Medical Outcomes Study short form 
questionnaire (MOS -20), Activities of Daily Vision Scale questionnaire (152), visual 
acuity and visual fields were measured. Significant differences were found in this 
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study between patients and normals in all but one subscale (pain) of the MOS -20. 
All subscales of the ADVS (day vision, night vision, far vision, near vision, glare 
impact, and overall vision) differed significantly between patients and control 
subjects. A moderate correlation was found between the ADVS subscales and 
visual field loss (r= -0.36- -0.59, overall r = -0.6, p<0.01). 
All of these studies showed (by means of a questionnaire) a steady decline 
in quality of life in glaucoma patients that was correlated with the amount of 
visual field loss. 
4.5.3 Relationship Between Self -Reported Disability and New 
Psychophysical Measures of Visual Function in Glaucoma 
Although studies by Mills and Drance (145), Gutierrez et al (135), Parrish et al (136) 
and Sherwood et al (63) examined visual disability in relation to visual field loss 
and visual acuity, the only reported study that performed a variety of other 
psychophysical tests was the one on the research work by Ross, Bron and Clarke 
in 1984 (41). They carried out a large number of contrast and flicker sensitivity 
tests to find out whether these would have better correlation with visual 
disability (using a questionnaire) than traditional clinical measures. 
The results of the study revealed that both contrast and flicker sensitivity 
were affected in glaucoma and that the results from a specific group of vision 
tests rather than of a single test offer the best predictive relationship between 
visual defects and visual disability. The best tests in predicting visual disability, 
particularly in relation to outdoor mobility seemed to be contrast sensitivity at 
2.88 c /deg, visual field and near acuity. 
Although glaucoma patients are often symptomless until late on in the 
course of the disease, this study showed, by means of the questionnaire, a 
43 
deterioration in the quality of life in patients which manifested itself in an anxiety 
element, which appeared to precede the stage where real difficulties were 
experienced. These early difficulties were found particularly in navigation out of 
doors where such factors as variation in the weather and the amount of traffic can 
affect the level of confidence of the patient. 
4.6 Influence of General Health, Demographic 
and Psychological Factors 
4.6.1 General Health and Demographic Factors 
Age and general health. Older people are more likely to have physical disabilities 
than younger people. Martin et al. reported on a national survey conducted by 
the Office of Population Censuses and Surveys (OPCS) (153), which found that 
the overall rate of disability in the population increased with age. Almost 70% 
disabled adults were aged sixty or more and nearly 70% were aged 70 or more. 
Older people were also more likely to have severe disabilities. The number of 
severely disabled in the population rose steeply at age of seventy and trend was 
even steeper at age eighty. 
In 1987, Cullinan reported on a survey of 15,000 households of older 
population in the UK (16). He found that, of those who said they had at least some 
difficulty with their vision, 45% did not identify poor sight as being their major 
problem. More recently, Bruce et al. (1991) found that 67% of visually impaired 
adults (total N =600) had another permanent illness or disability (excluding 
hearing) and 45% said that this illness or disability limited their daily activities (13). 
The most frequently mentioned illnesses were arthritis (25 %), heart condition 
(18 %), legs /mobility (14%) and diabetes (9 %). It should be remembered that the 
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actual rates of disability may be higher than those reported since older people 
may discount some disabilities that they assume to be a normal consequence of 
the ageing process. 
Mobility in Glaucoma. A number of authors suggested that glaucoma may 
occur not only as a result of physical damage to retinal nerve fibre layers caused 
by increased levels of intraocular pressure but also as a secondary condition to 
pre -existing vascular problems such as high or very low blood pressure, angina 
and other forms of heart condition, etc. 
This is very important to note when studying visual disability in glaucoma 
patients because a large proportion of them may suffer from breathlessness and 
therefore some mobility restrictions. Other conditions such as arthritis may further 
complicate the matter. When creating a visual disability questionnaire, it is 
advisable to include a section on general health. This section can deal with 
disability related to other than visual conditions which will allow for adjustment 
for general health in statistical analysis models. 
Sex. It is well known that men and women have different life and health 
expectancy, women being at an advantage (154). This may explain the difference 
in severity of glaucoma between men and women as reported by Orgul et al (155). 
Financial resources. It has also been hypothesised that the financial 
resources of the individual might be important in successful adjustment to a visual 
impairment (156). For example, difficulties encountered with usual daily activities 
would be decreased for those people who could afford to pay for services such as 
chiropody, cleaning, cooking, gardening, hairdressing and so on. However, this 
applies more to other ophthalmic conditions such as age -related macular 
degeneration or diabetic retinopathy because glaucoma in general is rarely a 
cause of severe vision impairment (0.8% according to the results of the Beaver 
Dam Eye Study, (142)). When considering importance of financial resources in 
relation to availability of medical treatment, countries with national health -care 
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service systems, such as U.K., are in advantage when comparing to countries 
with mainly private health-care systems, because availability of health-care is 
independent of financial resources of an individual. 
Level of social support and living circumstances. It has also been 
hypothesised that social support and living circumstances are important in 
adjustment to vision loss (156). It might also reflect different levels of life 
satisfaction. Neugarte et al. found that older people who were single (i.e. 
unmarried, divorced and widowed) had lower levels of life satisfaction than 
people who were married (157). There is evidence that the provision of social 
support by family and friends may be associated among older visually impaired 
people with decreased depression (158), improved mobility (159), and more 
successful use of low vision aids (160). However, all these studies were carried out 
on a sample of low vision patients. Glaucoma is not associated with clinically 
meaningful decrease in visual acuity (142). The proportion of glaucoma subjects 
amongst low vision patients is relatively small and a higher standard of quality of 
life is preserved (142, 161). 
4.6.2 Psychological Aspects of Coping with Disability 
In 1976 Faye wrote that visual acuity measures 'tend to distract from how well a 
patient manages' (162). The patient's personality, his unique attitude to life and the 
way he deals with the circumstances he has to face affect his final behaviour. 
One of the relevant issues is the individual's subjective rating of their own 
eye condition and the difficulties that it causes. Steinberg et al (1994) 
investigated this possibility among 766 people with cataract who decided to 
undergo cataract surgery (132). The patients were asked to rate fourteen activities 
(such as driving, cooking, reading a newspapers etc.) according to how difficult 
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they were. The five point scale was used, ranging from 'not at all difficult' to 
'unable to do'. They were also asked to make two general ratings: (a) how 
satisfied they were with their vision and (b) how much trouble they were having 
with their vision. The authors found that the subjective rating of difficulty with 
activities correlated more strongly with self -rated satisfaction with vision and 
perceived trouble caused by vision than did the clinic based measures of visual 
acuity. The correlation between visual acuity and satisfaction with vision was 
zero. Some people with particular visual acuity were satisfied with their vision 
while others with the same visual acuity were dissatisfied, regardless of whether 
that visual acuity was high or low. 
Another factor is patients' knowledge of their own eye condition. This 
may indicate how realistic are their expectations and understanding of their own 
abilities. In a national survey for the Royal National Institute for the Blind (RNIB) 
in 1991, Bruce et al. found that people were often vague about the cause of their 
visual problem and 20% of people aged 75 or more mentioned nothing more 
specific than "old age" (13). Davis et al. (1995) found that one third of people 
with ARM) in their study (total N =30) wrongly described or had no idea of the 
cause (163). 
Mental Health, Psychological and Social Factors 
Factors associated with vision may not be the only variables that influence one' s 
ability to carry out different visual tasks: psychological and social factors are also 
likely to play a role. Riffenburgh (1967) noted that visual disability would be 
affected by acuity, speed of onset of the vision loss and the age at which it 
occurred. "These things, however, will not determine the response, but will be 
influences on the reaction of the basic personality of the individual to his visual 
47 
loss" ((164), p.127). Some authors have since speculated about the specific nature 
of these personality factors and these are discussed below. 
Dodds suggested that self- efficacy is central to adjustment of visual loss 
and later visual disability (165, 166). Onset of visual loss deprives the individual of 
their usual abilities. If a person has a high sense of self -efficacy, then they will try 
new things and expect to succeed. If they have a low sense of self- efficacy, then 
they will avoid new things because they expect to fail. The perception of self - 
efficacy can therefore have an important motivating role as it can encourage or 
inhibit ability to strive for further successes. Dodds also describes the concept of 
locus of control stating that people with an internal locus of control are likely to 
be motivated whereas people with an external locus of control are more likely to 
be passive (166). Lack of efficacy and control may cause a person to perceive 
themselves incompetent, induce feelings of anxiety and depression and reduce 
self -esteem. 
A further source of negative self- perceptions occurs when the person is 
labelled "blind" or "partially sighted ". The degree to which the individual 
accepts their impairment was found significant as a result of previously held 
attitudes towards blind people (165, 166). Depression may be another factor that 
will hinder one's ability to make most of the residual vision (166). 
Contrary to many other ophthalmic pathologies chronic glaucoma is 
characterised by slow progression, often over many years. Even in progressing 
glaucoma, central vision may remain intact until the late stage of the disease. As a 
result visual disability is experienced to a comparably lesser extent than in many 
other ocular diseases and may often be restricted to particular situations, such as 
rapid changes in general lighting conditions, or activities, such as driving. Even 
then only a minority of glaucoma patients are banned from driving on the basis of 
their visual loss. The majority of patients can, overall, enjoy a high quality of life 
style for many years. Recent research reports on patients in glaucoma show that 
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these subjects do not tend to suffer from clinical depression in comparison to 
patients with retinal pathologies due to the comparably higher quality of life 
standard that can be preserved in glaucoma (161). 
4.7 Conclusion 
It is clear that more research work is necessary if we are to understand visual 
disability in glaucoma. The few listed studies indicate a number of important 
issues that need further explanation or scientific evidence support: 
Visual disability may provide useful additional information to the clinical 
examination results to fully understand outcomes of treatment for glaucoma (2, 
135, 149). 
Using visual acuity as the primary criterion of disability may lead to 
underestimation of visual disability if other objective measures such a contrast 
sensitivity or subjective perception of a patient are not taken into account (41). 
Self -reports on visual disability are sensitive to visual field loss (41, 135, 145). 
Self -reported visual disability seems to correlate well with near visual acuity, 
contrast sensitivity, visual fields and the Esterman Disability Score (41, 145). 
Visual field loss may be particularly related to difficulties in navigation out of 
doors, near vision, navigation at night, vision when cooking, activities 
demanding functional peripheral vision and falls (bumping into and tripping 
over objects) (41, 145, 147). 
Systemic effects of glaucoma medication may contribute more than the visual 
impairment itself to mobility difficulties (147). 
More evidence is needed to clarify the relationship between the visual field loss 
and multidimensional visual function tests such as contrast sensitivity, glare 
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disability, dark adaptation, stereoacuity and flicker /motion sensitivity and self - 
reported difficulties in daily activities. 
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Chapter 5 
THE MEASUREMENT OF PATIENT OUTCOMES 
IN MEDICINE 
5.1 The Measurement of Patients Outcomes 
5.1.1 What Should Be Measured? 
Until recently, the focus of health care assessment has been upon illness and its 
eradication, most often expressed in terms of a range of measurements which may 
be referred as `clinical' or `biomedical', with mortality, morbidity and service 
utilisation being the primary measures. This traditional perspective is increasingly 
being challenged by the view that since health cannot be adequately described 
solely in terms of a disease -based or biomedical model, it is insufficient that expert 
beliefs about ideal or optimal scores on technical measures should be the only 
elements which inform judgements of the quality of health care (167). 
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5.1.2 Why Measure Outcomes? 
The objective of quality assurance is to safeguard and improve the quality of 
health care and its outcome in terms of health, functional ability, well being and 
consumer satisfaction (168), while at the same time achieving this target in a 
pragmatic cost -effective manner. Various schemes have been proposed to 
evaluate care, the most well known being that of Donabedian who described 
three approaches to the assessment of the quality of medical care: structure, 
process and outcome (169). 
Structure refers to whether the necessary skills, infrastructure and 
resources are present to allow the health programme to operate. Thus a screening 
programme for glaucoma would require, among other things, sufficient resources 
to be able to carry out tonometry, perimetry and ophthalmic examination, clinical 
skills to interpret the findings, and a comprehensive register of subjects with 
increased risk of glaucoma within the target age group. Examination of the 
process would assess how these resources and skills were being used in practice, 
the percentage of subjects who had been invited and had attended for screening, 
and the reporting recall rate might be examined. Finally, assessment of outcome 
would consider the impact of the programme upon patient's or population's 
current or future health. 
The evaluation of outcomes is more difficult than that of structure and 
process. The validity of outcome measurement is dependent upon the salience of 
the chosen measures to the actual goals of health care, including patients' 
perception of those goals (167). 
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5.1.3 Definition of Outcome and Theoretical Framework 
Donabedian defined outcome as: 'a change in a patient's current and future 
health status that can be attributed to antecedent health care" (169). He includes 
within his definition social and psychological aspects, attitudes, knowledge and 
behavioural change. 
Outcome measurement can take place at the levels of the individual, 
groups with common disorders, hospital or the whole population and also may be 
carried out for a variety of different reasons such as evaluation of effectiveness 
and efficiency of health care, health care needs assessment, audit and resource 
allocation. 
Most health care resources in technologically advanced societies are 
devoted to the treatment of and research into the chronic diseases, where the 
major therapeutic goals are the maintenance and improvement of functional 
capacity, palliation, limitation and control rather than cure. Interventions, 
therefore, are more validly judged in terms of their impact upon patients lives or 
quality of life, both positive and negative. However, rapid advances in medical 
techniques and technologies have been accompanied by increasing ambiguity 
about the appropriate standards and goals of their use (167). For example, 
Wennberg reports that surgeons frequently disagree about the objectives of their 
treatments and, he says, often know relatively little about the range of probable 
outcomes, or about patients preferences (170). Naji and Sheldon argue that in the 
absence of robust studies of outcome, and concomitant theoretical and pragmatic 
development, debates about appropriate levels of service for populations and 
treatment choices will continue to be less then fully informed (167). 
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5.1.4 Problems of Measuring Patient Outcomes 
According to Naji and Sheldon many problems arise when terms such as health 
status, quality of life, and patient outcomes are widely used without sufficient 
definition of their meaning (167). Two different authors may use the same term in 
spite of addressing widely divergent topics. Whereas some outcome measures like 
for example, visual acuity, are relatively easily defined, others such as `quality of 
life' are very poorly defined and so difficult to assess. 
At the same time, many authors indicate that there may be some 
discrepancy between patients' and doctors' satisfaction with the outcomes of 
health care (171, 172). It has been thought that patients cannot judge the quality of 
care, and that it is too difficult to measure patient satisfaction. Nevertheless, 
several authors regard patient satisfaction as an outcome measure which provides 
an important dimension in the assessment of quality of care (173, 174). The 
interpersonal aspects, technical quality, accessibility, continuity, acceptability and 
perceived effectiveness of care are all integral parts of patients satisfaction. 
5.2 Questionnaire: An Outcome Measure Instrument 
Administration of a questionnaire is fast and relatively effortless way to obtain a 
large amount of information in a short period of time and therefore quickly 
became one of the most frequently used methods to evaluate an outcome from 
the patient's point of view whether it is perception of their disease, its influence 
on their life or a measure of satisfaction with the care provided. However, to be 
valued as a reliable source of information it has to meet certain criteria. It is 
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always advisable to use previously developed `gold standard' instruments whose 
validity, reliability and other characteristics were successfully published. 
5.2.1 Question Design 
Although the design process of every new questionnaire is unique, it is advisable 
to accept some general recommendations. Oppenheim (175) suggests that the 
following issues are relevant when designing a new instrument: 
Question generation sources. It is helpful to use previously developed 
instruments with similar research targets and facet theory on question 
accumulation (176). Personal experience of an expert in the investigated 
research area is invaluable. 
Question wording. It is necessary to formulate questions bearing in mind the 
demand for clarity and non -ambiguity. It is recommended not to use two 
negatives in one sentence or create double questions Emotive language and 
unusual terms should be avoided. 
Barriers to the truth. There are certain limitations in asking a question. 
Restrictions can be unreasonable demands on memory (questions on 
insignificant details in the past), impolite or irrational questions. Awareness, 
inadmissibility and self -incrimination could be further barriers to the truth to 
bear in mind. 
Context effects. It is important to bear in mind the context effect within the 
question and within the questionnaire. For example, questions on a water 
feature in children's playground can be understood as a source of drinking 
water, or alternatively, as a pond with water lilies depending whether question 
is addressing aesthetic or practical features of the playground. If the question 
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has a double meaning and a researcher is interested in one only, it is necessary 
to specify the context. 
Discriminatory questions. It is wise to avoid any possible offence using 
correct wording and restrict to factual questions rather than questions that may 
imply any form of discrimination for any involved group. 
Response types. Questions can be open ended or closed. Open ended 
questions are recommended for pilot studies as they are more informative. 
Closed questions are recommended for further examination following the pilot 
study as they are easier to analyse across large samples. 
Levels of measurement and anticipation of data analysis. It is often useful to 
have some idea about the necessary statistical analysis. Much information may 
be lost if the questionnaire is designed in a style that is not possible to 
transform into a data file suitable for analysis. 
Number of response categories. Most authors agree on the necessity of 
midpoint and three, five or seven answer point scale according to the purpose 
of the questionnaire. 
Unipolar scales. The answer scale is recommended to be unipolar, i.e. answers 
to a question on satisfaction should be between `not satisfied'...`satisfied' 
rather than `dissatisfied ... satisfied' as verbal opposite of the original measure 
often does not represent psychological opposite in meaning. 
Acquiescence set. Some subjects tend to answer positively only, therefore it is 
advisable to change the polarity of questions, to alter positive and negative 
questions if possible. 
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5.2.2 Questionnaire Scale Design 
Scale design is the design of a set of questions which (when summed) give a 
measure of an attribute, attitude etc. Two characteristics of scale are necessary to 
bear in mind: 
validity 
reliability 
The subject of validity, reliability and other performance characteristics of a 
questionnaire will be discussed in detail in a further chapter. 
5.2.3 Questionnaire Design 
Covering letter. It is advisable to present any questionnaire with a covering 
letter assuring the subject of anonymity, confidentiality, data protection, the 
purpose of the questionnaire and aims and objectives of the research work. 
However the last point should be very brief without giving any real clue to 
the purpose of investigation as this may influence the attitude in which the 
subject answers the questions. 
Visual presentation. This is particularly important when the instrument is 
presented to the elderly or a visually impaired population. It is advisable to use 
easy to read density, font size and style. The layout of questions should be 
clear and easy to follow. 
Placement of responses categories. This will avoid answers in an open ended 
manner and lead to consistency for data input as well as for participant. 
Length. The shorter the questionnaire, the more response is expected and the 
more precise answers. 
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Sequencing of questions. The recommended order is: status, doing, knowing, 
attitudes and intentions. Sensitive questions are advised to be placed at the 
end and a few easy questions at the beginning. 
5.2.4 Summary 
The above points are guidelines only: there is no recipe book approach to 
questionnaire design. The main purpose of a questionnaire is to get useful 
information from a participant. It should therefore be unambiguous, easy to 
understand, not irritating or difficult to complete, it should convey credibility and 
usefulness. Piloting of a questionnaire is advisable if there is not a `gold standard' 
instrument available to be used instead of a new one. 
5.3 Questionnaire Review Criteria 
It was mentioned earlier that a questionnaire can be accepted as a valuable source 
of information only if it meets certain criteria related to its performance as a 
measure. These are validity, reliability, responsiveness, interpretability and burden. 
5.3.1 Validity 
Validity indicates the extent to which a test or technique measures what it is 
supposed to measure, and thus indicates the range of appropriate inferences that 
can be drawn (167). It is often expressed using correlation coefficients. Although 
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there are different ways of classifying validity, most authors identify the following 
main types (167, 177) 
Face validity considers the extent to which the test and its components 
appear to be relevant to its purpose. This is normally based upon subjective 
judgements derived from expert `review'. Although it may seem to be a rather 
superficial concept, the importance of face validity should not be underestimated. 
Content validity considers the extent to which components of the 
instrument represent a reasonable sample of the content domain to be measured. 
In the case of measuring visual disability as a result of peripheral visual field loss, 
the question would be whether the entire domain of issues relating to peripheral 
vision loss was included in the scale. How well balanced are questions relating to 
indoor and outdoor mobility, driving and other relevant issues? Wide sampling of 
items helps to achieve acceptable content validity. Methods commonly used to 
obtain evidence about content -related validity include use of lay and expert 
panel judgements of the clarity, comprehensives and redundancy of items and 
scales of a questionnaire (177). 
Criterion validity considers the extent to which scores on the measure 
correlate with some other instrument or assessment which has already been 
shown to be a valid and accurate measure of the same or closely related 
construct. A strong relationship between the two tests is evidence of validity 
provided that the criterion, i.e. the `gold standard' test was set up independently 
and that both the new test and the criterion are reliable. Correlation rarely exceed 
0.5 (175, 178). In the area of health status assessment, criterion validity often cannot 
be tested because of the absence of widely accepted criterion measures. 
Construct validity is used when there may not be appropriate criterion 
measures against which to test a new measure. It shows how well the test meets 
expectations of theoretical assumptions about the underlying attribute. Using the 
previous example in subjects with loss of peripheral vision it would be expected 
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that those with advanced loss would have more difficulties walking on steps or 
stairs and possibly a higher occurrence of falls. 
5.3.2 Reliability 
Reliability covers two aspects of test design: the homogeneity of scale items and 
the reproducibility of the instrument (167, 177). The principal definition of reliability 
is the degree to which an instrument is free from random error. 
Internal consistency. Coefficient (Cronbach' s alpha) provides an estimate 
of reliability based on all possible correlations between each question with the set 
of questions. 
Test - retest reproducibility is the degree to which an instrument yields 
stable scores over time among respondents who are assumed not to have 
changed on the domains being assessed. The influence of test administration on 
the second administration may overestimate reliability. Conversely, variations in 
health, learning, reaction, or regression to the mean may yield test -retest data 
underestimating reliability. Despite these cautions, information on test -retest 
reproducibility data is important for the evaluation of the questionnaire. 
Interviewer reproducibility is examined if the questionnaire is 
administered by an interviewer. The correlations between two or more 
interviewers are examined. 
The length of a test can affect the reliability, it is usually increased with 
additional items (provided that they are appropriate to the test). The size of the 
sample on which reliability figures are calculated should be above 30. 
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5.3.3 Responsiveness 
Responsiveness refers to an instrument's ability to detect change, often defined 
as the minimal change considered to be important by the persons with the health 
condition or their health -care providers. The criterion of responsiveness requires 
asking whether the measure can detect differences in outcomes that are 
important, even if those differences are small (167, 177). 
Common methods of evaluating responsiveness include comparing scale 
scores before and after an intervention that is expected to affect the construct, 
and comparing changes in scale scores with changes in other related measures 
that are assumed to move in the same direction as the target measure. 
Medical Outcomes Trust recommends assessment of responsiveness 
involving estimation of the effect size. Effect size is an estimate of the magnitude 
of change status. the before - and -after changes into 
a standard unit of measurement. Different methods may be used to calculate effect 
size (177). 
5.3.4 Interpretability 
Interpretability is defined as the degree to which one can assign qualitative 
meaning to an instruments quantitative scores (177). 
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5.3.5 Burden 
Respondent burden is defined as the time, energy, and other demands placed on 
those to whom the instrument is administered. Administrative burden is defined as 
the demands placed on those who administer the instrument (177). 
5.4 Types of questionnaires 
5.4.1 Generic versus Specific Measures 
Generic measures are those which have been designed to be applicable to a wide 
variety of conditions, treatments, populations or contexts. Most common of these 
instruments are health- profiles. These are single instruments which aim to provide 
assessments of multiple dimensions of people's lives and yield a set of scores for 
each of those dimensions; or a single summary score, in which case the measure 
may be referred to as an `index' (167). A health index aggregates the dimensions 
of interest to produce a global score. This technique has been favoured by some 
authors investigating visual disability (135), however some serious reservations 
have been expressed about the practice of collapsing dimensions into a single 
number (179, 180). Some well known and widely used examples of generic health 
measures are the Index of Activities of Daily Living (181), the Nottingham Health 
Profile (182), the Sickness Impact Profile (183), the Quality of Well -Being Scale (184) 
and the Medical Outcomes Study Instrument (151). 
There are a number of potential advantages associated with the use of 
generic measures. They have often been subject to much more examination and 
refinement than is usual within medical measurement. The constructs which they 
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claim to measure, such as health status and quality of life should be relevant to 
most, if not all, conditions so that their use offers the possibility of meaningful 
comparisons, especially if measures which yield index scores are included. 
The limitations of generic measures lie predominantly in the fact that the 
provision of some overall picture may be obtained at the expense of assessing a 
dominant symptom or factor which may be of major importance to patients and 
amenable to intervention by elements of process. 
In contrast, one may be interested in outcomes that are more discrete, 
proximate and more intimately related to aspects of the process of care under 
investigation. The outcomes and their measures may be specific to the disease, 
population or some other factor, and each is measured individually and 
independently. In many cases specific measures may be more relevant to patients 
and doctors and can therefore serve as a means of stimulation to respond to the 
given health -care for patients. They may be required for a measurement of small 
but significant changes associated with particular interventions, and for 
identifying important concerns of patients with particular conditions. 
The main disadvantage of specific measures is that they are not, by 
definition, comprehensive and cannot easily be used for comparisons across 
conditions or populations. A restricted approach may therefore fail to assess the 
impact of disease and treatment upon wider aspects of patients' lives. 
5.5 Outcome Measures in Medicine 
The need to provide some outcomes in health care was obvious some decades 
ago. Rheumatologists have been pioneers in the development and use of clinical 
measures for outcome assessment (185). The Lansbury Index developed in 1958 
and the Empire Rheumatism Gold Trial performed in 1960 (185) both used 
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sophisticated pseudo -placebo -controlled trial designs and standardised 
prespecified clinical outcome measures to establish the clinical usefulness of a 
drug whose benefit did not become evident until it was administered for several 
months. Since these studies, other studies have established the clinical and 
statistical groundwork for rheumatoid arthritis outcome measures. In 1980, the 
Health Assessment Questionnaire and the Arthritis Impact Measurement Scales 
were added (185). Research work on quality of life of patients suffering from 
arthritis was accompanied with studies investigating costs of different forms of 
treatment. Direct costs of rheumatoid arthritis were found to be high but indirect 
costs to society caused by decreased work capacity were even higher due to 
considerable morbidity and functional impairment (186, 187). Comparison in 
outcome when performing total hip arthroplasty and drug therapy has been 
evaluated (188). When analysis of the economic impact and quality of life impact 
of drug treatments was performed, the influence of the side effect of treatment 
was also taken into account as associated allergic reactions and gastrointestinal 
events could significantly decrease quality of life of patients and considerably 
add to the economic burden of society (189). Comparison of outcomes in inpatient 
and outpatient rehabilitation in arthritis was also examined (107). In addition, 
outcomes of functional status and patient satisfaction when care was provided by 
primary care physicians and specialist were compared with positive outcome and 
less disability for care provided by specialists (108). 
In asthma, quality of life assessments show that this disease also has a 
significant socio- economic impact, not only on the patients themselves, but on the 
whole family (190). A significant amount of research work on outcome measures 
was done to determine functional status, patient health- related quality of life and 
patient satisfaction. At the same time the relationship between these and clinical 
measures was investigated and finally studies on the cost -effectiveness of 
treatment were carried out. Quality -of -life benefits were examined in different 
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treatment strategies using specific asthma instruments, the Living With Asthma 
Questionnaire and Asthma Quality of Life Questionnaires (in (191)). These disease - 
specific quality of life questionnaires were assessed as reliable instruments in 
reflecting disease severity but also in detecting changes in quality of life 
produced by different asthma treatments (in (109, 191)). On the basis of studies on 
outcome, international guidelines have been introduced to improve asthma 
management (190). The resulting improvements in control of asthma are expected 
to reduce the number of hospitalisations associated with asthma. A positive 
correlation between total costs of asthma and the degree of severity was found 
by a German research team (192). As prevention is the best treatment strategy in 
any disease, a national education and prevention programme was established in 
the USA (193) where asthma affects up to 15 million people (194). 
A number of generic health measures were designed to allow examination 
of functional status across various conditions. These reliable instruments became 
a form of `gold standard' in outcome research and the most widely used are the 
Index of Activities of Daily Living (181), the Nottingham Health Profile (182), the 
Sickness Impact Profile (183), the Quality of Well -Being Scale (184) and the Medical 
Outcomes Study Instrument (151). 
5.6 Outcome Measures in Ophthalmology 
In ophthalmology, good examples of the use of outcome measures are the studies 
on outcomes in diabetic retinopathy. Prior to the availability of laser 
photocoagulation, little treatment was available for proliferative diabetic 
retinopathy. The natural history of the problem was therefore well documented. 
When the laser became available, scientific methods were applied to compare laser 
treatment with no treatment (195, 196). Results showed decreased morbidity and 
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the positive economic benefits of early detection and treatment (197). Subsequent 
epidemiological studies provided a profile of the disease so that a rational 
approach and method of screening could be undertaken (198, 199). 
Similarly, a number of studies has been carried out on cataract patients (132, 
141, 143, 152, 200, 201). According to the data from 1993, cataract surgery is one of 
the most frequently performed surgical procedures in Medicare beneficiaries in 
the USA, with more than 1.1 million procedures performed annually and more 
than $2 billion in Medicare costs (200). It was important to prove the cost - 
effectiveness of the procedure. Although the success of cataract surgery was 
generally measured in terms of improved Snellen visual acuity, it was suspected 
that the patient's subjective assessment of visual function and /or quality of life 
may be a more important measure. Research projects started attempting to 
develop techniques and visual disability questionnaires to measure outcomes of 
the surgery in one and both eyes (132, 141, 152, 200). The findings of this research 
work both in the USA (Javitt et al, 1993 (200)) and in the UK (Laidlaw et al, 1998 
(202)) clearly supported the policy recommendation that cataract surgery in both 
eyes remained the appropriate treatment for patients with bilateral, cataract - 
induced visual impairment on the grounds of major benefits in the resulting 
quality of life. 
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5.7 Outcome Measures in Glaucoma 
"It is evident that the outcomes information which will be required by the health 
care revolution is not currently available in glaucoma." 
Zimmermann, J Glaucoma,1996 (2). 
In 1996 the authors Zimmerman, Karunaratne and Fechtner challenged the 
current guidelines for the treatment of glaucoma with the statement: "We are not 
in the business of lowering intraocular pressure. We are not in the business of 
preventing further disc damage. We are not in the business of stopping field 
defects. We are in the business of keeping a patient functioning visually at a level 
that does not hamper or impede the highest quality of life possible. In addition, 
we should accomplish the above in the most effective and economical manner. 
How can we meet these challenges ?" ((2), p.151). 
In contrast to the case of diabetic retinopathy, treatment for glaucoma has 
been available for more than 100 years and little is known about the natural 
history of the untreated disease. In contrast to the case of cataract, subjective 
visual disability in glaucoma was not documented either Zimmerman and 
colleagues argue that the cost of 20 years of medical care for one glaucoma 
patient in the USA translates into about $20, 000 for the patient and /or society to 
cover the necessary outpatient visits, visual field tests, optic disc photography, 
and medical therapy (2). In the UK, Spencer, Sparrow et al reported an average 
cost of £30 -50 per appointment in a shared care scheme aimed at monitoring 
glaucoma patients by community optometrists (203). 
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Zimmerman et al stressed the need to carry out studies that would in a 
scientific manner provide some outcome measures that could answer questions on 
who, when and how should be treated, how much treatment should be given, 
whether all the individuals should receive the same treatment and what is best for 
the individual and for society (2). Refocusing and refining the goals of glaucoma 
treatment is seen as inevitable (2). 
5.7.1 Outcome Measures in Glaucoma: New Goals 
Outcome research focuses on the impact of medical interventions on patients' 
functional status and health- related quality of life. The results can be used in 
numerous ways: 
Evaluation , planning and assessing needs of health care: 
Evaluation of medical care, assessing needs and determining the allocation of 
resources (2, 183, 204). 
Examination of the quality of health care is important for decision making in 
clinical practice and for management of the health care system. Evaluation is 
not only oriented toward the patient but also begins to provide a sense of the 
importance and value of restoring or preserving a given level of visual 
function (204). 
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Clinical decision making: 
To provide a measure of perceived health status and visual disability. (183). 
Research work on developing a questionnaire specific for patients suffering 
from glaucoma has only recently been started and only a small number of 
studies and abstracts have been published (149, 205). There is a need to find out 
more about the degree of disability that patients perceive in certain stages of 
the disease and the role of treatment in increasing the disability and lowering 
the quality of life. Gutierrez et al found that among persons with mild to 
moderate field loss, glaucoma- specific syndromes as blurred and hazy vision 
negatively affect vision -targeted health- related quality of life more than the 
field loss (149). These findings emphasise the importance of considering and 
monitoring symptoms to maximise health- related quality for persons in 
glaucoma by a wisely chosen treatment strategy. 
Defining the line between over and under -treatment (204). From what was 
stated earlier, it is clear that there are some questions to be answered in 
relation to management of glaucoma. Gutierrez and Mangione et al found 
that in the mild to moderate stages of the disease, patients experience more 
discomfort or disability in relation to glaucoma- specific symptoms (ocular 
discomfort, burning, itching, smarting, blurring of vision etc.) rather than the 
field loss itself (149). Caputo and Katz have also suggested, that it is sometimes 
difficult to determine whether treatment has more detrimental effects on 
quality of life than the disease itself, because of the adverse effects of beta 
blockers, miotics, carbonic anhydrase inhibitors and surgical treatment (133). 
Zimmerman et al points out that although the technological advances have 
made it possible to detect glaucomatous visual field loss and optic nerve 
damage at an earlier stage that have ever been possible, little work has been 
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done on visual disability (2). At the same time they feel that preventing visual 
disability that decreases the quality of life should be the determining factor in 
the treatment of glaucoma. Do medical interventions stop visual disability from 
glaucoma without over - treatment? A recent review identified only 16 of 102 
randomised clinical trials published between 1975 and 1991 had adequate 
data to compare medical treatment versus placebo or no treatment (144). The 
results showed a statistically significant reduction in mean intraocular 
pressure, but only three of the studies gave evidence on long term visual field 
changes. None addressed the question of visual disability. The difference in 
prevalence and the response to the treatment was found between different 
populations, for example open -angle glaucoma is four times more prevalent in 
African- American population (206) and the prevalence of blindness from 
glaucoma is several times higher (112). Is this a result of the natural history of 
the disease or of its management (207)? 
Monitoring patients progress in relation to functional decrement and /or 
treatment compliance. While visual acuity and visual fields remain an 
important component of the evaluation for treatment strategy, recent findings 
in ophthalmology suggest that it is the decrement in a patient's functional 
status that is the critical factor - and that the functional decrement is to be 
evaluated from the patient's own subjective, individual point of view (204). 
Compliance and the side effects of treatment may be difficult to evaluate 
without the patient expressing his difficulties and experiences. Every patient 
is different and treatment may vary according to patient's personal 
preferences in relation to his quality of life. Some patients tolerate pilocarpine 
well, others may experience dramatic decrease in their quality of life because 
blurred vision restricts them from driving. Diggory and Franks report that 
many elderly patients, without a history of bronchospasm and apparently 
using topical timolol without complaint, experience significant impairment of 
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lung function tests (25) with the possible effect of decreased mobility. 
Monitoring of any changes in the patient's functional status and health - 
related quality of life can affect the choice of topical medication and otherwise 
influence the treatment. 
Standardisation of policies on preventing /minimising visual disability. 
Lack of knowledge about visual disability in daily activities of glaucoma 
sufferers results in the absence of the support services that are provided for 
patients with age -related macular degeneration. Mills and Drance (145) 
reported increased difficulty in obstacle avoidance, tripping over objects, 
walking on steps and stairs and uneven ground in glaucoma. Therefore 
subjects with glaucoma are at higher risk of falls which are one of major 
accidental causes of death in the elderly (129, 145). Dengler -Harles et al found 
that forward light scatter exaggerates existing glaucomatous loss (58). The 
practical question arises of what could possibly be done for the patients in 
their homes or in the way that public buildings are designed? 
Home improvements. There are a number of strategies targeted to decreasing 
glare in the environment by careful choice of contrast conditions in certain 
areas (208). For example, a pair of light coloured curtains on a north- facing 
window will significantly decrease glare perception that is present when 
windows are surrounded by dark colours. Increased levels of brightness and 
markings on stairs may prevent falls. 
Architectural and environmental changes. Similar to the situation in homes 
some changes can be made in public areas to increase safety and comfort of 
the visually impaired (208). General rules on glare prevention can be applied as 
well as marking on steps and increased lighting in critical areas. A number of 
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authors reported on way -finding difficulties of the visually impaired in large 
public buildings (hospitals, shopping areas, community dwellings) (209 -211). As 
an extreme example of encountered difficulties, anecdotal evidence suggests 
some partially sighted residents will not travel 30 m to the TV room for fear of 
not finding their way back. This may result in severe restriction of social life 
and mobility and contribute to depression and a decrease in general health 
status. More research work is needed on this subject. 
Standardisation of criteria for driving. 
Currently set driving standards for the visually impaired are questioned (212, 
213). Controversy exist between authors investigating driving in glaucoma and 
low vision. Johnson et al examined relationship between frequency of road 
crashes and incidence of visual field loss in 20, 000 eyes with chronic open - 
angle glaucoma. The study concluded that subject with visual field loss had 
higher incidence of road crashes than normal controls (120). Other authors 
claim that visually impaired people are usually aware of their visual deficit 
which results in self- imposed restriction in driving at night or in areas of 
potential hazard (214). 
Financial decision - making. 
Financing decisions and cost -effectiveness in health care (2, 141, 204). A 
positive example were the studies on binocular cataract surgery outcomes. 
When the health -care reformation in the USA started at the beginning of the 
nineties with its era of cost containment, it may have been attractive for 
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insurers to provide disincentives to second eye surgery on the notion that the 
major improvement in vision and quality of life follows cataract surgery in the 
first eye. The data from the study by Javitt et al that followed in 1993 
contradicted that notion (200). The study covered a broad range of medical, 
functional, and social outcomes and found a benefit associated with restoring 
binocular vision in the population. The findings supported the policy 
recommendation that cataract surgery in both eyes was the appropriate 
treatment with benefits to the patient and to society (200). 
Protecting patients' needs in cost -effectiveness programmes (2, 141, 204). The 
recent example from USA in Oregon of the low priority, and therefore, non 
allocation of Medicare funding for laser therapy of central retinal vein 
occlusion has shown that decisions, which may be considered unfavourable, 
are made when relevant scientific information is lacking to prove the 
cost/benefit and cost/effectiveness of the management of the disease that is for 
the best of the patient (2). 
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SECTION II 
PATIENT'S PERCEPTION OF VISUAL 
IMPAIRMENT IN GLAUCOMA 
A Pilot Study 
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Chapter 6 
PATIENT'S PERCEPTION OF VISUAL 
IMPAIRMENT IN GLAUCOMA 
A Pilot Study 
6.1 Introduction 
When this study commenced in 1995, there was little by way of published papers 
on visual disability in glaucoma. The subject has not been covered since the 
studies by Ross in 1984 (41) and Mills and Drance in 1986 (145) were published. 
None of the questionnaires available, such us the Activities of Daily Living Scale 
(152) or the Visual Functioning -14 Questionnaire (132), were tested on glaucoma 
patients. There was a large spectrum of issues that needed to be addressed as no 
information was available on the range of day to day problems encountered by 
patients and its relevance to clinical measures. A decision was made to carry out 
two studies in this project. In the first part, the pilot study, we would deal with 
patient's perceptions of visual impairment in glaucoma and related the findings to 
a measure of visual field loss. In the second part, the main study, the relationship 
between visual disability and visual function in its various aspects would be 
examined. 
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The aims of the pilot study were to identify the most commonly perceived 
disabilities in the daily life of glaucoma patients by means of a questionnaire, to 
rank the perceived problems with regard to frequency, to group related visual 
problems and assess their impact on daily life activities, and to examine the 
relationship between perceived visual difficulties and the severity of visual field 
loss, looking in particular at those variables which could discriminate between 
different grades of visual field loss. A pilot questionnaire was developed for the 
purpose of this study. A further task was to identify a glaucoma- specific 
subgroup of questions and to test the validity and reliability of this newly created 
questionnaire subscale. 
6.2 Subjects 
6.2.1 Visual Disability Questionnaire 
Sixty -three patients attending the glaucoma review clinic within a three month 
period were enrolled in the study. There were 31 males and 32 females in the 
sample. The mean age of the sample was 70 years (standard deviation: 14 years) 
ranging from 45 to 90. Snellen visual acuity varied between 6/4 and 6/36, with 
the mean value of 6/6. Patients with clinically significant cataract, macular 
degeneration or any other ophthalmic condition were excluded from the study. 
Glaucoma was diagnosed on the basis of glaucomatous disc cupping and 
reproducible visual field damage in one or both eyes. Eighty percent of the 
subjects suffered from primary open angle glaucoma (intraocular pressure 
>21mmHg), and the remaining 20% were patients with other types of chronic 
glaucoma (normal pressure, angle closure, pseudoexfoliative ). All 63 patients 
completed the questionnaire. 
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6.2.2 Relating Subjective Visual Disability 
to a Measure of Severity of Binocular Visual Field Loss 
Although the questionnaire was anonymous, a subsample of 39 patients 
spontaneously agreed to give us their name and to allow us to gather further 
information on their visual field loss. A further analysis of the data in relation to 
the severity of visual field loss was performed on these patients. The patients in 
this subsample suffered from different degrees of visual field loss. Twenty three 
males and 16 females were included in this analysis, with a mean age 71 years 
(SD 10 years) ranging from 45 to 90. Only patients with Snellen visual acuity less 
or equal to 6/12 in the better eye were included in the study (mean VA 6/6). Only 
two patients had vision in the fellow eye worse than 6/12. The central 24 degrees 
of visual fields (threshold and suprathreshold strategies) were plotted using 
automated perimetry and the central visual fields were classified (by Mr. Coln 
O'Brien) into three groups of severity as mild, moderate or severe (details in 
Methods). 
6.3 Methods 
6.3.1 Visual Disability Questionnaire 
A pilot questionnaire was used to record self -reported disability in glaucoma 
patients. The process of developing this questionnaire benefited from previous 
studies on visual disability in glaucoma (41, 145) and other ocular conditions (9, 132, 
152, 201, 215) as well as from the clinical experience of a glaucoma specialist (Mr. 
Colin O'Brien). 
77 
All patients were interviewed by the same person (Mrs. Patricia Nelson) before 
they were given the questionnaire. Note of patients' age, sex, Snellen visual 
acuity and diagnosis was made. Patients with clinically significant cataract, 
macular degeneration or any other ophthalmic condition were excluded from the 
study. The task of the interviewer was to make sure that every participant 
understood the nature of the study and how to answer the questions on a five 
point scale ranging from "no difficulty at all" to "severe difficulty ". It was also 
made clear that patients had to answer questions in relation to their vision alone. 
An extra option was given in the questionnaire in case the patient did not carry 
out a particular task for other than visual reasons. After the short interview, 
patients were asked to complete the questionnaire themselves during the time 
they were waiting in the clinic. The questions were formulated in plain English 
and easy to understand. 
The questionnaire comprised of a total of 62 questions (Appendix I). These 
covered 47 different activities of daily living (ADL) in ten main areas of daily life: 
mobility indoors and outdoors, housework, reading, watching television (TV), 
social life, leisure activities, travelling, ability to enjoy scenery and driving. 
Confidence in Performing Routine Daily Tasks. As the questionnaire 
took 20 to 30 minutes to complete, only a subgroup of 35 patients were 
administered a further group of 19 questions dealing with the subject of patients' 
confidence rather then disability in performing certain tasks. These patients were 
asked how confident they felt to carry out daily tasks such as cooking, crossing 
the road, walking on steps etc. The purpose was to find out whether patients 
experience increased anxiety and lack of confidence in their daily life resulting 
from their visual difficulties. 
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6.3.2 Relating Subjective Visual Disability 
to a Measure of Severity of Binocular Visual Field Loss 
The central 30 degrees of visual fields (threshold and suprathreshold strategies) 
were plotted with the Humphrey Visual Field Analyser (Humphrey Instruments, 
Inc.; Allergan Humphrey, San Leandro, Ca, USA) or the Medmont Automated 
Perimeter (Medmont Pty. Ltd. Melbourne, Australia). The central visual fields 
were classified (by Mr. Colin O'Brien) into three groups of severity as mild 
(unilateral loss with less than half of the visual field lost), moderate (unilateral loss 
with more than half of the visual field lost, or, bilateral loss with less than half of 
the visual field lost in each eye) or severe (bilateral loss, more than a half of the 
visual field lost in either eye). Using this qualitative subdivision, 10 patients had 
mild field loss, 15 had moderate damage and 14 severe visual field loss. The 
groups were compared for differences in relation to age, gender or visual acuity 
using chi - square test and Kruskal -Wallis ANOVA. No statistically significant 
difference was found in relation to any of these categories in the three groups of 
visual field loss. 
6.4 Statistical Analysis 
6.4.1 Visual Disability Questionnaire 
Factor analysis using the Varimax rotation of the Principal Component Analysis 
provided by SPSS statistical software package (SPSS for Windows; Version 6.0, 
SPSS, Chicago, IL) was used to process the results of the questionnaire. It is a 
data reduction technique, in which an initial set of intercorrelations between 
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variables is given a simplified structure by the formation of groups from the initial 
set (216). A small number of new groups or patterns emerged called factors which 
account for most of the variation in patients' responses. 
6.4.2 Relating Subjective Visual Disability 
to a Measure of Severity of Binocular Visual Field Loss 
Using SPSS, a Kruskal- Wallis one way analysis of variance (ANOVA) was 
performed on the three groups (mild, moderate and severe field loss) followed by 
the Mann -Whitney U test for two independent samples. As the direction of 
significant difference was predicted a priori, i.e. with progressing field loss 
increased visual disability was expected, a one -tail test was used for analysis of 
the data. A probability value of p <0.05 was considered as a critical level for 
significant results. 
Validity and reliability of the glaucoma -specific subset of questions. 
Those activities which best separated the groups with different levels of visual 
field were used to create a glaucoma- specific subset of questions. The validity of 
this newly created subset of questions was evaluated using Spearman correlation 
coefficient between the computed average score for those questions and the 
severity of the visual field loss. Reliability analysis of the subset of glaucoma - 
specific questions was carried out using Cronbach's a as a measure of internal 
consistency (SPSS for Windows; Version 6.0, SPSS, Chicago, IL). 
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6.5 Results 
6.5.1 Visual Disability Questionnaire 
The frequency of reported difficulties is presented in Table 3. A high percentage 
of glaucoma patients complained about problems with common, everyday 
activities. Of particular note was the percentage of patients who experienced 
problems with glare (70 %) and adaptation to different levels of lighting (54 %) 
followed by difficulties when walking on steps or kerbs (49 %), reading activities 
(43 %), shopping (42 %), crossing the road (36 %), using the bus or train (26 %), 
visiting friends and restaurants (20 %), etc. Most vehicle drivers also complained 
of increased difficulty with glare when driving towards the sun or oncoming 
headlights (72 %). A small number of patients (approximately 10 %) mentioned 
that because of problems with glare they had to stop driving at night or during 
winter months. Among other examples of reported visual disability were driving 
at night time (52 %), the ability to see the control panel in the car at night (33 %), 
the ability to see traffic signs during day time (15 %) and reversing (15 %). 
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TABLE 3. Frequency of self -reported difficulties. 
Percentage Patients who failed to answer Activities 
or did not perform activity for 
non -visual reasons 
70% 2% Glare 
54% 5% Adaptation to different levels of 
lighting 
49% 2% Walking on steps or kerbs 
43% 6% Reading newspapers 
42% 3% Shopping 
40% 30% Needlework 
36% 2% Crossing the road 
32% 2% Recognising faces and expressions 
26% 3% Using bus or train 
26% 4% Watching television 
25% 6% Indoor mobility 
20% 6% Visiting friends or restaurants 
17% 7% Housework & cooking 
17% 5% Enjoyment of scenery 
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Factor Analysis. While the frequency of reported difficulties gives information 
about their occurrence (i.e. presence or absence of problems), factor analysis deals 
with interrelationships within the data. It reveals therefore the key groups of 
questions which underpin the problems reported by the patients. 
Factor analysis identified nine new groups of questions (factors). Taken 
together, the first four factors accounted for most of the variability in patients' 
responses (72 %) and are summarised under the following general headings: 
outdoor mobility / navigation, lighting & glare and activities demanding 
functional peripheral vision, household tasks and personal care. The technique 
simplified the 62 questions in the questionnaire into the four main groups and 
arranged them in descending order in which they accounted for the variability in 
patients responses. To test the stability of this structure, a second factor analysis 
was performed with a smaller set of 18 questions. The activities with high (r>0.7) 
and moderate (r>0.5) correlations on the first five factors were included in this 
part of analysis. An identical factor structure was obtained with this secondary 
analysis. 
The frequency of occurrence of difficulties related to these four groups can 
be found in Table 4. The greatest frequency was observed in the second factor, 
lighting & glare and activities demanding functional peripheral vision (Table 
4). 
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TABLE 4. Frequency of occurrence of the main groups of difficulties 
experienced by patients suffering from glaucoma. 
FACTOR NAMES FREQUENCIES 
Glare and lighting 70% 
Outdoor mobility day and night 32 -56% 
Household tasks 17% 
Personal care 8 -12% 
Frequency of occurrence shows the number of patients experiencing difficulty 
with the listed groups of activities. 
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Questions that correlated best on the four factors are listed in Table 5. For the first 
factor, highly correlated activities were observed relating to outdoor mobility/ 
navigation such as walking outside in the street during the day or at night, 
crossing the road, moving in traffic and also activities related to judging distances. 
The second factor (lighting & glare and activities demanding functional 
peripheral vision) indicated difficulty with disability glare and adaptation to 
different levels of lighting either indoors or outdoors. Activities demanding 
functional peripheral vision such as tripping over when walking, bumping into 
objects or failing to see people or objects in the periphery also correlated mostly 
on this factor, even though the correlation was not as strong as for glare disability 
and lighting. Ability to judge distances correlated evenly on the first two factors. 
The third factor (household tasks) clearly defined problems with typical 
household activities indoors and in the garden. Personal care tasks like 
dressing, washing and bathing correlated on the fourth factor. 
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TABLE 5. Factor structure of the data. Intercorrelation coefficients of 
different daily activities on the first four factors that accounted for most of the 
variance in the patients responses. 














Outdoor mobility in general .70 
Crossing the road .77 
Seeing moving vehicles .78 
Walking outdoors after 
dark .75 
Ability to see outdoors 
after dark .71 
Judging distances .57 
Glare in general .70 
Adaptation to different 
levels of lighting .75 
Bumping into objects .62 
Seeing in periphery .63 






Colour vision .82 
PV Peripheral Vision 
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6.5.2 Relating Subjective Visual Disability to a Measure of Severity 
of Binocular Visual Field Defect 
Further analysis of the data was carried out on a subgroup of 39 patients as 
described above. Kruskal -Wallis ANOVA and Mann -Whitney tests were 
performed on the three groups of patients with different levels of visual field loss 
(mild, moderate and severe) (Table 6). 
TABLE 6. Group differences in visual disability questionnaire responses with 
regard to the severity of binocular visual field loss . 
ANO VA 
Kruskal - Wallis 
Mann - Whitney U Test 
All groups Mild vs. Moderate Mild vs. 
Activities (p- value) Moderate vs. Severe Severe 
(p- value) (p- value) (p- value) 
ADL in general 0.07* 0.04 0.01 
ADL performed in dim 
lighting 0.04 0.0 3 0.15* 0.07* 
Adjusting to bright lighting 0.055 0.02 0.14* 
Tripping over 0.04 0.09* 0.16* 0.01 
Going from bright to dark 
room or vice versa 0.15* 0.16* 0.05 
Confidence in going out in 
the street 0.01 0.03 0.0 2 
ADL Activities of Daily Living. (* Indicates trend towards significance. Significance may be 
achieved with a larger sample size.) 
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Using the ANOVA assessment significant differences across all groups were 
found in patients confidence when going out in the street (p =0.01) and in 
tripping over when walking (p= 0.04). Glare disability when adjusting to high 
levels of lighting had a borderline probability value (p= 0.055) (Table 6). These 
variables are related to the first and second factor of the factor structure 
(`outdoor mobility', 'glare & lighting and activities demanding functional 
peripheral vision'). Also, in the responses to the general question on perceived 
"difficulty in activities of daily living (ADL) performed in dim lighting" there was 
a significant difference between the groups (p= 0.04). 
The ANOVA was followed by Mann - Whitney U test for two independent 
samples (Table 6). With increasing severity of binocular visual field loss, the 
number of significant differences between the groups increased. The only 
significant difference found between mild and moderate visual field loss groups 
was in two general questions on "activities of daily living performed in dim 
lighting" (p =0.03) and "activities of daily living in general" (p= 0.04). There 
were no differences in any of the specific daily tasks among these two groups of 
patients. When comparing the groups with moderate and severe field loss the best 
predictors were a confidence question on "going out in the street "(p =0.01) and 
glare disability (p= 0.02). Significant differences were found between groups with 
mild and severe visual field loss in the questions on performance in ADL in 
general (p= 0.01), tripping over objects (0.01), confidence when going out in the 
street (p =0.02) and adaptation when going from dark to light room or vice versa 
(p= 0.05). 
Finally the groups with mild and moderate loss were combined and 
compared with the group with severe loss (Table 7). The Mann -Whitney U test 
showed significant differences between these two groups in adjusting to bright 
lighting (p= 0.02), a general question on difficulty with glare (p =0.02) and 
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tripping over objects (p= 0.04). Adaptation when going from a bright to a dark 
room or vice versa had a borderline probability value (p= 0.055). All these 
questions were related to the second factor of the factor structure. 
TABLE 7. Comparison of the combined group of mild & moderate field loss 
with the severe binocular visual field loss group (Mann- Whitney U test). 
Activities p -value 
Adjusting to high levels of lighting 0.02 
Disability glare in general 0.02 
Tripping over 0.04 
Going from bright to dark room or vice versa 0.055 
6.6 Validity and Reliability of the Questionnaire Subscales 
Validity. This questionnaire was based on several examples in the literature from 
a range of ophthalmic conditions including glaucoma. The purpose was to find 
questions which would show a relationship with a measure of severity of visual 
field loss. The validity of the questionnaire could therefore be tested only in 
relation to possible glaucoma- specific subgroup consisting of the questions found 
to be able to discriminate or contribute to the discrimination between the three 
groups with varying degrees of visual field loss. The validity of the specific 
questions was demonstrated in their relationship with a measure of visual field 
loss, Tables 6 and 7. Most of these questions were related to the factor `glare & 
lighting and activities demanding functional peripheral vision'. The average score 
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(mean value) for these questions has also been computed and correlated with the 
measure of severity of binocular visual field loss. The Spearman coefficient was 
used for evaluation of this relationship with the resulting value of r =0.37 
(p <0.05). 
Reliability. The Cronbach's a showed high internal consistency for all 
the subscales of the questionnaire as suggested by the factor analysis: outdoor 
mobility (0.96), disability glare & lighting and activities demanding functional 
peripheral vision (0.93), household tasks (0.92), personal care (0.97). Internal 
consistency of a possible glaucoma- specific subgroup of questions related to 
factor `glare & lighting and actions demanding functional peripheral vision' was 
also found to be high (0.96). 
6.7 Discussion 
6.7.1 Visual Disability Questionnaire 
This study has identified outdoor mobility, glare and lighting, household tasks 
and personal care as the main groups of problems encountered by glaucoma 
patients. This factor structure confirmed the previous findings of Ross et al. (Table 
8) (41). Both the sample in the study of Ross and the sample in this study were 
comparable in their size and considered the same age group. Both studies 
examined subjects with varying degrees of the visual field loss and used a similar 
technique to analyse the data. 
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TABLE 8. Comparison of the factor structure reported by Ross et al 1984 (41) 
with the factor structure resulting from this study. 
Present study Ross et al 
Outdoor mobility Navigation outdoors 
Disability glare & lighting Navigation at night 
Household tasks Vision when cooking 
Personal tasks 
Near vision Near vision 
The first factor described by Ross as navigation outdoors (41) is identical with 
the group of experienced disabilities that correlated on the factor outdoor 
mobility in our study. Problems with navigation at night (41) indicating 
difficulty with adaptation to different levels of lighting were confirmed in this 
study, in relation to the second factor. The questions related to glare disability 
and activities demanding functional peripheral vision, like tripping over and 
bumping into objects or ability to see objects coming from the side also correlated 
on this factor. Naturally, one would expect a correlation of activities demanding 
functional peripheral vision on the outdoor mobility factor. This was partially the 
case as the correlation of these activities was spread across the first two factors, 
but predominant on the second one. It is difficult to explain at this stage why the 
relationship of these activities with glare problems seems to be stronger than with 
outdoor mobility difficulties. 
Vision when cooking (41) was one of the activities that correlated on the 
factor with the general heading of household tasks in this study. Near vision (41) 
corresponds with the fifth factor in the present study. This factor did not 
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significantly increase the proportion of variance in the patients' responses and 
therefore was not described in detail. In relation to the use of factor analysis, it is 
necessary to note that because the sample size in this study was smaller than the 
usually recommended ratio of 2:1 (number of subjects : number of questions), or 
20 times the number of factors (216), a secondary analysis was performed to test 
the stability of the factor structure. A smaller set of 18 questions which correlated 
strongly (r>0.7) or moderately (r>0.5) on the first five factors were entered into 
the secondary analysis and an identical factor structure was obtained. 
A loss of confidence in performing certain tasks was observed by the 
glaucoma patients in this study before real problems with visual disability were 
apparent, an observation also reported by Ross (41). These difficulties were 
particularly related to outdoor mobility (going out in the street, visiting friends), 
where a change in weather conditions and the amount of traffic can cause some 
anxiety and affect the level of confidence of a patient. 
6.7.2 Relating Subjective Visual Disability to a Measure of Severity 
of Binocular Visual Field Defect 
The results of this study indicate that subjective data can discriminate between 
patients with mild /moderate and advanced binocular visual field loss as defined in 
this study (see Subjects). The best discriminators seems to be the second factor 
given by the factor structure in this study, i.e. disability glare, adaptation to 
different levels of lighting and activities demanding functional peripheral vision. 
However, these subjective discriminators do not seem to be sensitive enough to 
detect differences between mild and moderate binocular field loss as defined in 
this study. Although patients with moderate damage may have some idea of 
increased difficulties with daily life activities in general, no difference is found 
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between the two groups when performing any particular task. This suggests that 
patients may progress from the mild to the moderate stage of the visual field 
damage (as defined herein) without noticing it in their daily routine. Normal 
subjects were not considered in this study as the purpose was to examine visual 
disability between groups with varying degrees of visual field loss. 
Disability glare and lighting have separated mild / moderate from severe 
visual field loss in this study (Table 7). In every day situations, glare disability is 
observed when driving at night against oncoming car's headlights or during 
sunny winter days, entering dark rooms, and when indoors with mirrored areas 
facing lighting sources. Although the results of this study in regard to disability 
glare and lighting cannot be directly compared to any other study, the work by 
Sherwood et al in a very recent publication indicates that glaucoma patients 
experience glare and have difficulty with night vision when compared to normals 
(63). In 1989 Dengler -Harles et al (58) showed that forward light scatter 
exaggerates existing visual field loss in glaucoma patients. In 1992 Ochsner and 
Zrenner included some glaucoma patients in their glare sensitivity study (88), and 
suggested that changes in the visual acuity - luminance function accompanied 
with high glare sensitivity are most often due to pathological changes in 
neuronal circuity of the retina. They remark that sensitivity to glare is an 
unspecific ophthalmologic symptom which can be caused by different anatomical 
structures, and although it can be related to optical and to cortical structures, it 
can also be due to defects in the neuronal mechanisms of the retina that control 
adaptation processes (88). Van den Berg found that visual acuity correlates rather 
weakly with the amount of scatter (89). Since the amount of scatter causes a 
considerable loss of visual function, the results of his study showed that for glare 
sensitive patients the standard Snellen visual acuity test gives a rather limited 
impression of visual handicap. Hoshino and Mizokami found a significant 
correlation between glare sensitivity measured with the Millar- Nadler glare tester 
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and central visual field damage in patients with early to middle stage glaucoma 
(59). Others studies have shown that objectively measured glare disability when 
taken together with other tests (especially contrast sensitivity and visual acuity) 
made a distinct contribution to the overall characterisation of visual function (9). 
The issue of dark adaptation in glaucoma was addressed by Glovinsky, Quigley 
and Drum et al who found abnormal scotopic sensitivity in glaucoma patients 
when compared to normals (56). More research into the problems associated with 
intraocular light scatter, brightness acuity and sensitivity and scotopic sensitivity 
in glaucoma is needed. 
Our patients also had problems with vision in activities demanding 
functional peripheral vision, particularly when walking. With advancing 
glaucoma damage the number of subjective discriminators seems to increase 
(Table 6). These results reaffirm the conclusions of Mills and Drance (145) who 
used the Esterman binocular test as an objective measure of visual function and 
compared the performance scores to the self- reported disability in patients with 
severe visual field damage. They found a significant correlation between the 
Esterman test and responses to a short visual disability questionnaire, particularly 
in activities demanding peripheral vision, i.e. questions on tripping over, bumping 
into people or objects and following the line of print or finding the next line (145). 
A number of groups have recently demonstrated visual disability in glaucoma 
patients using a questionnaire. A study by Gutierrez et al showed that a steady 
decline characterised the relationship between visual field loss and health -related 
quality of life (135). Sherwood and Parrish found a correlation between increasing 
field loss and a reduction in activities of daily living (63, 136). 
Some other signs of deterioration in the quality of life of a given patient 
were found in this study by a loss in confidence when performing certain 
activities, especially outdoor mobility tasks (going out in the street). Anxiety and 
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loss of confidence seem to precede the stage of actual problems in performing the 
tasks. 
As mentioned earlier the selection of questionnaire items in this study was 
based on several examples in the literature from a range of ophthalmic conditions 
including glaucoma. The summary measure of a single value used by some 
authors (135) as a performance measure across a number of questions was 
therefore inappropriate in this situation because of the basis on which the 
questions were chosen. 
The validity of the glaucoma - specific subgroups of questions was shown 
by the significant correlation with severity of visual field loss (Table 6). This 
correlation was similar to the value published by Gutierrez et al (135) in glaucoma 
patients. A high level of internal consistency was found in the questionnaire 
structure and the glaucoma- specific subgroup of questions. 
The influence of different forms of treatment (medical, laser, surgery) and in 
particular pupil diameter was not addressed in this study. Pilocarpine is known to 
cause a diffuse depression in the hill of vision due to pupil miosis (29, 30). Pupil 
enlargement may be associated with increased glare disability (217). Topical beta 
blockers can cause systemic side -effects which may influence general well being 
and have a bearing on subjective responses (25). A recent study by Wang aimed at 
developing a research instrument for measuring the effect of glaucoma and its 
treatment on quality of life and functional status (218), concluded that the 
Glaucoma Disability Index, a 31 item questionnaire showed high internal 
consistency and construct validity and is intended to be used to evaluate quality 
of life related to treatment. Sherwood et al found that glaucoma medication 
correlated with self- reported glare disability and night vision problems (63). All of 
the aspects relating to treatment and side -effects of therapy need further 
investigation (219). In our ongoing study we are also looking at the relationship 
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between other psychophysical tests of visual function and self- reported visual 
impairment in glaucoma. 
6.8 Conclusion 
This study has shown that from a large set of questions on daily living activities, 
the responses of glaucoma patients can best be described by four different areas. 
These are outdoor mobility / navigation, glare & lighting and activities 
demanding functional peripheral vision, household tasks and personal care. 
The results of this study also indicate that subjective data can discriminate 
between patients with mild /moderate and advanced binocular visual field loss, as 
defined in this study (see Methods). The signs of a reduction in quality of life 
were experienced in difficulty with adapting to glare and different levels of 
lighting and in activities demanding functional peripheral vision, particularly 
when walking (tripping over objects). A loss of confidence was apparent in 
patients when going out in the street, before the actual disability problems were 
noted. The validity of the glaucoma- specific subgroup of questions was shown 
by a significant correlation with the severity of visual field loss. A high level of 
internal consistency was found in the questionnaire structure. 
There is a clear need to find out more about visual disability in glaucoma. 
The results so far are challenging, particularly as experienced difficulties are a 
crucial outcome measure and quality of life indicator. As many reports indicate (2, 
63, 135, 218) this aspect of care is essential to the treatment and management of the 
glaucoma patient. Further studies are needed if we are to address the questions 
and problems of visual disability in glaucoma. 
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Chapter 7 
REVIEW OF THE PILOT STUDY 
7.1 Conclusions for the Main Study 
The first phase of this research project, the pilot study, fulfilled its purpose in 
focusing our attention on the three main aspects of daily activities that were 
found to have strong relationship with a measure of severity of visual field loss: 
outdoor mobility /navigation, glare & lighting and activities demanding 
functional peripheral vision. Understandably, these would be investigated in the 
main study in greater detail not only by means of a questionnaire but also by 
means of objective measures of visual function. 
7.2 Questionnaire for the Main Study 
When creating a new questionnaire for the second phase of this research project, 
the main study, the following steps were taken: 
Questions that had significant relationship with a measure of visual field loss or 
contributed to it were included. 
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 Questions that highly (r>0.7) and moderately (approx. r =0.5) correlated on the 
five factors (including the factor near vision) that emerged in the pilot analysis 
were included. 
Activities that were correlated with each other above the value r>0.7 were 
analysed and only the one with better performance was included. 
A section on general health, mental health (the MOS -36 short-form health 
survey (220)) and psychological aspects (the Nottinhgam Adjustment Scale (221), 
shortened version) that could influence one's visual disability were included 
following the recommendations of Cotton, Hill and Aspinall (215). These authors 
carried out an extensive study to investigate influence of demographic and 
psychosocial characteristics of older adults in relation to their visual 
impairment. Included were measures: general health (the Short Form -36 
Health Survey (151)), psychosocial measures such us the Nottingham 
Adjustment Scale (221) (a measure of psychological factors such as anxiety, 
depression, self- esteem, personal satisfaction, attitudes, acceptance etc.) and the 
Life Satisfaction Index (222, 223), demographic variables (finance, living 
circumstances and social support), a section on psychological factor hardiness 
and also a section on religious motivation. It was not possible to include all 
the factors that play important role in coping with visual impairment and in the 
resulting level of disability in the present study. However, the 
recommendations of Cotton, Hill and Aspinall (217) were followed to include 
the most important measures, i.e. the psychosocial characteristics: anxiety, 
depression, acceptance, personal satisfaction and attitudes. As a result, 10 
questions were added (2 for each measure) to the final questionnaire in the 
main study. 
An up -to -date literature search was carried out and a number of additional 
questions on social life and spare time activities were included (224). It was 
98 
shown that the ability to carry on with usual social life activities and hobbies 
plays a very important role in preserving one's quality of life level. 
The questionnaire designed for the main study comprised of a total of 58 
questions (Appendix II). Visual disability was assessed in the following areas: 
personal care and domestic tasks; glare and dark adaptation; navigation and 
mobility; navigation at night; near vision; and social contact and leisure activities. 
In addition, as already mentioned above, some questions were included 
addressing general, health, mental health, and psychosocial measures. The 
questions were to be answered on a five point scale ranging from "no difficulty 
at all" to "severe difficulty ". It was also made clear that patients had to answer 
questions on visual disability in relation to their vision alone. An extra option was 
given in the questionnaire in case the patient did not carry out a particular task 
for other than visual reasons. The experience from the pilot study showed that 
questions were formulated in plain English and easy to understand. 
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SECTION III 
RELATIONSHIP BETWEEN BINOCULAR 




RELATIONSHIP BETWEEN BINOCULAR VISUAL 
FUNCTION AND VISUAL DISABILITY IN GLAUCOMA 
The Main Study 
8.1 Introduction 
The purpose of the pilot study was to broadly examine patients' perception of 
visual impairment in glaucoma and to find out whether self -reported disability 
was correlated with a measure of visual field loss. The purpose of the main study 
was confirm this relationship and in addition investigate the correlation between 
self -reported visual disability and various aspects of visual function. The research 
work therefore consisted of two parts: 
Visual performance testing in a number of visual functions that were found to 
be compromised in glaucoma. The Esterman binocular visual field test was 
carried out and also additional measures of contrast sensitivity, flicker 
sensitivity, colour vision, dark adaptation, glare disability, and stereoacuity 
testing. 
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 A questionnaire was used to record self- reported visual disability in glaucoma 
patients. The questionnaire was successfully piloted prior to the main study on 
a sample of 65 patients and was designed to cover various aspects of 
everyday life. Visual disability was assessed in the following areas: personal 
care and domestic tasks; glare and dark adaptation; navigation and mobility; 
navigation at night; near vision, and social contact and leisure activities. In 
addition some questions were included addressing general health, mental 
health, and also feelings and attitudes that could be related to social and 
emotional aspects of the disease. 
8.2 Subjects 
A sample of 47 glaucoma patients and 20 normal control subjects who met 
eligibility criteria were enrolled from the glaucoma clinic at the Princess 
Alexandra Eye Pavilion of Royal Infirmary of Edinburgh, Scotland between July 
1996 and October 1997(Table 9). 
There were 22 males and 25 females in the patient group. The mean age of 
this sample was 68 years (standard deviation: 7.4 years) ranging from 53 to 81 
years with onset of glaucoma after 40 years of age and of at least one year 
duration. Snellen visual acuity varied between 6/4 and 6/12, with the mean value 
of 6/6. Glaucoma was diagnosed on the basis of glaucomatous disc cupping and 
reproducible visual field damage in one or both eyes. Fifty nine percent of the 
subjects (29 patients) suffered from primary open angle glaucoma (intraocular 
pressure >21mmHg), 37 % (18 subjects) suffered from normal tension glaucoma 
and 4 % were patients with other types of chronic glaucoma (angle closure, 
pseudoexfoliative). 
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TABLE 9. Characteristics of patients and normal controls. Kruskal- Wallis 
One -way Anova and Chi -square test. 









Age 67.72 67.21 71.70 66.50 p >0.05 
(SD 7.45) (SD 7.61) (SD 6.97) (SD 4.35) 
Sex 
Male / Female 8/10 9/10 5/5 6/14 p>0.05 
Snellen VA 6/6 6/6 6/6 6/6 p>0.05 
MD -7.34 dB -14.29 dB -27.61 dB -0.15 dB p<0.0001 
(SD 4.65) (SD 5.03) (SD 6.40) (SD 1.79) 
CPSD 7.28 dB 12.77 dB 12.24 dB 1.85 dB p<0.0001 
(SD 3.19) (SD 2.93) (SD 2.85) (SD 1.27) 
Pupil size 4.1mm 3.7mm 3.8mm 4.4 mm p>0.05 
(SD 1.7) (SD 1.0) (SD 1.7) (SD 1.1) 
(mean rank) 34.19 29.76 29.85 39.92 
General health 
(mean rank) 
38.86 32.63 42.72 25.35 p>0.05 
Mental health 
(mean rank) 




32.17 32.34 46.22 30.08 p>0.05 
Pilocarpine N=6 N=6 N=5 p >0.05 
medication 
(mean rank) 
23.33 22.92 27.75 (comparing 
patients groups) 
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Only patients with stable visual fields were eligible to participate in the study. The 
central visual fields were classified (by Mr. Co1m O'Brien) into three groups of 
severity as mild (unilateral loss with less than half of the visual field lost), 
moderate (unilateral loss with more than half of the visual field lost, or, bilateral 
loss with less than half of the visual field lost in each eye) or severe (bilateral loss, 
more than a half of the visual field lost in either eye). Using this qualitative 
subdivision, 18 patients had mild field loss (MD=- 7.3dB, SD 4.65; CPSD =7.28, 
SD 3.19), 19 had moderate damage (MD=- 14.2dB, SD 5.03; CPSD= 12.77, SD 
2.93) and 10 severe visual field loss (MD=- 27.6dB, SD 6.4; CPSD= 12.24, SD 
2.85), Table 9. Patients with clinically significant cataract, macular degeneration 
or any other ophthalmic condition were excluded from the study. Patients with a 
history of incisional eye surgery within three months before recruitment were 
excluded from the study (Table 9). 
Six men and 14 women were enrolled in the normal control group (Table 
9). These subjects were either members of the hospital volunteer staff, or spouses 
and friends of our patients. The mean age of this sample was 67 years (standard 
deviation: 4.4 years) ranging from 57 to 74 years. Snellen visual acuity varied 
between 6/4 and 6/12, with the mean value of 6/6. Subjects in the reference group 
were examined and had no underlying vision problem except for correctable 
refractive error. 
Both the patients and the normal controls had their central 24 degrees of 
visual field plotted using the Humphrey 24 -2 threshold strategy program 
(Humphrey Visual Field Analyzer, Humphrey Instruments, Inc; Allergan 
Humphrey, San Leandro, CA, USA). To minimise the possible influence of minor, 
clinically nonsignificant cataract in this age sample, the cut -off point for Snellen 
visual acuity was chosen at 6/12 for both groups. Refractive error was corrected 
for any of the tests and only respondents with refractive error smaller than 4 
104 
dioptres and a stigmatism of less than 2 dioptres were included in the study. Pupil 
size was recorded in all subjects. General health and mental health were measured 
using a shortened form of the MOS -20 (220), based on the recommendations of 
Cotton, Hill and Aspinall (215). These authors, as it was previously mentioned in 
the review of the pilot study, carried out an extensive study considering the 
influence of psychosocial and demographic variables on visual impairment. Based 
on their recommendations, the factors with the strongest influence were included 
in this study: 10 questions addressing psychosocial variables (questions 
originated from the Nottingham Adjustment Scale (221), based on the 
recommendations of Cotton, Hill and Aspinall (215)). The type of local ophthalmic 
medication was also noted (Pilocarpine or other). All respondents had to 
understand and speak fluently in English to respond to the questionnaire. 
The four groups (three patient groups and normal control group) were not 
significantly different in relation to age, sex, Snellen visual acuity, pupil size, 
general health, mental health or psychosocial measures (Table 9). There was no 
statistically significant difference among patient groups in relation to local 
ophthalmic medication (Pilocarpine or other) (Table 9). 
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8.3 Methods 
8.3.1 Visual Disability Questionnaire 
A newly created questionnaire was used to record self -reported disability in 
glaucoma patients. The process of developing this questionnaire benefited from 
previous studies on visual disability in glaucoma (41, 145) and other ocular 
conditions (9, 132, 152, 201, 215) as well as from the clinical experience of a glaucoma 
specialist (Mr. Colm O'Brien). The questionnaire was piloted prior to the main 
study on a sample of 65 glaucoma subjects with various degrees of visual field 
loss. The process of developing the questionnaire and examining its performance 
characteristics were described in detail in the section dealing with the pilot study. 
Just to remind the reader, a significant correlation with the measure of severity of 
visual field loss was found thus demonstrating the validity of the questionnaire. 
The reliability of questionnaire Cronbach' s a 
was very high at minimum a =0.92. 
The questionnaire used in the main study comprised of a total of 58 
questions. Visual disability was assessed in the following areas: personal care and 
domestic tasks; glare and dark adaptation; navigation and mobility; navigation at 
night; near vision, social contact and leisure activities. In addition questions were 
included addressing general health, mental health (shortened form of the MOS -20 
(220), based on the recommendations of Cotton, Hill and Aspinall (215)) and 
psychosocial measures (shortened form of the Nottingham Adjustment Scale (221), 
based on the recommendations of Cotton, Hill and Aspinall (215)). The questions 
were to be answered on a five point scale ranging from "no difficulty at all" to 
"severe difficulty ". It was also made clear that patients had to answer questions 
on visual disability in relation to their vision alone. An extra option was given in 
the questionnaire in case the patient did not carry out a particular task for other 
than visual reasons. The experience from the pilot study showed that questions 
were formulated in plain English and easy to understand. The patients 
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administered the questionnaire themselves for two reasons. Firstly, the patient 
was about to undergo a battery of psychophysical tests for a period of two hours 
and any extra time could increase the fatigue effect. Secondly, when consulting a 
psychologist with experience in questionnaire surveys (Prof. Peter Aspinall), a 
self -administered questionnaire was recommended because experience has shown 
that patients reacting to hospital staff tend to try to answer in a more positive 
manner than they would in their home environment and underevaluate the real 
extent of their difficulties. 
8.3.2 Assessment of Visual Function 
All patients and normal controls underwent a series of visual function tests by the 
same person (Mrs. Patricia Nelson) with the exception of visual field plots and 
Snellen VA test in some patients who had had these tests done previously as a 
part of their clinical examination. When it was necessary, subjects had their vision 
corrected using clear monofocal glasses. The order of the test administration was 
randomised and a trial run was performed to ensure that subjects understood the 
nature of the test. The experimental protocol took on average two hours. 
Subjects were given at least one break during the experiment. Normal controls or 
patients who had not had their visual fields plotted on the Humphrey Visual Field 
Analyser before were given this test on a separate day prior to the experiment. A 
note was taken of pupil diameters in mm (estimating by eye, under the same 
lighting conditions for all subjects) and ophthalmic medication. The tests were 
performed in a time -frame that was aimed to avoid the time -frame of a daily 
ophthalmic medication regime as some drops containing Pilocarpine or Propine 
could in some cases affect visual performance. 
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Distance Visual Acuity 
Visual acuity was measured using the Snellen chart (details see chapter `Visual 
Function in Glaucoma'). In comparison to the pilot study, where visual acuity 
was requested to be 6/12 or better in the better eye, only subjects with visual 
acuity 6/12 or better in each eye were included in the main study. This decision 
was made following further literature search on correlation between monocular 
and binocular visual performance (225). 
Visual Field Examination 
The Humphrey Visual Field Analyzer (Humphrey Instruments, Inc; Allergan 
Humphrey, San Leandro, CA, USA), an automated static perimeter was used in 
this study to plot visual fields in all patients and normal controls. Two programs 
were used and a trial run was given before either of them: 
Humphrey 24 -2 threshold strategy monocular test plotted the central 24 
degrees of visual field in both eyes. This test is clinically used for quantitative 
assessment and progression of visual field damage separately in each eye. Apart 
from statistical evaluation this test offers a grayscale picture of visual fields. In all 
subjects the right eye was done as first in this study. This test was used when 
grouping the patients into the three groups of severity of visual field loss as 
described in Subjects. The resulting Mean Deviation (MD), a measure of a 
generalised loss, and Corrected Pattern Standard Deviation (CPSD), a measure of 
localised loss, were recorded in dB units. This test was carried out on a separate 
day prior to experiment because it is time consuming (approximately 15 min per 
eye) and requires high concentration. 
Esterman binocular field test. This test is one of the tests used clinically for 
examination of driving abilities according to DVLA recommendations. It is a 
qualitative test using suprathreshold strategy. It provides information on 
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functionality of the binocular field of vision. The test plots the central 150 
degrees of binocular visual field. The result is recorded in % on the test 
performance. A subject is allowed to drive if the visual field defect does not affect 
the central 20 degrees of binocular visual field. The test takes approximately 5 
minutes. 
Contrast Sensitivity (CS) 
Pelli- Robson Letter Sensitivity Chart. The chart is placed at 1 m from the patient 
and illuminated to approximately 100 cd /m2 in accordance with recommended 
standards for vision testing (National Academy of Sciences - National Research 
Council, 1980). The Pelli- Robson chart consists of eight rows of six uppercase 
Sloan letters. The letters are arranged in triplets, two triplets per row. The letters 
are of constant size (6/190 Snellen equivalent), but triplets decrease in contrast by 
0.15 units. The test is administered an ordinary acuity test. The patient 
names the letters and the test continues until two or more errors are made in a 
triplet. Blank responses are not allowed so the test is truly forced -choice. 
Contrast threshold is determined by the last group in which at least two of the 
three letters are correctly identified and noted in log CS units. The test was 
performed both binocularly and also monocularly on each eye, right eye first. 
Some studies have shown that the Pelli- Robson chart is more reliable than 
sinewave grating charts (75). Although the test is limited to providing information 
only about low to medium spatial frequencies, this is the range that is most closely 
associated with visual performance in tasks like reading (226), face recognition (77), 
and mobility (78). In addition, the work of Elliot done in 1989 -90 has 
demonstrated that contrast sensitivity at higher spatial frequencies is more highly 
correlated with visual acuity and thus would be less likely to provide new 
information (79). 
109 
Visual Stimulus Generator (Cambridge Research Systems, Ltd., Rochester, 
England). This is a highly sophisticated research instrument designed to 
investigate contrast sensitivity. The instrument is fully automated. The software 
(Psycho for windows, Cambridge Research Systems, Ltd.) enables a scientist to 
design a test with the target that can alter in contrast, spatial and /or flicker 
frequency. In the visual disability study we used a test with a single disc shape 
target placed in the middle of the screen. Spatial frequency of 3 c /deg was chosen 
for the target as human vision reaches its maximum detection /resolution at this 
level (45). The target was viewed from the distance of 2 metres. One alternative 
forced -choice psychophysical technique was used during the test and the result 
of the test was the threshold level in log CS units recorded after seven reversals. 
Contrast decreased and increased in 2 dB steps. A trial run was given prior to this 
test. 
Critical Flicker Frequency (CFF) 
The Visual Stimulus Generator was used to perform this test. We used a single 
disc - shaped stimulus placed in the centre of the screen flickering at low contrast 
(30 %). When the test started, the stimulus was flicking at the clearly visible 
frequency of 27 Hz. During the test the frequency of flicker increased till the 
subject was not able to see the target. The one alternative forced -choice 
technique was used and a result of the test was the threshold level in Hz recorded 
after seven reversals. Flicker increased and decreased in 2 dB steps. A trial run 
was given before this test. 
Brightness Acuity Test 
The effect of glare on visual acuity and contrast sensitivity was investigated 
using the Brightness Acuity Tester (BAT) by Mentor O &O, Inc., USA. In the 
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present study the glare test was performed using the Pelli- Robson contrast 
sensitivity chart. The BAT is a hand -held tool used monocularly. The patient 
views the chart through the hole of the illuminated hemisphere. The result is 
taken as log CS of the last triplet that a subject is able to read. The test takes 
approximately 15 minutes when performed with two of the three glare conditions 
as provided by the manufacturer (moderate 200 ftL and high 400 ftL). We 
combined monocular results using probability summation of monocular fields 
recommended by Nelson -Quigg and Johnson et al (225) in their study on 
predicting binocular visual sensitivity of glaucoma patients using monocular data: 
Binocular Sensitivity = Square Root (Square(Sensitivity R eye) +Square(Sensitivity L eye)) 
Dark Adaptation 
Dark adaptation was tested using the Goldmann Weekers Dark Adaptometer. The 
30 minute procedure was shortened to 20 minutes using a 2 min pre -adaptation 
period at low luminance level. The decision was taken after a pilot experiment 
was carried out comparing the results of the standard test procedure (5 min pre - 
adaptation at 5000 cd /m2, 30 min dark adaptation) with a shorter test where the 
subject was pre- adapted at low luminance (2 min pre -adaptation at 100 cd/m2, 20 
min dark adaptation). The decision to use the shortened test was based on a 
paper which found that after 15 minutes of dark adaptation, anomalies were 
obvious in glaucoma subjects giving significantly different results from normal 
controls (84). 
The psychophysical method of limits was used in this test. After the pre - 
adaptation period, the patient's sensitivity of light perception was recorded. The 
luminance of the light source was increased and decreased and patient's response 
when he noticed the light for the first time or stopped seeing it completely was 
recorded. This procedure was repeated approximately every 2 minutes for 20 
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minutes. A dark adaptation curve was plotted. Note of the final dark adaptation 
threshold was taken for statistical analysis. 
Stereopsis 
The Frisby stereotest was used for the study purposes. The test set consists of 
three plates of different thickness made of clear plastic. Four identical squares 
with a pattern are printed on each plate. In one of the squares a small central part 
of the pattern is printed on the back side of the plate rather than on its front. The 
patient is supposed to see depth of the picture, i.e. thickness of the plate given by 
prints on each side in one of the squares, and asked to point to the square with 
the depth picture in it. By altering the thickness of the plates and changing the 
viewing distance a final result can be computed. The test takes approximately 5 
minutes. 
Colour Test 
The Farnsworth desaturated D -15 colour test was used as the measure of colour 
vision. It is a shortened version of the well known Farnsworth -Munsell 100 Hue 
Test. It is intended for screening purpose, rather than for the in -depth study of a 
colour vision defect. Each set of discs contains a reference or `pilot' cap, holding 
Munsell notation 10 B 5/4 and fifteen numbered disc which make up an 
incomplete colour circle. Each disc is partially safeguarded from being touched, 
and therefore spoilt, by mounting in a plastic cap. Subjects taking the test were 
asked not to touch the coloured surface. The performance on this test can be 
influenced by lighting conditions and therefore we used a light source 
recommended by the manufacturer of the Huematic -100 Colour Vision Test, 
Clement Clarke International Ltd. The patient was asked to arrange 15 colour 
caps into a line starting from a given colour. The presence of a significant defect 
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can be detected. In our study, the presence of any defect was recorded as 
`positive' (1) and the perfect arrangement was recorded as `negative' (0). 
8.4 Statistical Analysis 
Statistical analysis was carried out using SAS statistical software package (SAS 
Institute Inc., Cary, NC, USA) and SPSS statistical software package (SPSS for 
Windows; Version 6.0, Chicago, IL, USA). 
For the purpose of the statistical analysis, the results were adjusted for the 
influence of age, sex and physical disability. It was already mentioned earlier that 
the four groups (three patient groups and normal control group) did not differ in 
terms of age, sex, Snellen visual acuity, pupil size, general health, mental health 
and psychosocial measures, and that there was no difference between the three 
patient groups in local ophthalmic medication (Pilocarpine or other). Where 
necessary, monocular data (Mean Deviation perimetric values, Pelli- Robson 
contrast sensitivity and glare disability results, Snellen visual acuity) were 
transformed using a formula recommended by Johnson and Nelson -Quigg et al 
(225): 
Binocular Sensitivity = Square Root (Square(Sensitivity R eye) +Square(Sensitivity L eye)) 
Visual Disability Questionnaire 
Factor analysis using the Varimax rotation of the Principal Component Analysis 
was used to process the results of the questionnaire (216). 
Visual Disability Questionnaire in Relation to the Severity of Visual Field 
Loss 
The Fisher's Exact two -tail test (SAS) was used to determine the relationship (227). 
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Summary Performance Measure for Visual Disability Questionnaire 
As there were no missing values in the set of answers a summary performance 
measure was calculated by adding the scores on the 15 questions that were found 
to be significantly related with the severity of visual field loss. 
Severity of visual field loss. A General linear models procedure (Type III 
SS test) and Least square means procedure (227) was performed on the four 
groups with various degrees of visual field loss. 
Visual Function Tests in Relation to the Severity of Visual Field Loss 
in Glaucoma 
The General linear models procedure (Type III SS test) and Least square means 
procedure (227) was performed on the four groups with various degrees of visual 
field loss (227). 
Visual Disability Questionnaire and Measures of Visual Function 
Fisher's Exact two -tail test was used to determine the relationship (227). 
Summary Performance Measure for Visual Disability Questionnaire. 
Relationship with Visual Function Tests 
Analysis of variance of the General linear models procedure was carried out to 
investigate the relationship between a summary performance value and each of 




9.1 Visual Disability Questionnaire 
9.1.1 Factor Analysis 
Factor analysis, as was mentioned earlier, deals with the interrelationships within 
the data. It reveals the key groups of questions which underpin the problems 
reported by subjects. 
Factor analysis identified five new groups of questions (factors). Taken 
together, these factors accounted for most of the variability in patients' responses 
(79 %) and are summarised under the following general headings: central and near 
vision, peripheral vision (or actions demanding functional peripheral vision), dark 
adaptation and glare, personal care / household tasks and outdoor mobility. The 
technique simplified 36 questions in the questionnaire into five main groups. 
Questions that correlated best on the five factors of the factors structure 
are listed in Table 10. 
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TABLE 10. Factor structure of the data. 
FACTOR 1 FACTOR 2 FACTOR 3 FACTOR 4 FACTOR 5 DAILY ACTIVITIES 









Reading TV text .86 
Watching TV .79 
Bingo .78 
Following a line of print .75 
Reading letters .74 
Reading hymn numbers 
in the church .72 
.70 
Shopping .69 
Recognising faces .65 
Seeing bus numbers .64 . 
Bumping into objects .82 
Steps / stairs .76 
Seeing in periphery .68 
Indoor mobility .68 
Visiting friends & 
restaurants 
.66 
Judging distance of foot 
from step .64 
Tripping over .63 
Walking on uneven 
ground .55 . 
Adjusting to dim lights .81 
Going from light to dark .78 
Glare .77 
Seeing at night .74 
Walking in the dark .68 
Finding dropped objects .64 
Colour perception .40 




Needlework .60 . 
Walking on the street 77 
Crossing the road .72 
Using a bus .57 
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For the first factor, highly correlated activities were observed relating to central 
and near vision such as reading TV text, watching TV, watching bingo, following 
a line of print, reading letters, hymn numbers in the church or reading newspapers, 
shopping, recognising faces and seeing bus numbers. The second factor 
peripheral vision indicated difficulty with activities demanding functional 
peripheral vision such as bumping into objects, walking on steps or stairs, seeing 
in the periphery, moving in unfamiliar places while visiting friends and moving 
around in restaurants, judging distance of foot from step, tripping over objects 
and walking on uneven ground. Difficulties related to dark adaptation and glare 
such as adjusting to dim lights, going from light to dark or vice versa, disability 
glare, seeing at night, walking in the dark, finding dropped objects (this is an 
activity which is crucially dependent on sufficient lighting). Colour perception 
difficulties also correlated on this factor. A number of peripheral vision questions 
(Factor 2) had correlations which spread also across Factor 3; these are not 
presented in the Table 10 because the correlations were lower than the threshold 
of inclusion in the table. This is an indication that these two factors may integrate 
into a "glaucoma specific factor ". The fourth factor Personal care and 
household tasks clearly defined problems with typical household and personal 
activities: pouring tea, working in the garden, cooking, dressing, needlework. 
Outdoor mobility tasks like walking on the street, crossing the road and using a 
bus correlated on the fifth factor. 
117 
9.1.2 Visual Disability Questionnaire in Relation to a Measure of Severity 
of Visual Field Loss 
Fisher's Exact Test (2- tail), SAS was used to perform this analysis. Fifteen 
questions were found to be significant predictors of visual field loss (Table 11). 
Six of these questions correlated on Factor 3 (dark adaptation and glare) of the 
questionnaire factor structure, six questions correlated on Factor 2 (actions 
demanding functional peripheral vision), two questions correlated on Factor 1 
(central and near vision) and one question correlated on Factor 5 (outdoor 
mobility) (Tables 10, 11). The best predictors seem to be the questions on the 
following activities / abilities: walking after dark (p<0.001), seeing at night 
(p<0.001), seeing objects coming from the side (p<0.001), adjusting to dim light 
(p= 0.001), walking on uneven ground (p= 0.001), disability glare (p= 0.002), 
going from light to dark room or vice versa (p= 0.002), recognising faces 
(p= 0.002), tripping over objects (p= 0.004), finding dropped objects (p= 0.005), 
judging distance of foot to step (p= 0.005), crossing the road (p= 0.006), walking 
on steps / stairs (p= 0.009), reading newspapers (p= 0.01), bumping into objects 
(0.02). 
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TABLE 11. Glaucoma Visual Disability questionnaire in relation to a measure 
of severity of visual field loss. Fisher's Exact Test (2- tail). 
Daily Activity Severity Factor Factor Description 
of VF loss No. 
p -value 
Walking. after dark 




Seeing at night 
Seeing objects coming 
from the side 
Adjusting to dim light 
Walking on uneven ground 
Glare 
Going from light to dark room or vice 
versa (13) 
Recognising faces (30) 
Tripping over objects(17) 
Finding dropped objects (10) 
Judging distance of foot 
to step (20) 
Crossing the road (22) 
Walking on steps/stairs (16) 
Reading newspapers (27) 















Dark adaptation & glare 
Peripheral vision 
Dark adaptation & glare 
Peripheral vision 
Dark adaptation & glare 
Dark adaptation & glare 
Central & near vision 
Peripheral vision 




Central & near vision 
Peripheral vision 
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9.1.3 Summary Performance Measure for Visual Disability 
Questionnaire. Relationship with Severity of Visual Field Loss 
As there were no missing values in the set of answers a summary performance 
measure (or: questionnaire index) was calculated by simply adding the scores on 
the 15 questions that were found to be significantly correlated with the severity 
of visual field loss (Table 11). 
Severity of visual field loss. This summary measure was compared to 
perimetric Mean Deviation (MD) value (binocular transformation, details in 
`Statistical Analysis') as well as to the measure of severity of visual field loss as 
defined in Methods. General linear models procedure was used to analyse the 
data. The relationship was significant for both measures, using Type III SS test 
(p <0.0001). Correlation with perimetric MD value was significant (p <0.0001, r =- 
0.6). Within the patient group, group differences were noted between mild and 
severe visual field loss (p= 0.008), but not between the groups with mild and 
moderate (p =0.08) or moderate and severe (p =0.16) visual field loss (Table 12); 
however there was an evidence of difference between these groups and when 
increasing group numbers this difference could lead to significant results. There 
was a strong difference between normal subjects and all of the three patient 
groups (p <0.01). 
The reliability of the questionnaire subscale selected for the questionnaire 
performance index (Table 11) was tested using Cronbach's a. This value was 
found to be high at Cronbach's a = 0.92. 
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TABLE 12. Relationship between severity of visual field loss and visual 
disability questionnaire performance measure. Overall p- value <0.0001. 
(General linear models procedure, Least square means analysis). 
Questionnaire Normal VF Mild VF loss Moderate VF loss 
Normal VF 
Mild VF loss 
Moderate VF loss 















VF: visual field. Results adjusted for the influence of age, sex, physical disability, pupil size 
and local ophthalmic medication. (* Indicates trend towards significance. Significance may 
be achieved with a larger sample size.) 
9.1.4 Sensitivity / Specificity Ratios for the Questionnaire Performance 
Index. Unadjusted Values. 
Sensitivity and specificity ratios for the questionnaire performance index, as 
seen in Table 13, Figures 2 -5, were based on the original visual disability index 
values, i.e. raw data (no adjustment for other factors, see paragraphs below). 
When separating patients from normals the ratio was 77/82 %. When separating 
early glaucoma from normals, this ratio decreased to 65/82 %. The questionnaire 
index separated normals from patients with moderate visual field loss with a high 
sensitivity /specificity ratio 79/100% and this increased when separating normals 
from patients with severe visual field loss to 100/82 %. 
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Table 13. Sensitivity /Specificity ratio of the questionnaire performance index. 
Normal controls 
All patients 77/82 % 
Mild VF loss 65/82 % 
Moderate VF loss 79/100 % 
Severe VF loss 100/82 % 
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Figure 2. Sensitivity / Specificity relationship. Questionnaire Performance 


















Figure 3. Sensitivity / Specificity relationship. Questionnaire Performance 
Index (data prior to adjustment): Comparing normal controls and patients with 
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Figure 4. Sensitivity / Specificity relationship. Questionnaire Performance 
Index (data prior to adjustment): Comparing normal controls and patients with 
moderate visual field loss. 




Figure 5. Sensitivity / Specificity relationship. Questionnaire Performance 
Index (data prior to adjustment): Comparing normal controls and patients with 
severe visual field loss. 




9.1.5 Sensitivity / Specificity Ratios for Questionnaire Performance Index: 
Data Adjusted for the Influence of Age, Sex, Physical disability, Pupil 
Size and Ophthalmic Medication ( Pilocarpine or other) 
An attempt was made to adjust this relationship for the set of variables including 
age, sex, physical disability, pupil size and local ophthalmic medication 
(Pilocarpine or other) as stated in Subjects section. Pupil size emerged as a single 
parameter with significant impact on the summary (index) measure of self - 
reported disability (p= 0.027). Sensitivity /specificity relationship improved after 
adjustment (Figures 6,7). Figure 6: normal controls and patient group, Figure 7: 
normal controls and group with mild visual field loss. 
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Figure 6. Sensitivity / Specificity relationship. Questionnaire Performance 
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Figure 7. Sensitivity / Specificity relationship. Questionnaire Performance 
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9.2 Visual Function Tests in Relation to a Measure of 
Severity of Visual Field Loss in Four Groups with 
Various Degrees of Visual Field Loss 
The General linear models procedure of SAS statistical software was used to 
analyse the relationship between visual tests and measure of the severity of visual 
field loss. All the results were adjusted for the influence of age, sex, other medical 
conditions, pupil size and ophthalmic medication. All tests have been found to 
have very strong statistically significant predictive power (p <0.005), Table 14. 
Sensitivity /Specificity relationship is given in Figures 8 -15. Where necessary, 
values were fitted after exploring relationship with age, sex, pupil size and local 
ophthalmic medication (Pilocarpine or other) and resulted in improved 
sensitivity /specificity ratios. 
The majority of the psychophysical tests did not show statistically 
significant difference between mild and moderate visual field loss, and the number 
of tests separating the normal visual field and mild visual field loss groups was 
restricted to dark adaptation, glare disability and contrast sensitivity. 
For a detailed analysis of the relationship between the severity of visual 
field loss and performance on each of the tests, see Tables 15 to 22. The results are 
summarised in Table 23. 
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TABLE 14. Psychophysical tests in comparison to the severity of visual field 
loss. General linear models procedure. Type III SS test. 
Psychophysical test 
Snellen VA 




Pelli- Robson CS 
Glare BAT medium 













p-value < 0.05 * 










Figure 8. Sensitivity /specificity relationship. Esterman binocular visual field 
test: Comparing patients and normal controls. Original data. 
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Figure 9. Sensitivity /Specificity 
patients and normal controls. 







relationship. Stereoacuity: Comparing 
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B) Fitted values after exploring relationship with age, sex, pupil size and local 
ophthalmic medication 
0 
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Figure. 10. Sensitivity /Specificity relationship. Critical flicker frequency: 
Comparing patients and normal controls. 
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Figure 11. Sensitivity /Specificity relationship. Contrast sensitivity using Visual 
Stimulus Generator: Comparing patients and normal controls. 
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Figure 12. Sensitivity /Specificity relationship. Pelli- Robson contrast 
sensitivity: Comparing patients and normal controls. Original data. 
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Figure 13. Sensitivity /Specificity relationship. Brightness Acuity Tester glare 
disability (medium glare): Comparing .atients and normal controls. o 
A) Original data. 
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Figure 14: Sensitivity /Specificity relationship. Brightness Acuity Tester glare 
disability (high glare): Comparing patients and normal controls. 
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Figure 15. Sensitivity /Specificity relationship. Dark adaptation: Comparing 
patients and normal controls. 
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TABLE 15. Esterman binocular visual field test results in relation to visual 
field loss. General linear models procedure. Method of least square means. 
Normal VF Mild VF loss Moderate VF loss 
p -value p -value p -value 
Mild VF loss.............. 
:... 
Moderate VF loss 0.013* 0.013* 
Severe VF loss <0.0001** <0.0001** 0.011* 
*p <0.05 **p<0.01 
TABLE 16. Stereopsis test results in relation to visual field loss. 
General linear models procedure. Method of least square means. 
Normal VF Mild VF loss Moderate VF loss 
p -value p -value p -value 
Mild VF loss 
Moderate VF loss 







*p <0.05 * *p <0.01 
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TABLE 17. CFF test results in comparison to visual field loss. 
General linear models procedure. Method of least square means. 
Normal VF Mild VF loss Moderate VF loss 
p -value p -value p -value 
Mild VF loss 
Moderate VF loss 





0.009 ** 0.082 
*p <0.05 * *p<0.01 
TABLE 18. Contrast sensitivity (Visual Stimulus Generator) in comparison to 
visual field loss. General linear models procedure. Method of least square 
means. 
Normal VF Mild VF loss Moderate VF loss 
p -value p -value p -value 
Mild VF loss 
Moderate VF loss 






*p <0.05 * *p<0.01 
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TABLE 19. Pelli- Robson CS test results in comparison to visual field loss. 
General linear models procedure. Method of least square means. 
::. ,: F.::..v ..... rF ,rlh..h...F.::ñ..:..:.....:. :F'.':l ry.Y.., lr ¿:l.il : . ¿:h/rl.:.:.Ylt.::..:h:'A.: ,'.' ¿:ry ¿ {: ::.'.'.'.':,: ¿::...... .... ;. : . ......: ... :. :... ................... rllF/ r1.; 4' li.: yA:.','J Fi/./ Niiïll.:f,.llillN:.:.r ¿:;2y ..v. 
Normal VF Mild VF loss Moderate VF loss 
Mild VF loss 
Moderate VF loss 










*p<0.05 * *p<0.01 
TABLE 20. Glare BAT test results (MEDIUM) in comparison to visual field 
loss. General linear models procedure. Method of least square means. 
Normal VF Mild VF loss Moderate VF loss 
p -value p -value p -value 
Mild VF loss 0.008** 
Moderate VF loss 0.018* 0.722 
Severe VF loss <0.0001 ** 0.019* 0.009 ** 
*p <0.05 * *p <0.01 
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TABLE 21. Glare BAT test results (HIGH) in comparison to visual field loss. 
General linear models procedure. Method of least square means. 
Normal VF Mild VF loss Moderate VF loss 
p -value p -value p -value 
Mild VF loss 0.023* 
Moderate VF loss 0.029* 0.900 
Severe VF loss <0.0001 ** 0.010 ** 0.008 ** 
*p<0.05 * *p<0.01 
TABLE 21 Dark adaptation test results in comparison to visual field loss. 
General linear models procedure. Method of least square means. 
Normal VF Mild VF loss Moderate VF loss 
p -value p -value p -value 
Mild VF loss 0.0 13* 
Moderate VF loss 0.001** 0.354 
Severe VF loss <0.0001** 0.008** 0.047* 
*p <0.05 * *p <0.01 
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Table 23. Psychophysical tests 
Specific groups. 
Psychophysical Normals vs. 
tests Mild loss 
(p- value) 
in relation to severity of visual field loss. 
Normals vs. Mild loss vs. Mod. loss vs. 
Mod. loss 
(p- value) 
Mod. loss Severe loss 
(p- value) (p- value) 
Esterman VF test 0.971 0.013"..:..: 
:... 
0.013 0.011 
Stereopsis 0.598 0.497 0.879 0.000 
CFF 0.058 0.002 0.215 0.082 
CS (VSG) 0.028 0.013 0.785 0.006 
Pelli- Robson CS 0.039 0.001 0.241 0.014 
Glare disability 0.023 0.029 0.900 0.008 
Dark adaptation 0.013 0.001 0.354 0.047 
Comparing normals subjects and patients with mild visual field loss. When 
separating normals from mild glaucoma, a group of tests emerged including dark 
adaptation, glare disability and contrast sensitivity giving significant results when 
separating these two groups. The best results were obtained for dark adaptation 
(p= 0.013) and glare disability (p= 0.023), followed by contrast sensitivity using 
the Visual Stimulus Generator (p= 0.028) and the Pelli- Robson chart (p= 0.039) 
(Table 23). Sensitivity /Specificity ratios (Figures 16 -19), were adjusted, where 
necessary, for influence of age, sex, pupil size and ophthalmic medication 
(Pilocarpine or other), which resulted in improved ratios. 
No significant results were found in our study between normals and early 
glaucoma for critical flicker frequency, stereopsis and Esterman visual field tests 
(p >0.05) (Table 23). 
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Figure 16. Sensitivity /Specificity relationship. Dark adaptation: Comparing 
patients with mild visual field loss and normal controls. 
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Figure 17. Sensitivity /Specificity relationship: Glare disability. Comparing 
patients with mild visual field loss and normal controls. C 
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B) Fitted values after exploring relationship with age, sex, pupil size and local 
ophthalmic medication 
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Figure. 18. Sensitivity /Specificity relationship. Contrast sensitivity using Visual 
Stimulus Generator: Comparing patients with mild visual field loss and normal 
controls. 
A) Original data. 
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Figure 19. Sensitivity /Specificity relationship. Pelli- Robson contrast 
sensitivity: Comparing patients with mild visual field loss and normal controls. 
Original data. 
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Comparing normal subjects and patients with moderate visual field loss. 
Stereopsis was the only test in our study that did not discriminate normals from 
patients with moderate binocular visual field loss (p >0.05) (Table 23). The best 
performance was shown on the following tests: dark adaptation (p= 0.001), Pelli- 
Robson contrast sensitivity (p= 0.001) and critical flicker frequency (p= 0.002), 
followed by contrast sensitivity VSG (p= 0.013), Esterman visual field test 
(p= 0.013) and glare disability (p= 0.029). 
Comparing patients with mild visual field loss and patients with 
moderate visual field loss. None of the tests, with the exception of the Esterman 
binocular visual field test (p= 0.013), separated patients with mild from patients 
with moderate binocular visual field loss (p >0.05) (Table 23). The positive results 
of the Esterman test are not surprising as the initial grouping of patients into three 
groups, as mentioned in Subjects, was based on their perimetric results from 
Humphrey 24 -2 Programme. 
Comparing patients with moderate visual field loss and patients with 
severe visual field loss. All tests with the exception of CFF separated 
significantly (p <0.05) between moderate and severe glaucoma (Table 23): 
stereopsis (p= 0.000), contrast sensitivity VSG (p= 0.006), glare disability 
(p= 0.008), Esterman test (p= 0.011), Pelli- Robson contrast sensitivity (p= 0.014) 
and dark adaptation (p= 0.047). 
9.3 Relationship between Various Visual Function Tests 
and Specific Daily Life Activities. 
Fisher's Exact Test was used to investigate the relationship between visual 
function tests and items of the visual disability questionnaire in our sample of 
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patients and normals. Dark adaptation, binocular Esterman visual field test and 
binocular CFF were the tests that were significantly associated with a number of 
activities (Table 24). 
TABLE 24. Relationship between visual function tests and some daily 
activities / abilities. 
::. :...: nr:::::un.:. : ..... .........n.. /. ?:Kw:F. ?:.4.: ::hC::;ïIX ¿ +lrF..r ?vin +Fi ::: ?::: ?.:lnr.: .q ::.N:: :.: :..: :.r :::.: ::::::v... 
Activity Visual Function Test p -value Significance 
Indoor mobility dark adaptation .084 
Findings things Esterman .015 
that one's dropped Ross CS SD .019 * 
Glare CFF .091 
Ross CS .093 
Adjusting to dim light Esterman .049 * 
CFF .005 ** 
Ross CS SD .090 
dark adaptation .035 * 
Going from light to dark dark adaptation .067 
Colour Esterman .035 * 
Walking on uneven ground stereopsis .070 
Walking on steps or stairs Esterman .080 
Tripping over objects Esterman .019 * 
CFF .049 * 
Pelli- Robson .073 
dark adaptation .045 * 
Bumping into objects CFF .057 
dark adaptation .006 ** 
Seeing in periphery .017 * 
CFF .024 * 
Pelli- Robson .073 
dark adaptation .007 ** 
:?Uf.+h:hFi....[:::.iiii:fi+.+iilFAYfiI/f/I.HFI:r.:f.i'i.?+N.?L+.+I.G? Hï.i'l.?4.Fi'f.+iiq'Fif.FiiriFiFiifi:'f.+Ri'lFfiffi:fif.xiA'/.??x+lf.t+i.t?4:A'+FFR'iFfh:.Yü+P.C+Iin.J.IX. 
*p<0.05 * *p <0.01 
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TABLE 24. Relationship between visual function tests 
and some daily activities / abilities (continued from the previous page). 
Activity Visual Function test p -value Significance 
Judging distance of Esterman .050 
foot from steps or stairs CFF .068 
dark adaptation .030 
Walking on the street VA .030 
dark adaptation .005 * * 
Crossing the road Esterman .030 * 
CFF .006 ** 
dark adaptation .041 
Walk in after dark Esterman .078 
CFF .057 
dark adaptation .005 ** 
Seeing at night Esterman .069 
CFF .043 
dark adaptation .009 * * 
Reading newspapers Ross CS SD .055 
Pelli- Robson .035 
Following a line of print Esterman .045 
Pelli- Robson .035 
Recognising faces Esterman .003 * * 
,,,,,:::,:,. .::,::,..,«.;:: .ï:.>>,:,.; ..,.::<.:«<,::. ..:ï<:<:::;;,<<.,.... .., 
*p<0.05 * *p<0.01 
Dark adaptation correlated strongly with the questions (Table 25): walking on 
the street (p= 0.005), walking after dark (p= 0.005), bumping into objects (0.007), 
seeing in periphery (0.007), seeing at night (p= 0.009); and mildly with the 
questions: judging distance of foot from a step (p= 0.030), adjusting to dim light 
(p= 0.035), difficulty walking on steps (p= 0.0380), crossing the road (p= 0.041) 
and tripping over objects (p= 0.045). 
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TABLE 25. DARK ADAPTATION 
Relationship with questionnaire items. Fisher's Exact Test. 
Task / Activity p -value Significance 
Walking on the street 0.005 ** 
Walking after dark 0.005 ** 
Bumping into objects 0.007 * * 
Seeing in periphery 0.007 * * 
Seeing at night 0.009 ** 
Judging distance of foot 
from a step 0.030 
Adjusting to dim light 0.035 
Difficulty walking on steps 0.038 
Crossing the road 0.041 
Tripping over objects 0.045 
Going from light to dark 0.067 
Glare 0.070 
Indoor mobility 0.084 
,,,.v,,:.,,<...,,.....,. :,-,,.:.,«...,F,,,.,,,.....:.,.,,:>,..>...f,,.,.,..,,,:,,.;>:,. :<.,,.::,.....,,,,.,,: ,::::,.,:.,..... 
*p<0.05 **p<0.01 
Binocular Esterman visual field tests correlated strongly with the following 
problems (Table 26): recognising faces (p= 0.0031), falls (0.0042), finding dropped 
objects(p = 0.015), seeing in the periphery (p= 0.017), tripping over objects (0.019); 
and less strongly with the problems: crossing the road (p= 0.030), colour 
152 
perception (0.035), following a line of print (p= 0.045), adjusting to dim light 
(p= 0.049) and judging distance of the foot from a step (p= 0.050). 
TABLE 26. BINOCULAR ESTERMAN VISUAL FIELD TEST 
Relationship with questionnaire items. Fisher's Exact Test. 
Task Activity p -value Significance 
Recognising faces 0.003 * 
Falls 0.004 ** 
Findings things that one's dropped 0.015 
Seeing in periphery 0.017 
Tripping over objects 0.019 
Crossing the road 0.030 * 
Colour 0.035 
Following the line of print * 
Adjusting to dim light 0.049 
Judging distance 
of foot from a step 0.050 
Seeing at night 0.069 
Walking after dark 0.078 
Walking on steps or stairs 0.080 
....5 :ü+Ffl.:: fffl.M:J.:::'f.:ti:::f.FYYf::Yi'1.4f£.:lFfffFf.::%fl/.+f.'+.+lfFfJfflfflffff(fff.+/f.ti^'f. .: +ffFff.^YllKff.^Yfi:Y'f. f: fFiff.+l.F.:Y.:::4Jff.f+iYfFl: ffffr.+f.::+lF.Oi 
*p<0.05 * *p <0.01 
In Table 27, C1-4- correlated highly with having difficulties in: falls (p= 0.003), 
crossing the road (p= 0.004), adjusting to dim lights (p= 0.005), glare (p= 0.002); 
and mildly with the difficulties in: seeing in periphery (p= 0.024), seeing at night 
(p= 0.043) and tripping over objects (p= 0.049). 
153 
TABLE 27. CRITICAL FLICKER FREQUENCY 
Relationship with questionnaire items. Fisher's Exact Test. 
Activity / Task p -value Significance 
Falls 0.003 ** 
Crossing the road 0.004 ** 
Adjusting to dim lights 0.005 * * 
Glare 0.020 
Seeing in periphery 0.024 
Seeing at night 0.043 
Tripping over objects 0.049 
Steps 0.056 
Bumping into objects 0.057 
Walking after dark 0.057 
Judging distance from 
foot to step 0.068 
Glare 0.091 
*p <0.05 * *p<0.01 
The contrast sensitivity test, using VSG, correlated highly with difficulties 
resulting in falling (p= 0.011). In Table 28, the Pelli- Robson contrast sensitivity 
test correlated mildly with difficulties when reading newspapers (p= 0.035), 
following a line of print (p= 0.035) and going from light to dark or vice versa 
(p= 0.035) (Table 29). 
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TABLE 28. CONTRAST SENSITIVITY Visual Stimulus Generator 
Relationship with questionnaire items. Fisher's Exact Test. 
Activity / Task p -value Significance 
Falls 0.011 ** 
Glare 0.093 
*p<0.05 **p<0.01 
TABLE 29. PELLI- ROBSON CONTRAST SENSITIVITY. 
Relationship with questionnaire items. Fisher's Exact Test. 
Activity / Task p -value Significance 
Reading newspapers 0.035 
Following the line of print 0.035 
Going from light to dark or vice 0.035 
versa 
Tripping over objects 0.073 
Seeing in periphery 0.073 
Glare 0.096 
*p<0.05 * *p <0.01 
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9.4 Summary Performance Measure for Visual Disability 
Questionnaire. Relationship with Visual Function Tests 
The summary measure (calculated was a summed score on the basis of 
performance on 15 questions in the Table 11) correlated well with a number of 
psychophysical tests (Table 30): Pelli- Robson contrast sensitivity (p= 0.000), 
medium glare brightness (p= 0.000), Esterman binocular visual field test (p= 0.001), 
high glare brightness (p= 0.003), dark adaptation (p= 0.007), critical flicker 
frequency (p= 0.014), contrast sensitivity using the Visual Stimulus IGenerator 
(p= 0.016) and stereopsis (p= 0.044). 
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TABLE 30. Relationship between the summary performance measure for 
visual disability questionnaire and the visual function tests. 
Test p -value Significance 
Mean deviation <0.0001 ** 
Snellen VA 0.201 
Esterman VF 0.001 ** 
Stereopsis 0.044 
CFF 0.014 ** 
CS VSG 0.016 ** 
Pelli- Robson CS <0.0001 ** 
Glare medium brightness <0.0001 * * 
Glare high brightness 0.003 ** 
Dark adaptation 0.007 ** 
*p <0.05 * *p<0.01 
9.5 Influence of Age, Sex, Physical Disability, Pupil size and 
Ophthalmic Medication ( Pilocarpine or other) 
It was not a primary purpose of this study to investigate the relationship between 
visual function/disability and factors such as age, sex, physical disability, and 
ophthalmic medication (we compared patients who took Pilocarpine against the 
rest of the sample). However some comparisons were made, and very interesting 
results were obtained which, to our knowledge, have not been reported in other 
studies before and are in short summarised here. 
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Esterman binocular visual field test. No association with any of the above 
factors. 
Stereopsis. Association with pupil size (p= 0.038) and ophthalmic medication 
(p= 0.003). A larger pupil size was associated with better performance. In the 
group with severe visual field loss those patients who were on Pilocarpine 
performed better than those who did not take Pilocarpine. 
Critical flicker frequency. An age related decline was present (p= 0.002). Those 
patients who were on Pilocarpine had on overall lower CFF results than the rest 
of the group. Relationship with sex parameter was also significant (p= 0.010). 
Women performed worse than men. 
Contrast sensitivity VSG. Significant influence of age (p= 0.004) and ophthalmic 
medication (p= 0.014). A different relationship between age and contrast 
sensitivity depending on whether patients took or did not take Pilocarpine. Those 
patients on Pilocarpine had decreased contrast sensitivity when compared to the 
rest of the sample. 
Pelli- Robson contrast sensitivity. No association with any of these factors. 
Glare medium brightness. An age related decline was present (p= 0.004). Patients 
on Pilocarpine had worse glare scores than the rest of the sample (p= 0.023). 
Glare high brightness. An age related decline (p= 0.001). Patients on Pilocarpine 
performed worse than the rest of the sample (p= 0.001). 
Dark adaptation. Influence of age (p= 0.001) and ophthalmic medication 
(p= 0.001). Age and Pilocarpine result in comparatively worse threshold values. 
Questionnaire index. A smaller pupil was associated with better performance 
(p= 0.027). Pupil size seemed to have greater influence than visual field loss. 
Conclusion. These results seem to indicate that the effects of factors such as 
ophthalmic medication, pupil size and others have a lot stronger effect on visual 
function and visual disability than it is currently sought. For example, it would 
seem that Pilocarpine produces a decrease in contrast sensitivity and an increase 
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in glare disability that is greater than the difference resulting from glaucomatous 
damage. If these results will be confirmed in other studies, it could lead to 
dramatic changes in glaucoma treatment. In another example, it seems that pupil 
size may have stronger effect on overall performance than visual field loss itself. A 
number of questions arise considering the outcome. How does this reflect in 
performance, for example, drivers? Are drivers with smaller pupil at an advantage 
compared to those with larger pupil? What is the extent of combined pupil size 
and visual field loss on driving performance? Which influence is greater? A wholé 
new research area opens when considering these questions. 
However, it is necessary to note that the above differences could be 
associated with small differences in the mixture of patients in each of the groups. 
For example, although these differences were not significant (Table 9), group with 
severe visual field loss had slightly higher proportion of patients on Pilocarpine. 
A few studies recently attempted to estimate to what extent side effects of 
treatment result in decreased quality of life, however a little is known about the 
influence of these factors on visual function. More research work is needed if we 
are to understand visual function and visual disability in glaucoma. 
9.6 Summary 
Factor analysis reinforced the findings from the pilot study indicating that central 
and near vision, peripheral vision (or actions demanding functional peripheral 
vision), dark adaptation and glare, personal care / household tasks and outdoor 
mobility are major groups of concern for glaucoma patients. The technique 
simplified 36 questions in the questionnaire into five main groups and indicated a 
separation between the peripheral function questions, i.e. tripping over and 
bumping into objects etc., and the specific glare and dark adaptation questions. 
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Fifteen questions from the original questionnaire were found to have a 
strong correlation with the severity of binocular visual field loss. These questions 
were related to three factors: activities demanding functional peripheral vision 
(seeing objects coming from the side, walking on uneven ground, tripping over 
objects, judging distance of foot to step, walking on steps /stairs, bumping into 
objects), dark adaptation & glare disability (walking after dark, seeing at night, 
adjusting to dim light, glare, going from light to dark room or vice versa, finding 
dropped objects) and outdoor mobility (crossing the road). 
When exploring the relationship between severity of visual field loss and 
the summary performance measure for the questionnaire, it was found that within 
the patients, group prediction was possible between mild and severe visual field 
loss (p= 0.022), but not between mild and moderate (p= 0.150) or moderate and 
severe (p= 0.217) visual field loss. There was a strong difference between normals 
and any of the three patient groups (p <0.01). 
All psychophysical tests, i.e. Esterman binocular visual field test, 
stereoacuity test, critical flicker frequency, contrast sensitivity using Visual 
Stimulus Generator, Pelli- Robson contrast sensitivity, glare disability and dark 
adaptation did show highly significant relationship with a measure of visual field 
loss (p<0.01). The only exception was colour test using Farnsworth desaturated 
D -15. When looking in detail at the results of each test in our study, it is clear that 
although tests discriminate well between extremes, i.e. between normals /mild 
glaucoma and advanced glaucoma, the difference is not quite so pronounced and 
often not significant when comparing neighbouring groups, particularly mild and 
moderate glaucoma. Only tests on dark adaptation, glare disability and contrast 
sensitivity showed significant differences between normals and early glaucoma. 
A strong relationship was found between the summary performance 
measure of the questionnaire and all psychophysical tests (all tests p <0.01, 
stereopsis p <0.05). The relationship between function and visual disability was 
160 
strongest for Pelli- Robson contrast sensitivity (p<0.0001), medium glare test 
(p <0.0001), Esterman binocular visual field test (p<0.001), high glare test 
(p= 0.003) and dark adaptation (p= 0.007) and equally /comparably as strong as 




10.1 Visual Disability Questionnaire 
10.1.1 Comparisons with Previous Research Work 
This study has identified near vision, peripheral vision, dark adaptation and 
care and household tasks, and outdoor mobility as the main 
groups of difficulties encountered by glaucoma patients. This factor structure 
confirmed the findings of the pilot study in this research work and also the 
previous findings of Ross et al (41) (Table 31). 
Both the sample in the study of Ross and the sample in this study were 
comparable in their size and considered the same age group (41). Both studies 
examined subjects with varying degrees of the visual field loss and used a similar 
technique to analyse the data. 
A factor central and near vision corresponded to questions on reading 
tasks in our questionnaire and was observed in the pilot study as well as in the 
study by Ross et al (41). Two questions had a strong relationship with a measure 
of visual field loss in our study and were included in the shortened form of the 
questionnaire that was used for statistical analysis. These two questions were: 
recognising faces and reading newspapers. 
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TABLE 31. Comparison of the factor structure reported by Ross et al 1984 (41) 
with the factor structure resulting from the pilot and the present study. 
Present study Pilot study Ross et al 
Central and near vision Near vision Near vision 
Peripheral vision Activities demanding 
functional peripheral vision 
and 
Dark adaptation disability glare & lighting Navigation at night 
& disability glare 
Personal care Personal care 
and household tasks Household tasks Vision when cooking 
Outdoor mobility Outdoor mobility Navigation outdoors 
Although we are dealing with a disease that attacks peripheral vision primarily, 
good central vision is so essential to human beings that it is not surprising that it 
appears in our analysis as a separate issue. We understand that the cut -off point 
6/12 for visual acuity in our study would give some space for influences that 
resulted either from ageing or low tension glaucoma in our patients. For example, 
clinically non -significant cataract, uncorrected refractive error (many subject fail 
to visit an optometrist frequently enough) or scotoma near the central vision area 
may have some influence. In our pilot study this factor did not significantly 
contribute to the factor structure of the data and was not mentioned in great 
detail. In the main study the contribution of this factor to the factor structure was 
much greater. It is presumed that this difference between the pilot and the main 
study appeared as a result of slightly different patient mixture, possibly more 
severe stage of the disease in the pilot study as the cut -off point 6/12 for visual 
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acuity was taken for the better eye only, whereas in the main study we applied it 
for both eyes. In addition, because we used the cut -off point 6/12 for visual 
acuity in right and left eye, we have excluded a very severe group of patients 
with visual acuity below 6/12. These patients may have very considerable 
disability. 
Six out of fifteen questions which were found to be strongly correlated 
with a measure of severity of visual field loss were related to peripheral vision 
factor. These were: seeing objects coming from the side, walking on uneven` 
ground, tripping over objects, judging distance of foot to step, walking on 
steps /stairs and bumping into objects. In the pilot study these questions collapsed 
together with questions on disability glare and lighting into one factor, and we 
suggested that this seemed to be a factor specific for glaucoma. In the 
questionnaire for the main study we expanded on the range of questions that 
were related to both subjects, peripheral vision and glare & lighting and therefore 
two separate factors have emerged in the main study and came as no surprise. 
Questions similar to those used in our study were also listed by Ross et al 
in their study (41), for example walking on uneven pavement or walking on steps. 
We presume that in their study these questions would correlate with the factor 
called navigation outdoors. Contrary to Ross et al, in our study we decided to 
give the title outdoor mobility to a separate factor with questions such as 
walking on the street, crossing the road or using a bus. The difference 
here 
therefore is not a matter of different content but a different label. 
Difficulty with navigation at night as mentioned in the study by Ross et 
al (41) suggested the presence of difficulty with adaptation to different 
levels of 
lighting and this issue emerged in the pilot study and also in the 
main study as a 
separate factor dark adaptation and disability glare. Six questions 
had a strong 
statistically significant relationship with a measure of visual 
field loss. These were: 
walking after dark, seeing at night, adjusting to dim light, 
glare (disability glare, i.e. 
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degree of glare that restricts ability to see), going from light to dark room or vice 
versa and finding dropped objects. Although the last question initially seem to be 
out of place in this factor we presumed that it may be a task greatly dependent on 
the amount of light available and that may be the reason why it correlated on this 
factor. 
Vision when cooking listed by Ross (41) was one of the activities that 
correlated on the factor with the general heading of household tasks in the pilot 
study. In the main study, the two factors household tasks and personal care from 
the pilot study collapsed into one factor and included questions such as pouring 
tea, working in the garden, cooking, dressing and needlework. Most of these 
activities would require mainly good central vision and this was preserved in our 
patients in the main study. None of the activities showed a strong significant 
relationship with the measure of visual field loss and therefore were not included 
as part of the final shortened questionnaire that was used for the statistical 
analysis. 
The factor described by Ross (41) as navigation outdoors was identical 
with the group of experienced disabilities that correlated on the factor outdoor 
mobility in our pilot as well as the main study. The questions included the 
following activities: walking on the street, crossing the road or using a bus. 
Difficulty when crossing the road was one of the activities with a very strong 
relationship with a measure of visual field loss and it was selected into the fmal list 
of activities used for further analysis (Table 11). 
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10.1.2 List of Daily Activities with the Strongest Relationship with Visual 
Field Loss in Glaucoma 
Although it is useful to be able to ask as much about patients' difficulties as 
possible, for the purpose of a clinically usable tool as well as for research 
investigations it is often more suitable to work with a shorter form of a 
questionnaire. On the basis of the results in this study a number of daily activities 
strongly associated with a measure of visual field loss were selected. 
The shortened subscale consists of fifteen questions related to those 
aspects of daily life that seem to be compromised in glaucoma. All the questions 
were found to have a highly significant relationship with a measure of visual field 
loss in this study (Table 11) and were confirmed as beneficial in the previous 
investigations by Ross et al (41) and Mills and Drance (145) who came to similar 
conclusions. 
These questions related to three most important areas of difficulties as they 
were defined in this study: activities demanding functional peripheral vision 
(activities: seeing objects coming from the side, walking on uneven ground, 
tripping over objects, judging distance of foot to step, walking on steps /stairs, 
bumping into objects), dark adaptation & glare disability (walking after dark, 
seeing at night, adjusting to dim light, glare, going from a bright to a dark room or 
vice versa, finding dropped objects) and outdoor mobility (crossing the road). 
Two questions on central & near vision were also included (reading newspaper, 
recognising faces) because of the importance of information on central vision. 
The fully worded questions are listed in Table 32. 
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TABLE 32. List of daily activities with the strongest relationship with visual 
field loss in glaucoma (based on the results of this study). 
Patient instruction: Please, circle the correct answer on the scale ranging from 1 
to 5 where [1] stands for `no difficulty' and [5] stands for `severe difficulty'. If 
you do not perform any of the activities for other than visual reasons, please circle 
[0]. 






Reading newspapers 1 2 3 4 5 0 
Walking after dark 1 2 3 4 5 0 
Seeing at night 1 2 3 4 5 0 
Walking on uneven ground 1 2 3 4 5 0 
Adjusting to bright lights 1 2 3 4 5 0 
Adjusting to dim lights 1 2 3 4 5 0 
Going from light to dark 
room or vice versa 1 2 3 4 5 0 
Tripping over objects 1 2 3 4 5 0 
Seeing objects coming 
from the side 1 2 3 4 5 0 
Crossing the road 1 2 3 4 5 0 
Walking on steps / stairs 1 2 3 4 5 0 
Bumping into objects 1 2 3 4 5 0 
Judging distance of foot 
to step / curb 1 2 3 4 5 0 
Finding dropped objects 1 2 3 4 5 0 
Recognising faces 1 2 3 4 5 0 
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10.1.3 Relationship between the Questionnaire Performance Index and 
Severity of Visual Field Loss. Comparisons with the ADVS, NEI -VFQ 
and VF14 Questionnaires 
Validity of the questionnaire subscale (Table 11) used in this study was shown in 
a significant relationship with a measure of visual field loss (Table 12), as defined 
in Methods, and perimetric Mean Deviation value (r = -0.6, p <0.0001). This is 
similar to the results published by Sherwood et al on Activities of Daily Vision 
Scores (ADVS) (overall r = -0.6, p<0.0001) (63) and slightly higher than correlations 
for the National Eye Institute- Visual Functioning Questionnaire and the Visual 
Functioning 14 Questionnaire (r= -0.46, p <0.001, scores adjusted for visual acuity) 
(135), (136), 
In addition to these studies, we have also attempted to discriminate 
between various degrees of visual field loss and found that, using the 
questionnaire performance summary measure (questionnaire index), it is possible 
to discriminate between extremes in the glaucoma group, i.e. between mild and 
severe visual field loss groups. However, discrimination between mild and 
moderate or moderate and severe visual field loss groups was difficult as a result 
of overlap in performance. There was a tendency towards significant results and 
in the case of larger groups the results might have reached significant levels. The 
explanation may also lie in the lack of quantifiable objective difference in visual 
function between these groups. When looking in detail at the results of our 
objective psychophysical tests, it is clear that although tests discriminate well 
between extremes, i.e. between normals /mild glaucoma and advanced glaucoma, 
the difference is not quite so pronounced and often not significant when 
comparing neighbouring groups, such as normals and mild/moderate glaucoma. In 
addition, the overlap in performance may also be influenced by different factors 
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such as age, type of employment, education about disease and others. Based on 
observation during our study, although this was not noted for statistical analysis, 
younger people, people who had visually highly demanding jobs such as 
sculpturers, painters etc., and people with knowledge of how the disease 
develops and progresses did tend to be more aware of any changes in their vision 
and progress of their visual field loss. 
Reliability of the questionnaire subscale was shown using Cronbach's a = 
0.92, which was similar to the above mentioned questionnaires. 
Formal test -retest stability /reliability has not been completed at the present 
time However it is clear even now that the pilot study and the main study arrived 
at an identical conclusion with very similar factor structures using a different 
mixture of patients with similar sample characteristics. This seems to be an 
indication that a measure of reliability is present in re- testing characteristics of the 
questionnaire. In addition, the questionnaire was designed using the experience 
of previous research investigations on visual disability in glaucoma and other 
ocular conditions that were shown to have good performance characteristics or 
were shown to be confirmed in other studies (41, 132, 145, 152, 201). 
10.1.4 How much disability do patients suffering from glaucoma experience? 
Based on the results of the pilot and the main study, it seems that most of the 
patients up to the moderate stage of the disease as defined in this study 
experience very little disability as a result of glaucomatous damage to their 
eyesight. It is a good message for patients' prospects of retaining independence, 
mobility and general daily living functioning. However, if disability is 
experienced, this is most likely to be related to three major groups of difficulties: 
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 dark adaptation and glare disability 
activities related to functional peripheral vision 
outdoor mobility 
10.2 Relationship Between Various Psychophysical Measures 
of Visual Function and Severity of Visual Field Loss 
in Glaucoma 
Virtually all the psychophysical tests demonstrated a highly significant 
relationship with a measure of visual field loss (p<0.01) thus confirming the 
findings of many other authors who studied psychophysical function in 
glaucoma in its many aspects (40 -42, 48, 52, 56, 59, 62, 101, 145). 
The only exception was the colour test using Farnsworth desaturated D- 
15. This test was intended for screening purposes, rather than for the in -depth 
study of a colour vision defect. Bassi et al (1993) (100) found this test useful in 
their study on glaucoma and as a result of our literature search we expected 
similar results in our study. At the moment we do not have an explanation why 
this was not the case. The test was performed under the lighting conditions that 
were recommended by the manufacturer and the colour caps were completely 
new. Most of our patients performed the test with the correct result. 
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10.2.1 Comparing Normal Controls to Early Glaucoma and Early Glaucoma 
to Advancing Disease 
A lot of research work has been devoted to the identification of any functional 
differences between normal controls and early glaucoma in order to eliminate 
progress of the disease by early treatment. One of the most recent and most 
comprehensive studies on psychophysical and electrophysiological examination 
in glaucoma was published by Graham and Drance et al in 1996 (52). These 
authors concluded that although most parameters reflected glaucomatous damage 
to a varying degree, no single parameter from the psychophysical tests could 
identify all patients with early glaucoma and still maintain good specificity. They 
suggested that a combination of tests that use different visual functions would be 
useful in detecting early glaucoma or patients at risk for progression to definitive 
glaucoma and that multiple factor analysis with long -term follow up must be 
performed to address this possibility. 
When looking in detail at the results of each test in our study, it is clear 
that although tests discriminate well between extremes, i.e. between normals /mild 
glaucoma and advanced glaucoma, the difference is not quite so pronounced and 
often not significant when comparing neighbouring groups, particularly mild and 
moderate glaucoma (Table 33). Only tests of dark adaptation, glare disability and 
contrast sensitivity showed significant differences when separating normals from 
early glaucoma. 
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Table 33. Psychophysical test in relation to the severity of visual field loss. 
Specific groups. 
Normals vs. Normals vs. Mild VF loss Mod. VF loss 
Psychophysical Mild VF loss Mod. VF loss vs. Mod. VF vs. Severe VF 
tests loss loss 
(p- value) (p- value) (p- value) (p- value) 
Esterman VF test 0.971 0.013 0.013 0.011 
Stereopsis 0.598 0.497 0.879 0.000 
CFF 0.058 0.002 0.215 0.082 
CS (VSG) 0.028 0.013 0.785 0.006 
Pelli- Robson CS 0.039 0.001 0.241 0.014 
Glare disability 0.023 0.029 0.900 0.008 
Dark adaptation 0.013 0.001 0.354 0.047 
Comparing normal subjects and patients with mild visual field loss. When 
separating normals from mild glaucoma, a group of tests emerged including dark 
adaptation, glare disability and contrast sensitivity giving significant results when 
separating these two groups. The best results were obtained for dark adaptation 
(p= 0.013) and glare disability (p= 0.023). This supports the findings by Drum, 
Quigley, Congdon, Glovinsky and others (55 -57) who found abnormal scotopic 
sensitivity in glaucoma, and Hoshino and Mizokami (59) who studied glare in 
glaucoma. Contrast sensitivity was found useful in many studies, by Tyler et al in 
1981, Ross et al in 1984, Adams et al in 1985, Teoh et al in 1990, Sample et al in 
1991, Korth et al in 1989, Essock et al and Graham and Drance et al in 1996 (40, 
45). We used two methods, contrast sensitivity as measured using Pelli- Robson 
chart and contrast sensitivity using the Visual Stimulus Generator controlled by 
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Psycho V2.0 (Cambridge Research Systems, Cambridge, U.K.). Essock et al (62) 
successfully used the Pelli- Robson chart in their study claiming that binocular 
testing was generally more effective at detecting group differences than 
monocular testing. The difference in results between the two methods in our 
study was very small and for its practical advantages we would recommend the 
use of the Pelli- Robson chart. 
Critical flicker frequency, contrary to the results of Kosmin (82) did not 
show significant separation between normals and glaucoma patients with mild' 
visual field loss in our study although it was linked to perceived glare. Essock et 
al similarly did not find differences between normals and early glaucoma for 
either monocular or binocular CFF testing (62). 
No significant results were found for stereopsis and Esterman visual field 
test in our study between normals and early glaucoma (Table 33). 
Comparing normal subjects and patients with moderate visual field loss. 
Stereopsis was the only test in our study that did not discriminate normals from 
patients with moderate binocular visual field loss. Essock et al (62) found that the 
mean stereoacuity of glaucoma patients and suspects was significantly worse 
than the level of stereoacuity expected for normals with the same Snellen acuity 
level. In our study we confirmed the presence of abnormality between patients as 
a group and the normal controls, but this difference was not obvious between 
normals and glaucoma in the mild and up to moderate stage of the disease. It is 
well known that poor stereoacuity is associated with poor Snellen acuity (103). 
However, this was not the relevant consideration for either of the two studies 
because of the high acuity of the patients and that the groups did not differ 
significantly in terms of acuity. 
Comparing patients with mild visual field loss and patients with 
moderate visual field loss. None of the tests, with the exception of Esterman 
binocular visual field test, separated patients with mild from patients with 
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moderate binocular visual field loss. The positive results of the Esterman test are 
not surprising as the initial grouping of patients into three groups was based on 
their perimetric results from Humphrey 24 -2 Programme. In the pilot study we 
mentioned that there was virtually no difference between these two groups in 
relation to their disability and that patients could progress from mild to the 
moderate stage of the disease (as defined herein) without noticing much change 
in their daily life. This finding is supported by the above results from 
psychophysical tests. This suggest that there does not seem to be significant` 
difference between the two groups in most aspects of their visual function as 
measured by objective methods. The lack of difference in visual disability is 
supported by lack of difference in such aspects of visual function as stereoacuity, 
critical flicker frequency sensitivity, contrast sensitivity, glare disability and dark 
adaptation. 
Comparing patients with moderate visual field loss and patients with 
severe visual field loss. All tests with the exception of CFF separated 
significantly (p <0.05) between moderate and severe glaucoma. This is very 
interesting because we stated earlier that there does not seem to be much 
difference in objective visual function between mild and moderate visual field loss 
groups. It may be the case that while progressing to moderate stage, many aspects 
of visual function remain relatively well preserved, however as the damage 
progresses to the severe stage, all aspects of visual function suddenly show rapid 
deterioration. 
174 
10.3 Relationship Between Visual Disability and Various 
Psychophysical Measures of Visual Function in Glaucoma 
A strong relationship was found between the questionnaire summary 
performance measure and all psychophysical tests (all tests p<0.02, stereopsis 
p <0.05). The relationship between function and visual disability was strongest for 
Pelli- Robson contrast sensitivity, glare disability, Esterman binocular visual field 
test and dark adaptation (p <0.01) and equally as strong as for the mean deviation 
perimetric value (p <0.001). 
Our results support the findings of Ross et al (41) who found a relationship 
between visual disability and contrast and flicker sensitivity and findings by Mills 
and Drance (145), who reported Esterman visual field test as a useful tool for 
assessing visual disability in severe glaucoma. We were unable to find any study 
to which we could directly compare our findings about the relationship between 
dark adaptation, glare sensitivity, stereopsis and visual disability in glaucoma. 
However, some authors indicate that both glare disability and dark adaptation, as 
well as stereoacuity may be compromised in glaucoma (55 -57, 59). It may be an 
important finding from the patient's point of view, as a lot can be done in order to 
minimise the effect of glare in the environment. Information can be given to the 
patient which also influence his behaviour so that he /she takes precautions when 
driving or carrying out other activities where glare is unavoidable. 
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10.4 Consequences for Clinical Management and Enhancement 
of Quality of Life of a Patient with Glaucoma 
In traditional clinical practice, optic disc appearance, perimetric findings, Snellen 
visual acuity and side -effects of treatment have been used to monitor and 
evaluate the success or failure of different treatment methods for glaucoma. Of 
these clinical outcome measures, visual acuity testing may be the most important 
indicator of day -to -day functioning (228). Several authors have asserted that 
visual acuity, even when supplemented by other measures of visual functioning, 
may be inadequate as an indicator of degree of visual impairment, because it does 
not tell what patients can expect to accomplish with their residual vision (229, 230). 
The patient's self- assessment provides information on direct visual 
limitations consequent to the disease (131) and therefore, may be a more pertinent 
measure of visual functioning (63, 231). Sherwood et al suggest that information 
about purely physiologic results is inadequate when a physician and patient 
make decisions about treatment options that are comparable in their therapy 
effects but have different impacts on the patient's health- related quality of life 
(63). At this point it becomes important to consider global health issues as well as 
vision - specific quality of life. Thus, showing a way to improve the quality of life 
of a patient may become a key measure of success of a treatment, just as 
important as the traditional clinical outcome measures (63). In addition, in the 
context of managed healthcare, many patients, doctors, researchers and 
policymakers may require information that goes beyond traditional biologic and 
physiologic outcomes (63). A questionnaire designed to investigate visual 
disability and indicate a level of quality of life is the tool needed to fill an existing 
gap. Research investigations on subjective aspects of visual function and quality 
of life in patients with glaucoma has been initiated only recently and the work of 
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Sherwood et al (63), Parrish et al (136) and Gutierrez et al (135) as well as ours has 
attempted to establish correlations between visual disability/quality of life and 
clinical indicators. It is encouraging that similar conclusions have been drawn 
from these few studies. 
Zimmerman et al pointed out the other issues that were important in the 
relationship between visual disability and clinical measures: "Is a nasal step in 
one eye visual disability? Bjerrums in both eyes? Field defects within 10 degrees 
of fixation? Some guidelines speak to this but, these need to be refined 
specifically for glaucoma... "((2), p.153). And more questions could be asked: "How 
much vision does the average glaucoma patient have left? How much vision is 
lost per year by the average patient in the entire sighted glaucoma population or 
some subpopulation ? ", etc. In our study we attempted to answer some of these 
questions at least to the extent of comparing patients with mild, moderate and 
severe visual field loss as, to our knowledge, no previous study documents this 
relationship. The conclusion from our study suggests that patients may progress 
up to moderate stage of the disease without experiencing much disability in their 
every day life. It is good news for the patients' prospect of retaining 
independence, mobility and all aspects of daily living functioning. However, 
visual function tests show a gradual decline in various aspects of visual function 
and it is important to find out how much remaining vision can compensate for lost 
parts of visual field in relation to day -to -day functioning and particularly, driving. 
Johnson and Kellner, through their study with the California motor vehicle 
department, showed more violations and accidents in people with visual field 
defects (120). As this issue is so important for preserving one's independence, it 
would be useful to know where is the borderline between visual defects that lead 
to visual disability and visual defects which can be compensated by the 
remaining vision. A lot more research work will have to be done before we are to 
address what constitutes true visual disability in glaucoma. 
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From the patient's point of view, knowledge of difficulties may also provoke 
more responsible behaviour when driving or performing other potentially 
hazardous activities. On the other hand information about difficulties experienced 
by the patients suffering from glaucoma may initiate environmental changes 
being carried out in homes of visually impaired people, eye hospitals and in public 
areas to prevent accidents and increase comfort levels for those who suffer from 
glaucoma. For example, if dark adaptation and glare disability are affected in 
glaucoma, design of an interior should prevent rapid changes in lighting levels, 
avoid or diminish glare problems by increasing brightness levels in dark areas like 
staircases with narrow windows that can be a source of disability glare. It is also 
possible to design window positioning, large glass and mirror areas in accordance 
with having glare in mind. Dark walls can be repainted pale, curtains changed or 
blinds installed. All these simple measures can help to alleviate the problem (208). 
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10.5 A Way Forward ... 
Ageing of the population is becoming an increasingly important factor in quality - 
of -life studies because although most elderly people continue to live 
independently, it was reported that over 40% of people over 65 experience 
difficulty in performing their usual daily tasks as a result of age -related chronic 
disorders (105). 
Primary open angle glaucoma is a chronic disorder predominantly affecting 
the population aged 65 and over. World -wide, glaucoma is ranked as the third 
greatest cause of visual impairment, and blindness affects an estimated 5.2 million 
people (63). In economically prosperous countries it is the second commonest 
cause of blindness. Glaucoma causes irreversible visual field damage and 
measurable deterioration in many aspects of visual function, however in most 
cases good central vision is retained for many years. Little is known about visual 
disability resulting from glaucoma. 
One of the new findings coming out from this study on glaucoma was the 
relationship between visual disability and the dark adaptation/glare disability 
function. Only a few research groups have investigated visual disability in 
glaucoma and hardly any research work has been done which specifically 
addresses disabling glare in glaucoma. Our results show that glare disability is one 
of the most frequently reported problems experienced by patients. Furthermore, 
perceived glare and objectively measured glare disability were the most important 
factors in significantly discriminating between patients with different levels of 
visual field loss. 
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Learning from the Present Study ... 
We would like to draw attention to several points that are important when 
considering future research work. 
When examining glare disability, it is vital to isolate the effects of pre - 
receptoral light scatter caused by even minor, clinically non -significant cataract. 
This is very difficult to achieve. After excluding any subjects with clinically 
significant cataract only a few options remain. In this study, we only included 
subjects above a cut -off point for distance visual acuity (Snellen visual acuity 
6/12 or better in each eye). Some studies choose to statistically adjust formula for 
differences in visual acuity while enrolling subject with visual acuity below 6/12 
(136). Gutierrez et al (135) used a cataract Lens Opacities Classification System II 
(232) grade of 1 or less as the inclusion criterion for patients with nonvisually 
significant cataract. 
Similarly, patients who have undergone trabeculectomy may develop 
peripheral iridectomy which may increase the amount of scatter entering the eye. 
In this study we did not consider this influence and therefore some patients may 
have been included with peripheral iridectomy. 
Local ophthalmic medication may in some cases result in visual disturbance 
(see chapter `Visual Disturbance Due to Treatment'). Transitory reductions in 
visual acuity caused by ciliary spasm following the instillation of Pilocarpine have 
been well documented (23, 24). Ideally, patients on Pilocarpine should also be 
excluded. This was not possible in our study and we aimed for non - significant 
differences between patient groups and statistical adjustment for this influence. 
However, the group with severe visual field loss had a slightly higher proportion 
of patients on Pilocarpine (Table 9). 
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Snellen visual acuity was used in this study because of its value as a 
clinical measure, however the Bailey -Lovie chart is more reliable instrument (65, 
87). 
Differences in visual field loss pattern between normal- tension and high - 
tension glaucoma should not be overlooked (233). Visual field defects in normal - 
tension glaucoma are relatively more localized and closer to fixation (233). As a 
result, normal- tension glaucoma patients could experience increased visual 
disability in central vision activities. In this study central vision seemed to play a' 
relatively important role. Was it because of a lack of correction for refractive error 
in the daily lives of patients or was it due to the proportion of normal- tension 
glaucoma subjects in our sample? Further studies should consider these 
possibilities 
The Brightness Acuity Tester is a tool designed for monocular testing and 
therefore we had to use transformation formula (225) for glare disability results. 
Although certain techniques of converting monocular data to binocular results 
have been advocated (225), we would recommend that where a study is focusing 
on actual quality of life of patients, binocular measures would be preferred 
wherever possible. 
The definition adopted for grouping of our glaucoma patients into three 
categories with mild, moderate or severe visual field loss was strongly correlated 
(r =0.95, p <0.001) with the technique recommended by Johnson and Nelson - 
Quigg for prediction of binocular sensitivity from monocular data (225). At the 
same time a system of grouping into three categories was recommended by 
professional statisticians for analytical purposes (Dr. Bruce Worton, Department 
of Statistics, University of Edinburgh). However, for the purpose of comparison 
with other studies, the Esterman Disability Rating (145) or AGIS system (234) are 
more suitable alternatives. 
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A Way Forward ... 
On the basis of the pilot work published in this thesis we applied for research 
funding for a project that would explore this subject in greater detail. This 
research funding was approved by the Engineering and Physical Sciences 
Research Council for a project duration of three years. 
The title of this new research work is: "Glare disability and its practical 
consequences in patients with glaucoma ". The purpose of the study is: 
to confirm the relationship between glare sensitivity and field loss in glaucoma 
to quantify self -reported glare sensitivity by objective assessment of glare 
to identify those situations of primary concern to patients in relation to glare 
disability and give advice on minimising glare effects 
In the first phase of the proposed study specific lighting situations giving rise to 
glare will be identified and measured. Glare sensitivity will be objectively 
measured in relation to other aspects of visual function including field loss. 
Finally patients will be invited to set preferred lighting for different tasks so that 




Questionnaire used in the pilot study 
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Glaucoma Clinic (Dr. Colm O'Brien), Edinburgh 1996 
Vision Disability Questionnaire 
We are carrying out research aimed at finding out more about everyday problems 
of people with visual impairment. Please help us in this and answer to the 
questions about the problems your vision gives you in particular tasks. 
Age: Gender: M F 
GI) Although you may be attending the clinic on a regular basis ire 
you aware of any aspect of visual loss? (Please circle the appropriate 
answer.) 
none 1 little 2 some 3 large loss 4 severe loss 5 
G2) If yes, which eye is it? right I left 2 both 3 
In general, to what extent does your vision give you difficulty 
in carrying out the following activities? 
Please, say whether you do not have difficulty at all [1], or whether you have a little bit of 
difficulty [2], some difficulty [3], quite a lot of difficulty [4], severe difficulty [5] or whether 








severe don't do 
for other 
reasons 
G3) Your usual daily activities 1 2 3 4 5 0 
G4) Problems in every day activities 
when working under dim light 1 2 3 4 5 0 
G5) Indoor mobility 1 2 3 4 5 0 
G6) Outdoor mobility 1 2 3 4 5 0 
G7) Does glare give you any difficulty 
in your usual daily acti vides 1 2 3 4 5 0 
Does your vision give you any difficulty with? 
If you usually carry out the particular activity with your glasses on 
answer our question as if you had your glasses on, please. 
not a little some 
at all bit 
1) Seeing things because they 
quite 
a lot 
severe don't do 
for other 
reasons 
appear hazy or washed out 1 2 3 4 5 0 
2) Adjusting to bright lights 1 2 3 4 5 0 
3) Adjusting to dim lights 1 2 3 4 5 0 
4) Do you notice any variation in colour richness 
from time to time 1 2 3 4 5 0 
5) Going from dark to light room 
or vice versa 1 2 3 4 5 0 









severe don't do 
for other 
reasons 
7) Washing yourself 1 2 3 4 5 0 
8) Seeing food on a plate 1 2 3 4 5 0 
9) Cooking and preparing food 1 2 3 4 5 0 
10) Cleaning up Ind housework 1 2 3 4 5 0 
11) Recognising faces 1 2 3 4 5 0 
12) Seeing facial expressions 1 2 3 4 5 0 
13) Walking on uneven ground 1 2 3 4 5 0 
14) Seeing the edges of outside steps, 
kerbs or stairs 1 2 3 4 5 0 
15) Bumping into people or things 
off to the side 1 2 3 4 5 0 
16) Tripping over things 1 2 3 4 5 0 
17) Objects suddenly appear when you 
should have noticed them before 1 2 3 4 5 0 
18) Judging distance of foot to 
kerb or stair 1 2 3 4 5 0 
19) Judging distance of objects 1 2 3 4 5 0 
20) Moving in unfamiliar places 1 2 3 4 5 0 
21) Going out in the street 1 2 3 4 5 0 
22) Crossing the road 1 2 3 4 5 0 
23) Seeing moving vehicles 1 2 3 4 5 0 
24) Reading shop, street or traffic 
signs while walking 1 2 3 4 5 0 
25) Walking in the dark 1 2 3 4 5 0 
26) Seeing distant objects at night 1 2 3 4 5 0 
27) Shopping, reading price labels 
and instructions on packets etc. 1 2 3 4 5 0 
28) Making phone calls 1 2 3 4 5 0 
29) Going by bus and train 1 2 3 4 5 0 
30) Reading newspapers, magazines 
or books 1 2 3 4 5 0 
31) Reading small print 1 2 3 4 5 0 
32) Reading in dim light 1 2 3 4 5 0 
33) Following the line of print or 
finding the next line 1 2 3 4 5 0 
34) Reading or writing letters 1 2 3 4 5 0 
35) Watching television 1 2 3 4 5 0 
36) Reading TV text (subtitles) 1 2 3 4 5 0 
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Does your vision give you any difficulty with: 
not a little some quite severe don't do 
at all bit a lot for other 
reasons 
37) Seeing photos and pictures 1 2 3 4 5 0 
38) Doing needlework 1 2 3 4 5 0 
39) Seeing views 1 2 3 4 5 0 
40) Seeing flowers 1 2 3 4 5 0 
41) Gardening 1 2 3 4 5 0 
42) Going to restaurants 1 2 3 4 5 0 
43) Visiting friends 1 2 3 4 5 0 
44) Does your vision hinder you in any other activities? yes no 
If yes, what is it? 
How much does your vision hinder or limit you in this? 
not a little some quite severe don't do 
at all bit a lot for other 
reasons 
1 2 3 4 5 0 
Falls and fear of falling: 
F1) Have you fallen in the last 12 months? 
yes no 
F2) In the last 12 months have you ever been anxious or worried about falling 
or been aware of being frightened of falling? This may or may not be 
associated with a feeling of unsteadiness. 
yes no 
Would you, please, tell us how confident you feel in carrying out 
the following tasks. Please circle your answer on one of the five 
points of the scale from very confident [1] to not confident at all [5]. 
Cl) Getting dressed very confident 1 2 3 4 5 not confident at all 
C2) Cooldng and preparing food 1 2 3 4 5 
C3) Cleaning up and housework 1 2 3 4 5 
C4) Recognising faces 1 2 3 4 5 
C5) Walking on uneven ground 1 2 3 4 5 
C6) Walldng on outside steps, 
kerbs or climbing stairs 1 2 3 4 5 
C7) Judging distance of foot to 
kerb or stair 1 2 3 4 5 
C8) Judging distance of objects 1 2 3 4 5 
C9) Moving in unfamiliar places 1 2 3 4 5 
C l0) Going out in the street 1 2 3 4 5 
C11) Crossing the road 1 2 3 4 5 
C12) Reading shop, street or traffic 
signs while walking 1 2 3 4 5 
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C14) Shopping, reading price labels 
a 
and instructions on packets etc. 1 2 3 4 5 
C15) Going by bus and train 1 2 3 4 5 
C16) Reading newspapers, magazines 
or books 1 2 3 4 5 
C17) Doing needlework 1 2 3 4 5 
C18) Going to restaurants 1 2 3 4 5 
C19) Visiting fnénts- 1 2 3 4 5 
G8) In general, how much trouble do you have with your vision? I_=s i 
none, a little, some amount, quite a lot or a great deal? 
none 1 little 2 some 3 quite a lot 4 great deal 5 
Please, answer the foIIowing questions only if you drive a car or have 
driven one but had to give up driving because of problems with your 
eyesight. 







severe don't do 
for other 
reasons 
DI) Vehicles appearing unexpectedly 1 2 3 4 5 0 
D2) Other vehicles appearing to go 
too fast 1 2 3 4 5 0 
D3) Driving towards the sun 
or oncoming headlights 1 2 3 4 5 0 
D4) Difficulties with reading 
road signs 1 2 3 4 5 0 
D5) Problems when reversing 1 2 3 4 5 0 
D6) Driving at night 1 2 3 4 5 0 
D7) Seeing distant objects at night 1 2 3 4 5 0 
D8) Reading the instrument panel 
at night 1 2 3 4 5 0 
D9) Have you driven more carefully since you became 
aware of visual impairment? 
not at all /1 a little bit /2 some /3 quite a lot /4 extremely /5 
D10) Have you changed the distance that you leave between your own car and 
the car in front when driving since you became aware of visual 
impairment? . 
not at all /1 a little bit /2 some /3 quite a lot /4 extremely /5 
D11) If you have stopped driving because of the problems with your vision, 
please tell us how long ago it was: 
When you have finished, please, leave this questionnaire at the 
reception desk. Thank you very much for all your effort and help. 
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APPENDIX II 
Questionnaire used in the main study 
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Dear 
We would like to thank you very much for your decision 
to help us in our research aimed to help people with 
glaucoma in their everyday life. 
Enclosed is a questionnaire that is crucially important 
for finishing our research study. Please, complete it 
carefully giving yourself a plenty time, probably up to 
30 minutes. 
Thank you for your kindness. 
Yours sincerely 
Patricia Nelson 
(Research Assistant to Dr. O'Brien) 
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VISION DISABILITY QUESTIONNAIRE 
Glaucoma Clinic (Dr. C O'Brien) 
This questionnaire is confidential and no information from it \vill b 
passed on under any circumstances. 
Please, give yourself plenty time to complete this questionnaire 
probably '30 minutes. 
We are carrying out research aimed at finding out more about everyda,, 
problems of people with visual impairment. Please help us in this anc 
answer the questions about the problems your vision gives you it 
particular tasks. Please, circle the aoorooriate answer. 
ID: Age: Gender: M F 
1) in general, how much trouble do you have with your visior 
in your daily life? Is it none, a little, some amount, quite 
a lot or a great deal? 
none 1 little 2 some 3 quite a lot 4 great deal 5 
2) Have you noticed any deterioration of your vision over 
the last few years? 
none 1 little 2 some 3 large 4 severe 5 
3) If yes, which eye is it? 
right 1 left 2 both 3 
We are going to ask you about how much your vision gives you difficulty 
when carrying out particular tasks. Please, say whether you do not have 
difficulty at all [1], or whether you have a little bit of difficulty [2], 
some difficulty [3], quite a lot of difficulty [4] or severe difficulty [5]. 
If you do not do the particular activity for other reasons or health 
problems rather than your vision your answer will be [0]. 
If you usually carry out the particular activity with your glasses on then 
answer our question as if you had your glasses on. 
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PERSONAL CARE AND DOMESTIC TASKS 
Does your vision give you any difficulty with: 
not a little some quite severe don't do 
at all bit a lot for other 
reasons 
4) Indoor mobility 1 2 3 4 5 0 
5) Getting dressed 1 2 3 4 5 0 
and groomed 
6) Cooking and 
preparing food 1 2 3 4 5 0 
7) Pouring tea into a cup 1 2 3 4 5 0 
8) Gardening 1 2 3 4 5 0 
9) Shopping, reading price 
labels and instructions 
on packets, etc. 1 2 3 4 5 0 
10) Finding things that 
you have dropped 1 2 3 4 5 0 
GLARE, ADAPTATION AND COLOUR 
Does your vision give you any difficulty with: 
11) Adjusting to glare or being 
"dazzled" on sunny days 
or in bright lighting 1 2 3 4 5 0 
12) Adjusting to dim lights 1 2 3 4 5 0 
13) Going from dark to light room 
or vice versa 1 2 3 4 5 0 
14) Do you notice any variation 
in colour richness 
from time to time 1 2 3 4 5 0 
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NAVIGATION AND MOBILITY 
Does your vision give you any difficulty with: 
not 
at all 





severe don't do 
for other 
reasons 
uneven ground 1 2 3 4 5 0 
16) Difficulty on outside 
steps, kerbs or stairs 1 2 3 4 5 
17) Tripping over things 1 2 3 4 5 0 
18) Bumping into things 1 2 3 4 5 
19) Difficulty to see people 
or things coming from 
the side 1 2 3 4 5 0 
20) Judging distance of foot 
to kerb or stair 1 2 3 4 5 0 
21) Going out in the street 
on your own 1 2 3 4 5 0 
22) Crossing the road 1 2 3 4 5 0 
23) Going by bus and train 1 2 3 4 5 0 
24) Seeing bus numbers 1 2 3 4 5 0 
NAVIGATION AT NIGHT 
Does your vision give you any difficulty with: 
25) Walking in the dark 1 2 3 
4 5 0 
26) Seeing distant 
objects at night 1 2 3 
4 5 0 
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NEAR VISION 
Does your vision give you any difficulty with: 
not 
at all 





severe don't do 
for other 
reasons 
magazines or books 1 2 3 4 
5 0 
28) Reading or writing letters, 
cheques, mail etc. 1 2 3 4 5 
0 
29) Following the line of print or 
finding the next line 1 2 3 4 5 
0 
SOCIAL CONTACT, LEISURE ACTIVITIES, ETC. 







severe don't do 
for other 
reasons 
30) Recognising faces 1 2 3 4 5 
0 
31) Visiting friends, 
participating in church 
activities or in social 
and sports clubs 1 2 3 4 5 
0 
32) Seeing hymn numbers 
in the church 1 2 3 4 
5 0 
33) Seeing the activity at bingo, 
theatre, concerts, cinema 
and sports events 1 2 3 4 
5 0 
34) Watching television 1 2 3 
4 5 0 
35) Reading TV 
text (subtitles) 1 2 3 4 
5 0 
36) Doing needlework 1 2 3 
4 5 0 
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FALLS AND FEAR OF FALLING 
F1) Have you fallen in the last 12 months? Please, circle the right 
answer. 
yes n o 
F2) In the last 12 months have you ever been anxious or worried about 
failing or been aware of being frightened of falling? This may or 
may not be associated with a feeling of unsteadiness. 
yes no 
GENERAL HEALTH 
H1) Apart from the difficulties with your vision would you say your 
health is: 
excellent 1 very good 2 good 3 fair 4 poor 5 
H2) How much pain in your body have you had during past 4 weeks? 
none 1 very mild 2 mild 3 moderate 4 severe 5 
Apart from the difficulties with your vision, does your health 
limit you in any of the following activities? Please, say whether 
you are "not limited at all" [1], "limited [2] or 
"limited a lot" [3]. 
no, not limited yes, limited yes, limited 
at all a little a lot 
H3) Moderate activities (moving 
a table, pushing a vacuum cleaner, 
carrying groceries, bowling 
or playing golf). 1 2 3 
H4) Climbing several flights of stairs. 1 2 3 
H5) Walking more than a mile. 1 2 3 
H6) Walking 100 yards. 1 2 3 
H7) Eating, dressing, bathing 
or using the toilet. 1 2 
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For each of the following questions, please circle th 
one answer that comes closest to the way you have beer 
feeling during the past month. 
Our question is how much of the time in the oast month you have been 
feeling in a certain way. Your answer can be either "none of the time" 
[NT], "little of the time" [LT], "some of the time" [ST], " a good bit of 




M1) Have you been a very 
LT ST 
Little of Some of 
the time the time 
GET 
A good bit 







nervous person? 1 2 3 4 5 6 
M2) Have you felt downhearted 
and low? 1 2 3 4 5 6 
M3) Have you been 
a happy person? 6 5 4 3 2 1 
M4) Has your health limited 
your social activities 
(like visiting friends 
or close relatives) ? 1 2 3 4 5 6 
M5) Do you find your visual condition irritating? Please, 
circle the appropriate answer. 
not at all 1 quite a lot 4 
a little bit 2 great deal 5 
moderately 3 
M6) Do you find taking your eye drops a burden? 
not at all 1 quite a lot 4 
a little bit 2 great deal 5 
some 3 
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FEELINGS AND ATTITUDES 
I would like you to read the following statements and tell me whether 
you oersonaly agree or disagree with them on a scale from strongly 
agree to strongly disagree. You can respond with "strongly agree" [SA], 
"agree" [A], "neutral" [N], "disagree" [D], "strongly disagree" [SD] or 
"do not know ". 
SA A N D SD do not 
know 
Fl) I am able to do things as well 
as most other people. 1 2 3 4 5 0 
F2) I have little or no control over 
my progress from now on. 5 4 3 2 1 
F3) In spite of my eye problem 
I don't feel too miserable 
most of the time. 1 2 3 4 5 0 
F4) My eye problem is so annoying 
that I can't enjoy anything. 5 4 3 2 1 0 
F5) When I make plans, I am certain 
that I can make them work. 1 2 3 4 5 0 
F6) If something looks too complicated, 
I will not even bother to try it. 5 4 3 2 1 0 
F7) Most of my life gets spent doing things 
that are relatively worthwhile. 1 2 3 4 5 0 
F8) I really look forward 
to each new day. 1 2 3 4 5 0 
Al ) Visually impaired people 
are used to succeeding at 
most things that they do. 1 2 3 4 5 0 
A2) Most visually impaired people are 
dissatisfied with their life. 5 4 3 2 1 0 
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